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 ABSTRACT 
Plant growth and development, much like in animals, is a highly-coordinated 
process of cell division and differentiation which generate new cell types and tissues. 
Receptor kinases respond to extra-cellular cues and mediate appropriate downstream gene 
expression through auto and trans-phosphorylation events. Arabidopsis CRINKLY4 
(ACR4) is a plasma membrane localized receptor-like kinase that plays an important role 
in formative cell division and stem cell differentiation in root tip and initiates lateral root 
development in Arabidopsis. The Arabidopsis genome also encodes four homologs of 
ACR4, referred to as Arabidopsis CRINKLY4 Related (AtCRR) proteins. ACR4 and its 
homologs have equivalent architecture, comprised of an extracellular ligand binding 
domain, a transmembrane helix, and an intracellular kinase domain. Cell biology, genetic 
and in vitro biochemical studies have indicated potential interaction partners within the 
ACR4 family. However, very little is known of the ACR4 mediated network of interactions 
and the molecular mechanism of its regulation. 
In this dissertation, we report the identification of the catalytic subunit of Protein 
Phosphatase 2A-3 isoform (PP2A3c) as the first known substrate for the kinase activity of 
ACR4 and ACR4-homolog CRK1. We provide evidence of a regulatory reciprocal 
interaction between the catalytic subunit of PP2A3c and ACR4, with PP2A3c serving the 
dual role as a substrate for ACR4 kinase and as a regulatory phosphatase in modulating 
kinase activity.  To further advance in vitro biochemical and biophysical studies on the 
regulation of phosphatase activity, we describe expression and purification of MBP-tagged 
PP2A3c in E. coli. We demonstrate slow activation of phosphatase activity of PP2A3c over  
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time and further demonstrate the ability of the PP2A chaperone, PTPA, to more rapidly 
activate phosphatase activity in trans, in the presence of ATP. We provide a biochemical 
context to these results and the usefulness of our system in investigating the role of post-
translational modifications.  Additionally, we have characterized the biochemical 
properties of the recombinantly expressed intracellular kinase domain of the ACR4 
homolog, CRK1. The in-planta expression of this RLK in the cells of the root tip overlaps 
the expression pattern of ACR4 and PP2A and we demonstrate that PP2A3c is also a 
substrate for CRK1. Mass spectrometry analysis confirmed >30 sites of phosphorylation at 
Serine, Threonine and Tyrosine residues, spanning the entire intracellular domain of 
CRK1. Mutagenesis experiments identified phosphorylation sites within the activation 
loop that had both positive and negative effects on the kinase activity of CRK1. Finally, 
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CHAPTER 1: GENERAL INTRODUCTION 
  In response to extra-cellular stimuli both plant and animal cells have developed 
mechanisms to cope with the extremes of environmental changes. Cells utilize diverse 
enzymes to modulate cellular activities and maintain homeostasis. Reversible protein 
phosphorylation, mediated by kinases and phosphatases, is one of the major molecular 
mechanisms that regulate protein function and maintain the cellular well-being in response 
to the external cues. Phosphorylation is a covalent post-translational modification in which 
protein kinases catalyze the transfer of g phosphate group from ATP to the hydroxyl group 
of serine, threonine and tyrosine residues on its substrate and protein phosphatases 
hydrolyze the phospho-ester bond to generate free phosphate and dephosphorylated 
protein. In eukaryotic cells, the occurrence of phosphorylation is most commonly seen on 
serine (84-86%) followed by threonine (10-20%) and tyrosine 2–4% [1,2,3,4,5]. 
Almost, one-third of the cellular activities such as cell cycle progression, metabolic 
activity, ion-transport, developmental growth and, stress response is regulated by 
reversible phosphorylation [6,7]. Phosphorylation regulates protein function by triggering 
an allosteric conformational change, disruption and/or creation of interaction sites for other 
proteins [8,9,10], regulation of the sub cellular localization and turnover of its target. 
Protein phosphorylation and dephosphorylation, is by far the most prevalent and 
extensively studied post-translational modification amongst £200 different post-
translational modifications (PTM) including but not limited to ubiquitination, methylation 
and acetylation[11].  The rapid reversible nature, small metabolic cost and the ability to 
regulate function of target proteins [12], are important attributes of these protein 
modifications. As in mammalian systems, receptor like kinases (RLK) in plants mediate 
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downstream signal transduction which guide a host of cellular responses such as cell 
growth, proliferation and differentiation [13,14].  
 
Dissertation Organization 
This dissertation is organized into six chapters.  Chapter 1 briefly reviews the 
current state of knowledge of plant receptor-like kinases in general, the role of ACR4 and 
homologs and the emerging importance of PP2A as a major regulator of receptor function.  
Chapter 2 has been published in the Proceedings of the National Academy of Sciences, 
USA [15] in a collaborative study and my contribution as a first author is summarized.  
This paper for the first time describes the characterization of PP2A3c as a substrate for 
ACR4 and a regulator of formative cell division in the Arabidopsis root.  Chapter 3 is a 
manuscript that has been prepared for publication and describes the expression and 
purification of MBP-tagged PP2A3c and the activation of phosphatase activity in trans via 
the protein chaperone PTPA. Chapter 4 is prepared as a manuscript describing the 
characterization of the SUMO-tagged intracellular kinase domain of the ACR4 homolog, 
CRK1. This includes characterization of basic kinetic properties, the role of 
phosphorylation sites in the activation loop through mutagenesis studies and interaction 
with PP2A3c. Chapter 5 describes the path to the generation of a monoclonal antibody to 
the kinase domain of ACR4 and its value as a reagent for in vivo biological studies.  Lastly, 
Chapter 6 is a general conclusion that draws together the work described in the previous 
chapters and outlines potential future directions.
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Literature Review 
Plant receptor-like kinase (RLK) 
Plant RLKs represent one of the largest family of plant kinases [16] with more than 
600 RLKs present in the Arabidopsis genome representing 2.5% of the known coding 
sequences [14] and 60% of the total kinases encoded  [17]. Unlike animals, the absence of 
an “immune system” and the inability to be mobile, has led to the development of strategies 
to combat diverse environmental challenges and attacks by pathogens and insects.  The 
Leucine Rich Repeat domain (LRR)- RLKs represent the largest group of plant receptors 
with more than 200 members [18]. The LRR-RLKs interact with a wide array of proteins 
allowing for combinatorial variations in signal response specificity. Importantly, RLK 
mediated signaling plays a cardinal role in pathogen recognition followed by activation of 
plant defense mechanisms and developmental control [19].  
Architecturally, plant RLKs much like animal RTKs, are single transmembrane 
signaling protein, includes an extracellular ligand domain, a transmembrane domain and 
an intracellular protein kinase domain [16,20]. The extracellular domain perceives the 
extracellular ligand and the intracellular kinase domain mediates signal transduction [21]. 
The intracellular kinase domain further undergoes auto/trans-phosphorylation to form an 
active complex which elicits an amplified extracellular signal intracellularly by recruiting 
and phosphorylating the cytoplasmic downstream protein target [22,23,24,25]. The 
phosphorylated effector proteins can then affect gene transcription within the nucleus. 
Plant RLKs activate diverse signal transduction pathways, including those that control 
hormonal responses [26,27,28,29,30,31], flower development [32,33], innate immunity 
against bacterial pathogens [34], self-incompatibility [35], and root nodule formation 
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[36,37,38,39,40,41]. RLKs such as CLAVATA1, Brassinosteroid- insensitive 1(BRI1) and 
erecta regulate the development process [14,42], FLS2 and Xa21 mediate plant defense 
[14,42], HAESA regulates floral organ abscission and SYMRK manages root symbiosis 
with nitrogen-fixing bacteria or phosphate-acquiring arbuscular mycorrhizal fungi [21].  
Brassinosteriod-insensitive1 (BRI1) is one of the best characterized RLKs and 
serves as an ideal paradigm of our understanding of receptor activation and regulation in 
plants. Brassinosteriod, a steroid hormone acts as a ligand to BRI1, which on binding 
activates the hetero-dimerization of BRI1 with its co-receptor BAK1, and initiates 
intracellular signaling cascade involving recruitment and activation of membrane-localized 
kinases BSK1 and BSK2 [43], a protein phosphatase BSU1 [43,44], the cytoplasmic kinase 
BIN2 [45], and transcription factors BZR1 and 2 [45,46,47]. However, in the absence of 
BR stimulation, BRI activity is auto-regulated by inactive homo-dimerization [48,49] and 
interaction with inactive kinase inhibitor (BK1)[50]. In presence of low BR, BIN2 kinase 
phosphorylates and inactivates BZR1 transcription factor which in-turn inhibits the plant 
growth. However, a recent study describes the PP2A mediated dephosphorylation of the 
phosphorylated BZR1 [51,52] and highlights the earlier reports regarding the regulation of 
BR signaling by PP2A phosphatase activity [51,52]. In Arabidopsis, the initiation of BR 
mediated BRI1 signaling increased mRNA expression levels of sbiI (suppressor of bri1) 
which encodes a Leucine Carboxy-Methyl Transferase (LCMT), known to methylate 
PP2A and control its membrane associated localization. The degradation of the BRI1 by 
PP2A mediated dephosphorylation, requires its association with BRI1 on the membrane, 
which is driven by methylation of PP2A via sbiI (LCMT). Hence, PP2A is hypothesized 
to inactivate the BRI1 signaling by means of internalization [53].   
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Arabidopsis Crinkly4 (ACR4) 
Arabidopsis CRINKLY4 (ACR4, At3g59420) is an ortholog of maize CRINKLY 
4 ZmCR4.  ZmCR4 encodes gene for proper differentiation of epidermal tissues in aerial 
organs of plant. It regulates the epidermal cell specification and morphology in leaves and 
kernel [54,55]. ACR4 is important for the overall development of plant and thus is globally 
expressed in the plant. In aerial organs, ACR4 is present in the L1 layer of shoot apical 
meristem, ovule integuments, and epidermal layer of leaves [56,57,58] and, in roots, it is 
expressed in the quiescent center (QC), underlying columella cells and the flanking cells 
of the lateral root cap [57,59,60].  
The root and shoot system of plants originate from the root apical meristem (RAM) 
and the shoot apical meristem (SAM) respectively. On embryogenesis, pollen sperm cell 
fertilizes the female gametophyte [61] followed by post embryonic stages of development, 
where two polar stem cells niche flourish into the root and shoot apical meristem [62,63]. 
Root apical meristem (RAM) has a centrally located quiescent center (QC), composed of 
rarely dividing cells which signal to maintain a strict control of stem cell population in the 
undifferentiated state. Stem cell division give rise to daughter cells distal to quiescent 
center and the surrounding mature differentiated cells then stimulate daughter cells to 
differentiate into appropriate cell type [64,65]. Columella cells (CC) originate from 
differentiation of columella stem cells (CSC) present below the quiescent center. The CSCs 
differentiation leads the daughter cells to differentiate into columella cells, at a proper 
signal from underlying CCs [60,64,66,67]. 
ACR4 mediates columella stem cell differentiation in the root apical meristem 
(RAM) and is essential for proper lateral root formation. The RLK mediates the 
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differentiation of columella stem cells (CSC) into columella cells (CC) which when 
disrupted cause proliferation and disorganization of CCs in the root tip [59,60]. 
Additionally, double and triple mutants within ACR4 family have displayed increased 
lateral root meristems suggesting functional redundancy within ACR4 family of RLKs 
[56,59]. 
ACR4 is a single transmembrane RLK with the extracellular domain (ECD) ligand 
binding domain, made of 39 amino acid long seven repeat regions, followed by three 
cysteine-rich regions similar to the tumor necrosis factor receptor (TNFR) ligand binding 
domain. The single alpha helical transmembrane domain connects the ECD to the 
intracellular domain (ICD). The ICD of ACR4 is composed of juxta membrane (JMD) and 
the C-terminal (CTD) subdomains, flanking the core kinase domain (KD). The intracellular 
domain of ACR4 has been demonstrated to possess intrinsic kinase activity [56,57,58].  In 
vitro biochemical/biophysical studies of ACR4 have provided valuable insights to the 
properties of the kinase domain [68]. Investigation of specific phosphorylation sites in the 
JMD domain by means of phage display and peptide binding assay suggested a model for 
potential phosphorylation dependent intra-molecular interaction between phosphorylated 
JMD peptide and kinase domain through a ‘LXXLL’ motif [69] and potential inter-
molecular interaction between ACR4 and its homologs CRRs by the same motif [70].] 
Homologs of ACR4 
Arabidopsis genome encodes four homologs of ACR4, designated as 
AtCRR1(At3g09780), AtCRR2 (At2g39180), AtCRR3 (At3g55950) and AtCRK1 
(At5g47850), that share sequence similarly and architectural features analogous to ACR4 
[56,57,58] (Figure 1). Amongst the four homologs, AtCRK1 and AtCRR3 are kinase 
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active, but lack the TNFR like repeats in the extracellular domain. AtCRR1 and AtCRR2 
are intrinsically dead kinases owing to the absence the domain VIII in activation loop [56]. 
acr4 knockout plants showed similar phenotypic effects like cr4 mutant with 
developmental defects in integuments and seed coat but with no evident defects in embryo 
morphology, suggesting functional redundancy amongst the CRR family members [57].  
Meyer et al [70] have previously demonstrated the intermolecular interactions 
between the intracellular domains of ACR4 and the homologs and also used the mRNA 
co-expression analysis tool within CORNET 2 (https://cornet.psb.ugent.be/) [71,72] to 
show overlapping and comparable mRNA expression levels of the groups of RLKs in the 
quiescent center, lateral root cap, root tip, root cortex and columella root cap cells, 
consequently spanning the entire RAM. The co-expression of these genes is a strong 
indicator of potential overlapping function and in vivo interaction. CRRs may have the 
ability to compensate for the loss of ACR4 function in lateral root initiation with 
significantly enhanced density of lateral roots in acr4/crr triple mutant background much 
different from acr4 single mutant plant [60]. Additionally, hetero-dimerization of ACR4 
and CLAVATA1 (CLV1) has been reported to regulate the maintenance of root meristem 
and collectively restrict root stemness at the root tip [73]. CLV1 is an essential RLK, 
required for shoot stemness maintenance and a recent study described its ability to 
moderate root stemness in Arabidopsis through homo- and heteromeric interaction with 
ACR4.  Thus, heteromeric interaction of multiple RLKs driving a common signaling 
cascade, may be more common than the simplistic model of single receptor-single ligand 
driven downstream signaling. 
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Kinase domain structure and regulation  
Kinase enzyme catalyzes the transfer of g phosphate from adenosine tri-phosphate 
(ATP) molecule to serine, threonine and tyrosine amino acid in a specific substrate. 
Structurally the kinase domain folds into an N-terminal lobe predominantly composed of 
β- sheet and a C-terminal α-alpha lobe as described in the crystal structure of cyclic AMP 
dependent kinase [74,75,76]. The N and C terminal lobes create a pocket for active site of 
the kinase (Figure 2). The catalytic domain of kinase is subdivided into 11 distinct 
subdomains (Figure 3) with about 10 highly conserved residues/ motifs which contribute 
towards the kinase activity and stability. The b strands 1 & 2 in N-lobe host a Gly rich P –
loop which stabilizes the a and b phosphates of the bound ATP molecule. The conserved 
Lys in b strand 3 also helps to stabilize the a & b phosphates of ATP and form a salt bridge 
with invariant Glu residue in helix-C. C lobe is comprised of catalytic loop and activation 
loop. The catalytic loop present in the C lobe harbors HRD motif in which the aspartic acid 
functions as a catalytic base for the phospho-transfer reaction and chelates the Mg2+ ion 
bridging the a and g phosphate of the incoming ATP molecule. Mutation or loss of this 
aspartate causes complete inactivity of the kinase. Downstream to catalytic loop is the 
activation loop with two conserved DFG and APE/DPE motifs, which serve as hinge points 
for activation loop movement. The aspartic acid in DFG chelates Mg2+ ion and stabilizes b 
and g phosphates of ATP.  The APE/DPE motif act towards structural stability of the C-
lobe [76,77,78]. These conserved motifs and regions synchronize towards efficient 
phosphate transfer from ATP to the substrate molecule.
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Protein phosphatases: Regulators of protein kinases  
 Kinases and phosphatases mediate reversible protein phosphorylation and serve as 
an on-off switch controlling the cellular activities in eukaryotic cells [79]. Protein 
phosphatases are classified into five classes based on the primary sequence and catalytic 
mechanism: 1) PPP- Phospho-protein phosphatases, 2) PPM or PP2C- Metallo-dependent 
protein phosphatases, 3) PTP–phospho-tyrosine phosphatase, 4) Aspartate dependent 
phosphatases and, 5) DSP- Dual specificity phosphatases [5,80]. PPP and PP2C family of 
phosphatases comprise the largest family of well-studied phosphatases, catalyze 
dephosphorylation at serine & threonine residues, and are responsible for catalyzing about 
90% of the dephosphorylation reaction in eukaryotes [80,81]. PPP family is further divided 
into nine sub-classes: PP1 (protein phosphatase type one), PP2A (protein phosphatase 2A), 
PP4, PP5, PP6, PP7, SLP (Shewanella-like protein) phosphatase, and PPKL (protein 
phosphatase with Kelch-like repeat domains) [5]. Catalytically each member of the PPP 
family displays identical mechanism owing to the presence of highly conserved catalytic 
subunit throughout eukaryotes. 
Phosphatases in the PPP family conduct variety of biological and cellular functions 
in plants. PP1 along with its interactors mediate cell cycle regulation, cell division and 
patterning, cell differentiation, embryo development and cytokinin production. Protein 
phosphatase 2A (PP2A) has important role in growth and development [82,83], 
cytoskeleton structure formation [84], auxin transport [85,86], biotic and abiotic stress 
signaling [87], acid and ethylene signaling [88,89,90], light and abscisic acid (ABA) 
signaling, stomatal opening, and most notably, in brassinosteroid (BR) signaling [91]. PP6 
is involved in ABA signaling and maintenance of cell polarity, PP5 has roles in disease 
resistance, thermo-tolerance and light detection. PP7 has been involved in light sensing 
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and so far, no defined role is reported for PP4 in plants [5,81]. In humans, deregulation of 
PP2A has been associated with many debilitating diseases such as cancer [92,93,94,95], 
Alzheimer’s [96,97,98] and heart failure [94,99]. 
Protein phosphatase 2A: Structure, regulation and activation  
PP2A phosphatase is a heterotrimeric holoenzyme, comprised of highly conserved 
~ 36 kDa Catalytic ‘C’ subunit regulated by a ~65 kDa structural scaffold ‘A’ subunit, and 
together form the PP2A core protein (Figure 4A). This further interacts with a variable ‘B’ 
subunit which determines its substrate specificity and cellular localization. The sequence 
of ‘C’ and ‘A’ subunit is highly conserved through eukaryotes (Figure 5). 
In Arabidopsis, the phosphatases and kinases are disproportionately represented 
with ~150 protein phosphatases for ~1050 protein kinases [100,101]. Members of the PPP 
family have developed strategies to compensate for this disproportionality between kinase 
and phosphatases through specific interaction of catalytic subunit with varying regulatory 
subunits, specifically varying B subunits. This not only confers specificity towards its 
substrates but also allows for enormous substrate diversity. Arabidopsis has five genes for 
the catalytic C subunit (c1-5), three genes  for ‘A’ subunit (A1-3) where A1/RCN1 is 
encoded by the gene ROOT CURLS IN NAPHTHYLPHTHALAMIC ACID1 [85] and 
seventeen genes encoding for ‘B’ subunits [102], making a total of 255 possible 
combinations just within the PP2A subclass of PPP phosphatases.  
Crystal structure of heterotrimeric human PP2A [103,104,105] (Figure 4B) along 
with biochemical analysis have provided significant mechanistic understanding of PP2A 
function and assembly and, serves as framework for future studies amongst other 
eukaryotic phosphatases.  In mammalian cells, A/PR65 & C subunit each has two 
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isoforms a and b which share high sequence similarity, with a isoform present at higher 
abundance than b isoform [106,107,108,109]. The variable B subunit is subdivided into 
four families: B (PR55), B’ (B56 or PR61), B’’ (PR72) and B’’’ (PR93/PR110). The 
scaffolding A subunit contains 15 HEAT (huntingtin-elongation-A subunit-TOR) repeats 
made of conserved 39 amino acid residues. Each HEAT repeat consists of parallel a helices 
connected by an intra-repeat loop, and adjacent repeats are connected by inter-repeat loops. 
The catalytic subunit forms a compact ellipsoidal structure and recognizes one end of the 
elongated A subunit.  B (PR61/B56g1) subunit interact with the AC dimer on significant 
bending of HEAT repeats 12-15 towards the amino terminus of A subunit, which creates 
an interface of A-C interaction from HEAT repeat 2-7. A & B do not form a stable complex 
due to a relatively loose interacting interface. The B subunit has an elongated super helical 
structure comprised of 18 a helices, which fold like pseudo HEAT repeats, despite the lack 
of canonical HEAT repeat sequence. The B and C subunit dock on the apical side of the 
horse shoe A subunit and make extensive contacts between each other. In addition to these 
interactions, C subunit contains a highly-conserved C–terminal tail which docks on the 
interface of A and C subunit and reported to regulate the recruitment of B subunit by means 
of methylation of conserved carboxy- terminal leucine [110,111,112,113,114]. 
The active site of PP2Ac is structurally conserved throughout eukaryotes and is 
formed by protein loops connecting two central b sheets flanked by a helices. Six highly 
conserved residues on these loops, two aspartates (D), one asparagine (N) and, three 
histidines (H) coordinate the two catalytic metal ions and a catalytic water molecule. 
Incoming phosphorylated residues is coordinated by one conserved histidine and two 
arginine (R) residues. Dephosphorylation reaction proceeds through an Sn2 mechanism, 
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where activated water molecule carries out a nucleophilic attack on the incoming phosphate 
group attached to a Ser/Thr residue [115] (Figure 6). The active site conformation and its 
protein fold are reported to be highly dynamic in nature.  This is one of the reasons why all 
the crystal structures solved till date require potent inhibitors such as microcystin LR or 
okadaic acid for stabilization of the active site [104,105,116].   
Regulation of PP2Ac activity by post-translational modifications  
PP2A activity and holoenzyme assembly is highly-regulated by means of two 
important covalent post-translational modifications that occur on the conserved C-terminal 
tail “T304DPYGL309” of PP2A catalytic subunit namely:  Phosphorylation at T304 and 
Y307 [117] and, carboxy-methylation at C terminal Leu 309 [94,118]. 
Phosphorylation of Thr-304 & Try-307 residues in the conserved C-terminal tail 
is reported to be inhibitory to phosphatase activity [96,119,120]. Phosphorylation of these 
sites are regulated by PTB1, p60v-src and P56lck kinases [98,119,121,122]. The effect of 
the phosphorylation is generally thought to be inhibitory both in an in vivo and in vitro set 
up [122] although there are a few reports that suggest otherwise [96,119,123].  
 Carboxy-methylation is a reversible mechanism controlled by Leucine Carboxy- 
Methyl transferase (LCMT-1) and Phospho-Methyl Esterase (PME-1) [104,124]. The role 
of carboxy-leucine methylation towards phosphatase activity and holoenzyme assembly 
has been an open-ended question with contradictory results been reported by various 
groups.  Structural studies on mammalian PP2A has revealed the environment of C-
terminal leucine to be highly negatively charged, formed by three glutamic acid and one 
aspartic acid residue contributed by A subunit and an aspartic acid from C subunit. It is 
speculated that in the absence of C-terminal carboxy- methylation, the negative charge-
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charge repulsion does not favor the docking of C-terminal tail in this region and prevents 
binding of B subunit to the AC core enzyme [103]. In the crystal structure of PP2Ac with 
B/PR55 regulatory subunits, the interaction of PP2Ac with B/PR55 is suggested to be 
independent of methylation, with no indication of methylated C-tail present at docking site 
of C and B subunit [105,125]. On the other hand, methylation was reported to be important 
for PP2A core enzyme to interact with B’/PR61 and B’’/PR71 subunits 
[104,110,111,112,114,126,127]. However, in vivo, methylation of C-terminal leucine has 
been shown to be unequivocally critical for stable heterotrimeric PP2A assembly 
[93,118,128].  LCMT-1 binds directly to the active site residues and requires active 
conformation of PP2Ac subunit for methylation. Active PP2Ac selectively undergoes 
methylation and assembles into the holoenzyme, thereby minimizing the unregulated 
phosphatase activity of free C subunit [124].  PME-1 in addition to demethylation, also 
mediates PP2A inactivation by eviction of metal ions at the active site [104]. Methylation 
level of PP2A fluctuates throughout the cell cycle and knockdown studies describe LCMT-
1 to be essential for cellular functions, indicating that regulation of PP2Ac methylation and 
holoenzyme assembly is required for cell cycle regulation [94,114]. In Arabidopsis, 
LCMT-1 was reported to negatively regulate BRI1 signaling [52]. In melanoma tumor 
cells, methylation of PP2A was shown to tightly regulate the phosphatase activity [129] 
whereas, in a study reported by Ikehara et al [125], alanine and deletion mutants of Leu 
309 exhibited phosphatase activity indicating methylation to be irrelevant for phosphatase 
activity.   
Biogenesis of active PP2Ac by PTPA (Phosphatase Two A Protein Activator)  
The function and complete biogenesis of active PP2A heterotrimeric complex relies 
on proper activation of PP2A catalytic subunit (PP2Ac). Biochemical and structural studies 
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on mammalian PP2A has provided extensive understanding to a potential linear path 
towards generation of active PP2A in-vivo. Activation of PP2Ac facilitates carboxyl-
methylation of the C-terminal leucine and stable association of A subunit to form PP2A 
core AC dimer [6,124,130]. In a cellular environment, promiscuous activity of PP2A 
catalytic subunit (PP2Ac) is kept under control by interaction with stable latency factor a4 
[131], and/or PME-1 [95,128,132], which preferentially binds to partially folded PP2Ac 
by making contacts with both surface residues and inner structures of unfolded active site. 
(Figure 7)  
 PTPA, a phospho tyrosyl phosphatase activator/ phosphatase two A protein 
activator, is an essential protein involved in regulation of PP2A. PTPA is reported to 
possess an ATP –dependent activation energy [133,134] and a peptidyl-prolyl isomerase 
activity [135]. Together they drive activation of an inactive PP2A catalytic subunit. Crystal 
structure of PP2A-PTPA-ATPgS provide valuable insights to PTPA mediated activation of 
PP2A. The binding of PTPA stabilizes the inactive apo-PP2Ac conformation, orients 
phosphoryl groups of ATP molecule to PP2A active site, which selectively enhances 
binding and proper orientation of Mg2+ metal ions into the active site of PP2Ac, driving 
ATP hydrolysis and acquisition of phospho-serine/threonine activity. [133]. The structure 
reveals that the ATP hydrolysis requires both PP2A and PTPA to form an ATP binding 
pocket. PTPA is suggested to stabilize the dynamic and conformationally flexible active 
site of PP2Ac to a conformation suitable for phosphatase activation and methylation by 
LCMT-1[124]. Additionally, PTPA also interacts with the C-terminal tail of PP2Ac, 
phosphorylation of C-terminal tail at Ty307 and methylation at Leu309 was shown to 
abrogate this interaction with no effect observed when Thr304 is phosphorylated [117].  
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PTPA is also reported to have Peptidyl – Prolyl cis/trans isomerase (PPIase) 
activity which induces a reversible conformational change in PP2Ac at Proline190 [135]. 
Other PPIases such as cyclophilins or FKBPs cannot activate PP2A and underline the 
specificity of PTPA towards PP2A isomerization. The isomerization and activation energy 
of PTPA are correlated, since both are stimulated in the presence of Mg2+ and ATP. Proline 
isomerization is a rate –limiting step in protein folding and peptidyl prolyl isomerases 
catalyze the intrinsically slow proline isomerization property of proteins to much rapid 
extend [136]. Conformational switch due to trans-cis isomerization at the conserved 
proline in SAPNY motif is recently reported for human calcineurin, another 
serine/threonine PPP phosphatase [137]. Additionally, in-vivo, PTPA was shown to 
activate PP2A by reducing the level of inhibitory Y307 phosphorylation by upregulating a 
protein tyrosine phosphatase PTPB1 [138].   
Role of PP2A in root development 
In addition to the role of ACR4 RLK, recent gene knock out studies in plants have 
characterized the function of PP2A enzymes in root development [139,140,141]. Severe 
developmental defects including impaired root development, lethality in seedling are 
reported in pp2a3c and pp2a4c double mutant plants. PP2A3c and PP2A4c have redundant 
functions and control embryo patterning, root development and auxin flux processes. 
Different combinations of pp2a3c and pp2a4c null alleles showed dosage sensitive defect 
in the distal root meristem, ectopic QC division, abnormal cell division planes and unclear 
delimitation of the stem cell niche (SCN) along with dosage- sensitive defects in embryo 
patterning and development [139]. Additionally, PP2A-5c isoform is shown to positively 
regulate plant responses towards high salt concentration with pp2a5c mutant plant 
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exhibiting diminished root and vegetative growth, and over-expression of pp2a5c 
triggering improved growth under high salt concentrations [140]. The regulatory role of 
PP2A regulatory subunit has  also been reported with PP2A-B55 and PP2A-b’g 
antagonistically regulating the flowering time [142]. PP2A-A1/RCN1 (ROOT CURLING 
ON NPA1), PP2A-A2 and PP2A-A3, display dosage dependent sensitivity towards 
primary root meristem development, with rcn1 knockout affecting root-tip organization, 
abnormality in QC and columella cell number [82]. 
Scope of the Thesis 
ACR4 has been described as a major RLK with assigned role in root development. 
However, little is known of the signaling pathway, its interacting partners and the 
mechanism of its regulation. In-silico analysis, co-expression studies and biochemical 
analysis provide the basis for investigating the in vitro interaction and regulation between 
these co-expressed proteins: ACR4, ACR4 homolog- CRK1 and PP2A3c phosphatase and 
thus contribute towards advancing our knowledge of ACR4 mediated interactions in planta 
in the root meristem. Insights to PP2A function, holoenzyme assembly, activation and 
regulation have been obtained from biochemical investigations and structural studies on 
recombinant expression of protein in eukaryotic expression system, specifically insect 
cell–baculovirus expression system [103,143,144,145].  This study offers the E. coli 
platform as an alternative for recombinant expression of PP2A catalytic subunit and 
specifically investigating the role of post-translational modifications.  Lastly, we describe 
the production and characterization of a purified monoclonal antibody, highly specific 
against ACR4 kinase, with no detectable cross-reactivity within ACR4 homologs, thus 
offering an invaluable reagent for in planta and in vitro studies centered on ACR4 RLK.
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Figures 
 
Figure 1: Diagram of conserved architecture ACR4 Receptor-like kinase family. 
Extracellular region consists of the ‘Crinkly’ repeats (light blue) and TNFR-like domain 
(orange). Intracellular region comprises of the juxta membrane domain (blue), kinase 
domain (green), and C-terminal domain (red). A transmembrane helix (yellow) connects 
the extracellular and intracellular portions of the protein. AtCRRs lack the CTD domain, 
TNFR-like domains are absent in AtCRR3 and AtCRK1. AtCRR1 and AtCRR2 are kinase 
inactive RLKs. Diagram courtesy: Matthew Meyer 














Figure 2: Structural organization of a kinase domain. The diagram represents a 
homology model of ACR4 kinase domain modeled after Interleukin-1 kinase domain. 
Kinase domain has a bilobal structure with N-lobe primarily composed of b sheet (blue) 
and C-lobe predominantly composed of a helical structure (red) [68,146].






Figure 3:  Diagram of ACR4 kinase subdomains. Each subdomain is represented in a 
different color. Catalytically important residues are highlighted in black (bold). Regions 
involved in kinase activation and catalysis are underlined in black (adapted from[68,146]
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Figure 4:  Overall structure of the heterotrimeric PP2A holoenzyme. (A) Simplistic 
cartoon of the heterotrimeric PP2A holoenzyme, with conserved A and C subunit and 
variable B regulatory subunit. (B) Crystal structure of human PP2A holoenzyme composed 
of Aa–B56c1–Ca  with the scaffold Aa subunit (green), catalytic Ca subunit (blue) and, 
regulatory B56c1 subunit (orange) illustrated in the cartoon. Also present are two metal 
ions (purple) in the active site of C subunit and PP2A inhibitor microcystin is represented 
in sticks (adapted from [103]).
 A 
 B 
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Figure 5:  Multiple sequence alignment of the catalytic subunit sequence of 
Arabidopsis PP2A-3 isoform and Human PP2Ac a isoform. * Indicate identical amino 
acid and : indicate similarity between amino acids. Highlighted yellow represents the 
carboxy-terminal conserved tail. 
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Figure 6: Diagram depicts the catalysis at the conserved active site of PPP 
phosphatase. Shown is the active site of PP1 [147] and the bold amino acids represent the 
corresponding conserved residues in PP2A. M1 and M2 are the two chelated metal ions at 
the active site coordinating the nucleophilic attack on the incoming phosphate group by the 
water molecule (adapted from [148]).




Figure 7: Schematic of a potential linear array towards biogenesis of active 
heterotrimeric PP2A. Shown is a mammalian PP2A holoenzyme. Inactive PP2Ac is 
regulated by α4. PTPA in presence of catalytic Mg2+ ions, and ATP activate the C subunit, 
which binds to scaffold A subunit. Activated AC core enzyme is reversibly methylated by 
LCMT-1and PME-1. Methylation then allows the interaction of one of the substrate 
specific regulatory B subunit forming the completely active heterotrimeric PP2A 
holoenzyme (adapted from [116])
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CHAPTER 2: PP2A-3 INTERACTS WITH ACR4 AND REGULATES 
FORMATIVE CELL DIVISION IN THE ARABIDOPSIS ROOT 
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My Contributions 
 
 I contributed towards this study as a joint-first author, which involved performing 
all the in-vitro biochemical experiments. Mentioned below are my contributions towards 
this study: 
1)   Recombinantly cloned and established the protocol for expression and purification of 
catalytic subunit of Arabidopsis PP2A3c in E. coli system (Figure S11-S12)  
2)   Established the interaction between ICD of ACR4 and PP2A3c via in vitro studies such 
as pull down assays, overlay assays (Figure S3, B-E) and gel-filtration studies (Figure S3, 
F- K) 
3)   Performed radioactive kinase assay which provided the primary evidence of PP2A3c 
as a downstream substrate for ACR4 (Figure 3A, Figure S8) 
4)   Established the reciprocal regulatory interaction between ACR4 and PP2A3c, by 
performing a radioactive phosphatase assay and a non-radioactive Pro-Q-Diamond total 
phospho-stain assay, using human PP2Ac as a surrogate phosphatase (Figure 4A) 
 Other than performing the above definitive experiments which provided the basis 
for the in-planta studies, I have intellectually contributed towards analyzing the results and 
building up a model for the reciprocal interaction between ACR4 and PP2A3c, and, 
provided significant input towards corroborating the findings from all researchers towards 
development and writing of this paper.
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Abstract 
In plants, the generation of new cell types and tissues depends on coordinated and 
oriented formative cell divisions. The plasma membrane-localized receptor kinase 
ARABIDOPSIS CRINKLY 4 (ACR4) is part of a mechanism controlling formative cell 
divisions in the Arabidopsis root. Despite its important role in plant development, very 
little is known about the molecular mechanism ACR4 is affiliated to and its network of 
interactions. Here, we used various complementary proteomic approaches to identify 
ACR4-interacting protein candidates that are likely novel regulators of formative cell 
divisions and that could pave the way to unraveling the molecular basis behind ACR4-
mediated signaling. We identified PROTEIN PHOSPHATASE 2A-3 (PP2A-3), a catalytic 
subunit of PP2A holoenzymes, as a novel regulator of formative cell divisions and as the 
first described substrate of ACR4. Our in vitro data argue for the existence of a tight post-
translational regulation in the associated biochemical network through reciprocal 
regulation between ACR4 and PP2A-3 at the phosphorylation level. 
Significance Statement 
Plant growth and development are mediated through a wide range of proteins, 
including receptor kinases and phosphatases. The receptor kinase ACR4 is part of a 
mechanism controlling formative cell divisions in the Arabidopsis root. However, the 
regulation of ACR4 signaling and how it affects cell divisions remains completely 
unknown. We discovered that ACR4 phosphorylates the PP2A-3 catalytic subunit of the 
PP2A phosphatase holoenzyme, and that PP2A dephosphorylates ACR4. These data 
exposed a tightly regulated point in the associated biochemical network regulating 
formative cell divisions in plant roots.
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Abbreviations 
ACR4, Arabidopsis CRINKLY 4; AEBSF, 4-(2-Aminoethyl) benzenesulfonyl fluoride 
hydrochloride; ACN, acetonitrile; BRI1, brassinosteroid insensitive 1; BAK1, 
brassinosteroid associated kinase 1; CCR, crinkly4-related; CLE40, clavata3/embryo 
surrounding region 40; CLV, CLAVATA1; CORNET 2.0, Correlation network; DMSO, 
dimethyl sulfoxide; DTT, Dithiothreitol; FA, formic acid; FH6, formin homolog 6; eFP, 
electronic fluorescent pictographic; GO, Gene Ontology; GFP, green fluorescent protein; 
GST, glutathione s-transferase; HA, hemagglutinin; HTPA, hydroxy-
tetrahydrodipicolinate; ICD, intracellular domain; mACR4ICD, inactive mutant; MALDI, 
matrix assisted laser desorption ionization; PP2A, protein phosphatase A; PVDF, 
polyvinylidene fluoride; PTB, polypyrimidine-tract binding protein; RT, room 
temperature; rcn, root curls in naphthylphthalamic acid1; TAP, tandem affinity 
purification; TOF, time of flight; WOX5, wuschel related homeobox 5, Y2H- yeast two 
hybrid,  YFP, yellow fluorescent protein. 
 
Introduction 
 Plants rely on coordinated formative cell division for the formation of new cell 
types and tissues (1). For example, in the Arabidopsis root, the development of columella 
cells requires a tight coordination of formative cell division and differentiation (1). In the 
primary root apical meristem, columella stem cells − upon formative cell division − give 
rise to new stem cells and daughter cells that will differentiate (2) (Figure. S1 A). Several 
plant hormones and proteins that play a role in this process have been identified, and small 
regulatory networks have been proposed (3-11). However, our knowledge on the 
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mechanisms and signaling networks mediating formative cell divisions is sparse and is 
largely derived from transcriptional data (12). 
Reversible protein phosphorylation represents a major mechanism regulating cell 
signaling (13), and several kinases have been shown to play a role in primary root 
development (5, 6, 14). For example, the evolutionarily conserved plasma membrane-
localized receptor-like kinase Arabidopsis CRINKLY 4 (ACR4) marks the plasma 
membrane in the primary root tip columella and is part of a mechanism controlling 
formative cell divisions in the Arabidopsis root (5, 15, 16). ACR4 possesses an 
extracellular ligand binding domain, a transmembrane helix, and an intracellular domain 
that contains the juxta membrane and the C-terminal subdomains, which flank the core 
kinase domain with serine/threonine kinase activity (Figure 1 A). The intracellular juxta 
membrane domain is a likely recruitment site for interacting proteins and essential to 
facilitate downstream signaling (17, 18). ACR4 is expressed throughout plant development 
in specific cells and tissues, such as protoderm, columella and stage I lateral roots, and 
ACR4 preferentially localizes at plasmodesmata (15, 19-21). In addition to its primary and 
lateral root phenotypes, Arabidopsis loss-of-function acr4 mutants are affected in 
maintaining epidermal cell identity, including disorganized cell layers in the ovule 
integument (19, 21). Although ACR4 was the first receptor kinase to be assigned a role in 
root development (5), our knowledge about its signaling pathway in the root remains 
limited (15, 22). 
In addition to post-translational modifications such as phosphorylation, 
developmental programs and cellular functions largely rely on interactions between 
proteins, forming complex networks to control biological processes (23). While membrane 
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proteins play a crucial role in many biological processes, knowledge of the in-planta 
membrane interactome is limited (23). Notwithstanding the recent progress with respect to 
global analyses of membrane protein interactions, so far ACR4 was not represented in a 
membrane-linked Arabidopsis interactome (24). Therefore, the objective of this study was 
to use ACR4-centered, protein-focused systems biology approaches to gain insight into the 
ACR4 signaling cascade and to identify new potential regulators of formative cell division.  
Results and Discussion 
Mapping putative ACR4 interactions. 
To identify novel regulators of formative cell division in Arabidopsis, we combined 
in silico, tandem affinity purification (TAP), yeast two-hybrid (Y2H), and phage display 
approaches to define potential ACR4-interacting proteins. Given the technical difficulties 
associated with plasma membrane proteins, we focused on intracellular ACR4 domains for 
our in vitro and in vivo studies (Figure. 1 A). We first interrogated available protein-protein 
interaction (PPI) databases for experimental and predicted interactions by applying the PPI 
tool within CORNET 2.0 (25) to ACR4 (AT3G59420). This resulted in a network with 85 
nodes which mainly lacked experimental validation (Figure. S2 and SI Appendix). Second, 
we applied a TAP approach to Arabidopsis cell suspension cultures expressing the N- or 
C-terminally tagged ACR4 intracellular kinase domain (Figure. 1 A and Figure. S3). This 
analysis resulted in 4 putative ACR4-interacting proteins, of which 2 occurred in at least 2 
biological replicates and in both assays with N- and C-terminally tagged ACR4 
intracellular kinase domain, and were not present in any in house background list, namely 
4-HYDROXY-TETRAHYDRODIPICOLINATE REDUCTASE 1 (HTPA REDUCTASE 
1/DAPB1; AT2G44040) and HTPA REDUCTASE 2/DAPB2 (AT3G59890) (SI 
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Appendix). Based on TAP data alone, two other candidates, PROTEIN PHOSPHATASE 
2A-3 (PP2A-3; AT2G42500) and PP2A-4 (AT3G58500), could not be conclusively 
identified as bona fide ACR4-interacting proteins as they were only detected in one 
technical repeat. Third, we applied a conventional high throughput Y2H assay to screen 
for potential interactions with the ACR4 intracellular domain (Figure. 1 A). This revealed 
4 potential ACR4-interacting proteins with high confidence (SI Appendix). Finally, we 
screened a synthetic 15-mer peptide encompassing the Ser475 phosphorylation site within 
the intracellular juxta membrane domain of ACR4 (Figure. 1 A) against a 21-amino acid 
phage-peptide library (26, 27). When the resulting consensus binding motifs for the 
phosphorylated peptide were queried against the Arabidopsis protein database, over 4000 
potential ACR4-interacting proteins were identified (SI Appendix). Taken together, our 
complementary approaches identified several putative ACR4-interacting proteins, but 
when we searched for overlap between the different approaches this was limited to absent 
(SI Appendix). This could mean that different approaches yielded different subsets of 
putative ACR4-interacting proteins or that we picked a large number of likely false-
positives. In silico quality assessment of putative ACR4 interactions. To increase the 
confidence in the potential ACR4-interacting proteins listed in SI Appendix and to select 
candidates for functional analyses, we performed in depth in silico quality assessment. 
Correlated gene expression is an indicator of co-functionality of genes incommon pathways 
and processes (28), and interacting proteins are often significantly co-expressed. First, we 
used CORNET 2.0 (25) to globally explore co-expression of ACR4 and genes encoding 
potential ACR4-interacting proteins, which showed some co-expression (Pearson 
correlation coefficient > 0.55) between ACR4 and some CORNET (2/85) and phage 
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display hits (44/4402) (SI Appendix). Second, to further support potential PPIs in the root 
tip and during lateral root initiation, we used available cell- and tissue-specific transcript 
profiling datasets (5, 29). Visualization of root tip in silico expression patterns for TAP 
(3/4) and Y2H candidates (2/4) through the BAR Arabidopsis eFP Browser (30), revealed 
distinct expression patterns that, at least partially, overlapped with the ACR4 expression 
domain (Figure. S2). In addition, some of the CORNET (8/85) and PHAGE DISPLAY 
candidates (360/4402) were – similar to ACR4 – also transcriptionally differentially 
regulated in a transcriptome study of pericycle cells undergoing lateral root initiation (5) 
(SI Appendix). Based on the above observations, we generated a priority list for CORNET, 
TAP, Y2H and PHAGE DISPLAY hits, narrowing down the number of candidates from 
4495 to 525 (SI Appendix). Next, to globally assess interactions between ACR4 and 
potential interacting proteins, we used the PPI tool within CORNET 2.0 (25). Indeed, 
several of the CORNET, Y2H, TAP and prioritized PHAGE DISPLAY hits are connected 
with ACR4 and with each other in predicted and experimentally validated protein-protein 
interaction networks focusing on pairwise interactions (SI Appendix). To gain insight in the 
molecular functions represented in this protein-protein interaction network, we determined 
that several statistically overrepresented Gene Ontology (GO) categories with respect to 
biological process (5%) and molecular function (5%) were related to phosphorylation (SI 
Appendix), which is in agreement with the fact that ACR4 is a receptor kinase. Taken 
together, through our in-silico assessment we increased the confidence in a subset of 
potential ACR4-interacting proteins (SI Appendix). However, our dataset is not necessarily 
comprehensive, as, for example, WUSCHEL RELATED HOMEOBOX 5 (WOX5), 
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CRINKLY4-RELATED (CCR) proteins, and CLAVATA1 (CLV1), which were shown to 
interact with ACR4 (15, 31), were not retained.  
ACR4 interacts with PP2A-3.  
Taking the results of SI Appendix into account allowed us to impose additional 
criteria to select candidates for functional analyses. Among the candidates selected by at 
least two approaches and with a high score in the priority list (SI Appendix), we retrieved 
sequences that match PP2A-3 and/or PP2A-4, which are isoforms of catalytic PP2A C 
subunits and that form a subclade in the family of 5 Arabidopsis PP2A C subunits (32). In 
general, the PP2A heterotrimeric holoenzyme, which is a major, highly conserved 
eukaryotic serine/threonine phosphatase, consists of a catalytic C subunit, a type A 
scaffolding/regulatory subunit, and a type B regulatory subunit (33). In Arabidopsis, PP2A 
phosphatases have been implicated in various hormone-regulated, cellular and 
developmental processes, including spatial control of cell division and columella 
organization, and in innate immunity, but little is known about their dynamic and highly 
regulated function (34-37). In the context of our focus on formative cell division, we 
selected PP2A-3 (and PP2A-4) for subsequent in depth functional characterization. First, 
an overlay assay indicated that PP2A-3 can specifically interact with both the naïve ACR4 
intracellular domain (ACR4ICD) (endogenously phosphorylated at a limited number of 
residues in E. coli through an unknown mechanism) and fully in vitro auto phosphorylated 
ACR4
ICD
 (26) (Figure. S3 and SI Supplemental Notes). Second, gel-filtration analyses 
further confirmed the interaction between the ACR4 intracellular domain (ACR4ICD) and 
PP2A-3 (Figure. S3 and SI Supplemental Notes). Subsequently, the purified recombinant 
MBP: ACR4ICD was effectively pulled down with GST: PP2A-3 in vitro (Figure. 1 B). 
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Moreover, in Nicotiana benthamiana transient expression assays, ACR4: YFP: HA was 
able to co-immunoprecipitate FLAG: PP2A-3 in planta (Fig. 1 C). Taken together, these 
data strongly indicate that ACR4 and PP2A-3 interact with each other. 
ACR4 and PP2A-3 are co-expressed.  
As mentioned above, Arabidopsis eFP Browser data suggested that PP2A-3 is 
weakly expressed in columella stem cells and in the root apical meristem (Figure. S2). To 
confirm this, we analyzed seedlings expressing a pPP2A-3::n3xGFP fusion and assessed 
expression in the root tip. In 5 independent transformants we indeed observed pPP2A-
3:n3xGFP expression in the root tip, but PP2A-3 was more broadly expressed than ACR4 
(5) (Figure. 2 A and Figure. S1). In addition, we observed PP2A-3 expression during early 
lateral root initiation (Figure. S1), which also overlapped with ACR4 expression at this 
stage (5) (Figure. S1). Taken together, these results show that ACR4 and PP2A-3 are 
expressed in overlapping domains, further supporting that they can physically interact. 
PP2A-3 is involved in columella stem cell differentiation.  
To test genetically if PP2A-3 plays a role in ACR4-mediated stem cell regulation, 
we analyzed primary root length and columella stem cell differentiation in a previously 
characterized pp2a-3 mutant (36). The primary root of pp2a-3 is slightly longer than wild 
type (Figure. 2 B-C). With respect to columella stem cell differentiation, we observed less 
differentiation in pp2a-3 compared to wild type, which is similar to acr4 (Figure. 2 D-E). 
However, since such a columella phenotype can also be explained by altered auxin 
distribution, levels or response (11), the similarity between the pp2a-3 and acr4 mutants 
does not provide conclusive support for a genetic and/or physical interaction. This is 
especially relevant since PP2A-3 has been shown to play a role in auxin transport (38). We 
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therefore tested to what extent acr4 and pp2a-3 are affected in their sensitivity to NPA with 
respect to primary root length and columella differentiation. In these assays, acr4 and pp2a-
3 appeared equally sensitive to NPA treatment as Col-0 (Fig. S4), suggesting that there is 
no apparent auxin transport-mediated effect in this case. The genetic interaction between 
ACR4 and PP2A-3 was further supported by the acr4 pp2a-3 double mutant, where we 
could not record an additive effect arguing both are active in the same pathway (Figure. 2 
D-E). Although we cannot rule out cell-specific changes, we have excluded that the 
similarities in phenotype are due to a broad differential regulation of ACR4 or PP2A-3 
expression in pp2a-3 and acr4 mutants, respectively (Figure. S5). Taken together, our 
observations indicate a role for PP2A-3 in cellular patterning during primary root 
development that overlaps with ACR4 function, and further suggest that this is possibly 
independent of an affected auxin transport capacity. 
PP2A-3 and PP2A-4 redundantly affect primary root growth. 
Given that PP2A-4 is closely related to PP2A-3, we explored possible redundancy 
with respect to primary root growth. Indeed, a double pp2a-3 pp2a-4 mutant displayed a 
short primary root, further reduced columella differentiation and severely disrupted cell 
organization in the root tip compared to wild type (Figure. 2 B-E) (36). However, this 
double mutant phenotype appeared to be less severe than the one obtained by Ballesteros 
and co-workers (38), which is possibly due to the use of different T-DNA lines. Short root 
phenotypes associated with disrupted cell division and/or cellular patterning in the root tip 
are often associated with a loss of quiescent center cell identity (39, 40). To assess if the 
quiescent center was absent in the disrupted root tip of pp2a-3 pp2a-4, we analyzed the 
expression of the quiescent center marker QC184 (7). Surprisingly, notwithstanding the 
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dramatic impact on the regular cellular pattern in the root tip, QC184 expression was not 
abolished, and even appeared to expand into the columella (Figure. 2 F). The latter might 
suggest that the stemness gradient in pp2a-3 pp2a-4 is perturbed. Furthermore, we applied 
cantharidin – an inhibitor of PP2A and PP2A-related phosphatases (SI Supplemental Notes) 
– to the QC184 and pWOX5::GUS markers (7), demonstrating that quiescent center identity 
is not lost when interfering with PP2A activity (Figure. 2 G and Figure. S6). Interestingly, 
WOX5 expression was shown to be similarly affected in the clavata3/embryo surrounding 
region 40 (cle40) mutant, and ACR4 was identified as a target of CLE40 signaling (15, 
22), further corroborating the potential connection between PP2A and ACR4. Next, 
evaluating sensitivity to cantharidin with respect to primary root growth revealed that acr4 
is equally sensitive to cantharidin treatment as pp2a-3, and both are not significantly more 
sensitive than the control (Figure. S7). We furthermore established that cantharidin does 
not negatively affect ACR4 expression levels, and observed a similar (minor) up-regulation 
as in pp2a-3 pp2a-4 (Fig. S5). Taken together, these results further suggest that ACR4 and 
PP2A-3 act in the same pathway.  
ACR4 phosphorylates PP2A-3.  
PP2A activity and function in eukaryotic cells is regulated via post-translational 
modification of PP2A subunits (41). For example, PP2A complex assembly depends on 
the phosphorylation status of the catalytic subunit and phosphorylation of protein 
phosphatases has been shown to inactivate the enzyme (41, 42), but this has not been 
demonstrated in plants. To evaluate if ACR4 affects the phosphorylation status of PP2A-
3, we compared the phospho-proteomes of Col-0 and acr4 seedlings. However, although 
we could detect a peptide (NH3-GAGYTFGQDISEQFNHTNNLK-COOH) for PP2A-3 (or 
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PP2A-4) in all samples, we did not observe any (differential) phosphorylation. Since PP2A 
holoenzymes act in various pathways (37, 38, 43, 44) and since ACR4 only acts in a few 
cells, it is likely that subtle differences mediated by ACR4 could be masked. Therefore, we 
explored if PP2A-3 could be phosphorylated by ACR4 in vitro. Indeed, in vitro kinase 
assays demonstrated that purified recombinant auto phosphorylated SUMO: ACR4ICD, but 
not a mutant inactive version of ACR4ICD with K540A and D641A amino acid exchanges 
(mACR4ICD), could phosphorylate purified recombinant PP2A-3 (PP2A-3::6xHIS) 
(Figure. 3 A). Subsequently, we identified the ACR4-dependent PP2A-3 phosphosites from 
the in vitro kinase assay using high resolution mass spectrometry analyses. This revealed 
a total of 9 – so far unknown – phosphorylated residues of which five are at Ser, three are 
at Thr and one is at Tyr (Figure. S8 and SI Appendix). Mapping these sites on a three-
dimensional homology model of Arabidopsis PP2A-3, based on the structure of the 
catalytic chain within the trimeric human PP2A enzyme, showed that these residues were 
predominantly solvent exposed even in the trimer structure and, therefore, quite likely 
accessible for phosphorylation by ACR4 (Figure. S8 and SI Appendix). Taken together, our 
results pinpoint PP2A-3 as a substrate for ACR4 kinase activity. Phosphorylation of the 
tail of the PP2A catalytic subunit plays an important role in regulating the assembly – and 
thus activity – of PP2A holoenzymes (41). We therefore explored PP2A activity in cellular 
extracts prepared from acr4 seedlings using a PP2A phosphatase assay system (37, 45, 46). 
In our hands, this revealed a decrease in PP2A activity of about 19% in acr4 compared to 
wild type, which was similar to that associated with the PP2A regulatory subunit mutant 
rcn1 (22%) and the catalytic subunit mutant pp2a-3 (16%) (Figure. 3 B). Although the 
results did not achieve statistical significance (p-value for acr4 = 0.083), likely because the 
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ACR4 impact on PP2A activity is diluted, they are reproducible and suggestive of ACR4 
being required for some of the cellular PP2A activity. 
PP2A-3 dephosphorylates ACR4.  
With respect to receptor kinases, PP2A has been shown to modulate the 
phosphostatus of BRI1 and the co-receptor BAK1 (37, 47, 48), so we also evaluated if 
PP2A-3 is capable to dephosphorylate ACR4. First, using E. coli-expressed PP2A-3 in a 
phosphatase assay did not yield a convincing difference with respect to dephosphorylation 
of ACR4ICD (Figure. S8 and SI Supplemental Notes). Therefore, to determine whether 
ACR4 could be a substrate of PP2A, we used – in accordance with Wu and colleagues (47) 
– a purified, active human PP2A to dephosphorylate the ACR4ICD that had been 
phosphorylated in vitro. This demonstrated PP2A-mediated dephosphorylation of the 
phosphorylated ACR4ICD (Figure. 4 A), and pinpoints ACR4 as a substrate for PP2A 
phosphatase activity. To assess the biological importance of altering the PP2A-mediated 
phosphorylation status of ACR4, we analyzed ACR4: GFP in the root of the pp2a-3 pp2a-
4 double mutant. This revealed a weak GFP signal in pp2a-3 pp2a-4, with reduced 
membrane localization, as compared to the control (Figure. 4 B), which is likely not due to 
a change in ACR4: GFP expression levels (Figure. S5). To explore this, further, we 
investigated ACR4: GFP in the presence of the PP2A inhibitor cantharidin. This revealed 
a reduced membrane association of ACR4: GFP upon inhibiting PP2A activity within 5 
hours, while the membrane localization of the routinely used membrane marker FORMIN 
HOMOLOG 6 (FH6): GFP (49), was largely unaffected (Figure. 4 C-D and Figure. S9). 
Overall, these results suggest that membrane localization of ACR4 is dependent on PP2A-
3 (and potentially PP2A-4). 
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Conclusions 
Interactions between membrane-associated proteins and soluble proteins are 
essential for signal transduction and for regulating plant growth and development. Here, 
we used various approaches to generate a prioritized list of potential ACR4-interacting 
proteins that are possibly involved in formative cell division, cell-to-cell communication 
and root development. Taking all our interaction data together and since there is limited to 
no overlap between the different approaches, it seems that to study protein-protein 
interactions the use of multiple approaches is preferred as each technique seems to expose 
a distinct subset of potential interactors and can increase confidence in some potential 
interactors that would otherwise be discarded. Starting from the prioritized, potential 
ACR4-interacting candidates, we identified PP2A-3 as the first described ACR4 substrate 
and showed that PP2A-3 plays an important role in the control of columella stem cell 
divisions and/or differentiation. Previously, it was shown that PP2A complexes associate 
with membranes in growing seedlings and that PP2A may interact with plasma membrane 
components (35, 43). Similar to the PP2A effect on BRI1 where dephosphorylated BRI1 
is internalized (47, 48) and on BAK1 (37), we showed that PP2A can dephosphorylate 
ACR4. In this context, we also showed that PP2A activity affects the membrane 
localization of ACR4. The resemblance of the acr4 and pp2a-3 columella stem cell 
phenotype, together with the cell biological data, suggest that PP2A acts as a positive 
regulator of ACR4 function and that it is the dephosphorylated form of the ACR4 protein 
that is localized to the plasma membrane and functional. On the basis of the available data, 
we propose a tentative model whereby on the one hand ACR4 phosphorylates the PP2A-3 
catalytic subunit of the PP2A holoenzyme, possible facilitating complex assembly, and on 
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the other hand, PP2A dephosphorylates ACR4, regulating its membrane localization and 
possibly activity (Figure. S10). The balance between these two likely affects formative cell 
divisions and cell differentiation in the root, and as such ACR4 and/or PP2A appear to 
control their own activity. In future, it will be important to characterize the importance of 
the individual ACR4 and PP2A-3 phosphosites, and evaluate these in the context of ACR4 
localization and/or activity and PP2A activity and/or complex assembly, respectively. 
Here, it should be taken into account that, for example in brassinosteroid signaling, PP2A 
type B subunits usually recruit substrates and regulate their activity (44, 50) and that 
membrane localization of PP2A C subunits is regulated by methylation and in turn impacts 
target dephosphorylation (47). 
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Figure 1: ACR4 interacts with PP2A-3. (A) Schematic representation of ACR4 with key 
domains and regions used for protein–protein interaction studies. (B) In vitro GST pull-
down experiment using GST: PP2A-3 and MBP: ACR4ICD according to indicated 
combinations (+). PP2A-3 and ACR4ICD were detected by Western blotting with anti-
GST and anti-MBP antibodies, respectively. (C) In planta YFP pull-down experiment 
using ACR4: YFP: HA and FLAG:PP2A-3 transiently coexpressed in tobacco leaves by 
Agrobacterium infiltration according to indicated combinations (+). PP2A-3 and ACR4 
were detected by Western blotting with anti-FLAG and anti-HA antibodies, respectively.




Figure 2. PP2A-3 mediates columella stem cell divisions. (A and B) Representative 
images (A) and quantification (B) of columella stem cell daughter cell differentiation (20 
≤ n ≥ 96) and irregular cellular pattern in pp2a-3 pp2a-4 (A, Right). Statistical significance 
(Z Test Calculator for 2 Population Proportions, P < 0.05) compared with Col-0 (*) or acr4 
(#) is indicated. (C and D) Expression of QC184 and pWOX5::GUS in 5-d-old pp2a-3 
pp2a-4 seedlings (C) or in 5-d-old seedlings grown on 10 µM cantharidin (D). 
Representative pictures with number of seedlings with similar expression pattern indicated. 
Pink arrowhead, quiescent center. Yellow asterisk, first columella cell layer with starch 
granules.





Figure 3. PP2A-3 is phosphorylated by ACR4 kinase. (A) Autoradiogram for co-
incubated E. coli-expressed PP2A-3 and ACR4 kinase (ACR4ICD) or mutant inactive 
kinase m ACR4ICD as indicated (Upper). The lanes in A are, from left to right, molecular 
weight standards, 1 µg of auto phosphorylated ACR4ICD, 1 µg of auto phosphorylated 
ACR4ICD incubated with 10 µg PP2A-3, 1 µg of mutant inactive kinase mACR4ICD, 1 µg 
of mutant inactive kinase mACR4ICD incubated with 10 µg PP2A-3, and 10 µg PP2A-3. 
Corresponding Coomassie blue-stained gel (Lower) was used as loading control. (B) Bar 
diagram for PP2A activity detected in whole 12-d-old seedling protein extracts as average 
of three bi- ological repeats (with three technical repeats each) ± SE. Statistical significance 
(Student’s t test) compared with Col-0 is indicated: *P value < 0.05.
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Figure. 4. PP2A-3 dephosphorylates ACR4. (A) Pro-Q-diamond stained gel showing the 
phosphorylation status of ACR4ICD coincubated without or with PP2A-3 as indicated 
(Upper). The same gel stained with Sypro Ruby (Lower) as loading control. (B–D) 
Localization of ACR4: GFP in pp2a-3 pp2a-4 background (B) and following treatment 
with DMSO or 50 µM cantharidin for indicated hours (C and D). Red asterisk, plasma 
membrane with ACR4 localization; arrowhead, plasma membrane analyzed in D. (D) 
Detail of indicated membrane in C (yellow arrowhead) and quantification of GFP signal 
across the yellow line as smooth average graph. Black arrowhead, position of plasma 
membrane.
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Supplementary Information (SI) 
Supplemental note on cantharidin 
Cantharidin has been used extensively to inhibit PP2A (and PP2A-related) 
phosphatases (1-5). We have addressed the (potential) PP2A specificity by growing 
seedlings on 50 µM cantharidin and evaluating primary root growth (Figure. S7). Our 
results suggested that Col-0, acr4 and pp2a-3 are equally sensitive to cantharidin, while 
the pp2a-4 mutant is more sensitive. In addition, the pp2a-3 pp2a-4 double mutant still 
presented some sensitivity to cantharidin, suggesting additional PP2A and/or PP2A-related 
phosphatases are targeted in the absence of PP2A-3 and PP2A-4. Furthermore, primary 
root length of the pp2a-4 mutants approached the root length of pp2a-3 pp2a-4 double 
mutants. Interestingly, this suggests cantharidin, at least in the context of PP2A-3 and 
PP2A-4, preferentially targets PP2A-3 (see additive effect on primary root length in the 
absence of PP2A-4), making this a suitable chemical for our cell biological analyses, where 
we largely want to affect PP2A-3. Nevertheless, we cannot fully exclude that there are 
other cantharidin targets (as indicated by the still mildly sensitive pp2a-3 pp2a-4 double 
mutant). 
Supplemental note on protein overlay assay 
The overlay assay, also known as the far-western blot, is a widely-used technique 
to detect and quantitate protein-protein interactions (6-9). The technique is dependent on 
the separation of target proteins by SDS-PAGE, blotting to polyvinylidene fluoride 
(PVDF) or nylon membranes, renaturation, probing the immobilized target with the bait 
protein followed by appropriate detection. Intrinsic to the technique is proper refolding of 
the protein upon renaturation and reconfiguration of binding sites. Consequently, non-
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specific interactions are also often observed in this technique.  Indeed, in our experiment, 
we have not been able to completely eliminate non-specific interactions particularly with 
control proteins GST-PTB and BSA (Figure. S3). It should, however, be noted that the 
negative control bait protein, SUMO (Figure. S3) also shows similar non-specific binding. 
The non-specific binding may therefore be attributed to the binding of the SUMO tag to 
the negative control proteins. Importantly, however, the SUMO protein shows no binding 
to PP2A-3 (Figure. S3).   
Supplemental note on gel-filtration analysis 
Interestingly, PP2A-3 alone, which has a calculated molecular weight of ~37 kDa, 
elutes in the void volume of the column (~ 8 ml) as a higher order oligomer (Figure. S3, 
solid double-headed arrow (F) and corresponding SDS-PAGE of this fraction (G). On the 
other hand, as demonstrated in an earlier publication (10), ACR4ICD elutes predominantly 
in later fractions (Figure. S3, dashed double-headed arrow (H) and corresponding SDS-
PAGE of this fraction (I)) and has no detectable protein in the void volume fraction peak 
that could be attributed to the formation of an oligomer (Figure. S3, solid double headed 
arrow (H) and corresponding SDS-PAGE (I)). In contrast, when the two proteins are mixed 
and subjected to gel filtration, ACR4ICD now co-elutes with PP2A-3 in the void volume 
peak (Figure. S3, solid double-headed arrow (J) and corresponding SDS-PAGE of this 
fraction (K) unambiguously establishing the interaction between the two proteins. 
Supplemental note on dephosphorylation assay – E. coli PP2A-3 
We examined the ability of E. coli-expressed PP2A-3 to dephosphorylate ACR4ICD 
in a dephosphorylation assay using two approaches, as described in SI Materials and 
Methods. In the approach using radiolabeled ACR4ICD as substrate, when the protein was 
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incubated with PP2A-3, a slight reduction in the intensity of the P32labeled ACR4ICD was 
observed (Figure. S8) in comparison with the intensity of the control protein without 
incubation with PP2A-3 (Figure. S8). In the corollary approach, dephosphorylation of 
ACR4ICD (phosphorylated with cold ATP) by PP2A-3 was monitored by staining with Pro 
Q Diamond stain. However, no discernible difference could be observed in intensities of 
the control protein (Figure. S8) and the protein treated with PP2A-3 (Figure. S8). These 
experiments suggested that the E. coli-expressed PP2A-3 with a C-terminal His-tag may 
have little or no phosphatase activity, presumably because of the requirement of a free C-
terminal Leu residue and/or its carboxymethylated form for optimal activity as well as 
phosphorylation of specific sites that have been reported to inhibit activity (11-13). This 
shortcoming could be overcome when using a purified, active human PP2A that was 
expressed in baculovirus and post-translationally modified at the C-terminal Leu and 
consisted of the catalytic subunit PP2Ac and the scaffold subunit PP2Aa (Figure. 4 A) 
   SI Materials and Methods 
Plant materials, constructs and growth conditions 
 T-DNA lines were previously described: pp2a-3, pp2a-4 and pp2a-3pp2a-4 (14), 
acr4-2 (15), rcn1-6 (3).  The FLAG: PP2A-3 construct was previously published (16). For 
phenotyping and expression studies, seeds were surface sterilized and stratified at 4 ℃ in 
the dark for 2 days. Seeds were germinated on vertically positioned Petri dishes in a growth 
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Primary and lateral root phenotyping 
Photographs of each plate were taken and measurements of primary root lengths 
were performed using ImageJ. Lateral roots were counted and lateral root density was 
calculated. For columella phenotyping, seedlings were stained with lugol and mounted in 
Hoyer’s solution as previously described (15) (REF). 
Statistics 
The Z Test Calculator for 2 Population Proportions (two tailed - 0,05) 
(www.socscistatistics.com/tests/ztest/Default2.aspx) was used when we wanted to know 
whether two populations or groups differ significantly on some single characteristic. In 
other cases, either two-way ANOVA or Student’s t-test were performed as indicated. For 
two-way ANOVA, analysis of variances was performed in R statistics program, using R 
studio (version 0.99.486). 
Light microscopy 
        Olympus BX51 stereomicroscope or a differential interference contrast (DIC) 
microscope (Leica) was used for observations of the root tip (Olympus BX51 with a digital 
camera). 
GUS Assay 
 Seedlings were stained in multi-well plates (Falcon 3043; Becton Dickinson). GUS 
assay were performed as described previsouly (17). Samples were mounted in 90% lactic 
acid.  
mSP-PI staining 
Whole seedlings were fixed in fixative (50% methanol and 10% acetic acid) at 4°C 
for at least 2 days. Next, seedlings were rinsed with water and incubated in 1% periodic 
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acid at room temperature for 40 min. The seedlings were rinsed again with water and 
incubated in Schiff reagent with propidium iodide (100 mM sodium metabisulphite and 
0.15 N HCl; propidium iodide to a final concentration of 100 µg/mL was freshly added) 
for 1 to 2 h or until plants were visibly stained. The samples were then transferred into 
chloral hydrate solution (4 g chloral hydrate, 1 mL glycerol, and 2 mL water) overnight at 
room temperature. Then removed chloral hydrate and transferred seedlings onto 
microscope slides and mounted seedlings with Hoyer's solution (30 g gum arabic, 200 g 
chloral hydrate, 20 g glycerol, and 50 mL water). Slides were left undisturbed for a 
minimum of 3 d to allow the mounting solution to set (18). 
Cantharidin treatments 
 pWOX5: GUS, QC184::GUS and QC184::GUS x pp2a-3pp2a-4 seedlings were 
grown vertically on ½ MS media supplemented with and without 10 µM catharidin. The 
plants were submerged in 90% (v/v) acetone at 4°C for 1 hour and transferred to a GUS-
staining solution of 2 mM 5-bromo-4-chloro-3-indolyl-β-D-glucuronide and 0.5 mM 
K3Fe(CN)6 in buffer containing 100 mM Tris and 50 mM NaCl (pH 7.0) (TBS buffer). 
After 1 hour of incubation at 37°C in the dark, the tissue was transferred to TBS buffer and 
stored at 4°C. For microscopic analysis, samples were cleared by mounting in 90% (v/v) 
lactic acid (Acros Organics). All samples were analyzed by differential interference 
contrast microscopy (BX51, Olympus). In other cases, seedlings were grown on vertical 
square plates containing 1/2 MS for 5 days, then transferred to plates containing cantharidin 
or DMSO, put back to the growth chamber vertically and kept for corresponding time. 
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Confocal microscopy 
 Zeiss LSM Zeiss LSM710 Laser Scanning Microscope and the LSM Brower 
software (Zeiss) were used for confocal microscopy. GFP fluorescence was imaged with 
488-nm excitation of Argon laser in the frame-scanning mode alternating GFP fluorescence 
via a 500-/550-nm band pass emission filter. For Figure S2, seedlings have been grown 
under day/light conditions (16h/8h respectively) on 1/2MS media. 5-day-old roots have 
been stained with a 20-30 µM propidium iodide (PI) solution and inspected in the following 
30 min. An inverted confocal microscope (Zeiss LSM780, objective: Plan-Apochromat 
40X (1.4 oil DIC M27) has been used to excite PI with an Argon laser at 488nm and the 
emission was captured between 565 and 650 nm. For the signal of pACR4::ACR4: GFP a 
multiphoton unit excited the GFP with 910 nm and the emission has been collected between 
515 and 545 nm. 
pACR4::ACR4: GFP analyses and quantification 
 To analyze membrane localization of ACR4: GFP we processed images in ImageJ 
using the Plot Profile option across a selected line. Subsequently, the plot data were 
processed according to a moving average calculation of 5 values to smoothen the graph. 
Multiple cells (n > 4) in multiple seedlings (n > 2) were measured and showed similar 
results. 
qPCR.  
Seeds of Col-0 were sterilized using gas sterilization and then sown on 1/2 MS 
medium without (5 hours) or with nylon mesh (6, 24, 48 hours). Seeds were vernalized at 
+ 4°C overnight (in the dark) and placed in the growth chamber. Seedlings were grown 
vertically until 5 days after germination and then transferred on 1/2 MS medium with 50 
 62  
µM cantharidin (in DMSO) and on 1/2 MS with the same volume of DMSO as a control. 
Roots of seedlings were collected at 5, 6, 24 and 48 hours after transfer. RNA was extracted 
using RNeasy Mini Kit (Qiagen) according to the protocol provided by manufacturer and 
eluted in 30 µL of RNAse-free water. The RNA concentration was measured on NanoDrop 
ND-1000. cDNA was synthesized using iScript™ cDNA Synthesis Kit (BIO-RAD) 
according to the protocol provided by manufacturer and diluted 8 times.  Samples for qPCR 
were prepared by JANUS® Automated Workstation (PerkinElmer) and qPCR was 
performed on LightCycler® 480 (Roche). All samples include 2-3 biological and 2-3 
technical repeats. Gene-specific primers for refererence genes ACTIN 
(ACTCTTCCTGATGGACAGGTG and CTCAACGATTCCATGCTCCT) and EEF 
(CTGGAGGTTTTGAGGCTGGTAT and CCAAGGGTGAAAGCAAGAAGA), GFP 
(GAAGCGCGATCACATGGT and CCATGCCGAGAGTGATCC), PP2A-3 
(GAACCACACCTTCATCCAGTTT and TGAGATGAGTCTGTGTCCAGTGA), 
PP2A-4 (TCTGCGAAAGTATGGCAATG and CCACCGTGAAGGCAGAATA), and 
ACR4 (ATAAACGCACTCTTGGACCCG and TTCCCTCTCATTCTCACGCAT) were 
used. Calculations were done in qbase+ 2.5. 
pPP2A-3::n3xGFP expressing plants 
 A 2000 bp promoter of PP2A-3 upstream of the start codon was amplified from 
the genomic DNA (Ecotype: Col-0) using the high-fidelity DNA polymerase Phusion (New 
England BioLabs), and a pair of primers [PP2A-3PF 
(GCGAATTCCGACTGGATTTGTCACTT) and PP2A-3PR 
(CGGGATCCTTTCGTTAATTCGTCT)]. Previous to cloning into the intermediate vector 
pGem-T-easy, the blunt end PCR products were gel purified and A-tailed with dATP and 
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Taq DNA polymerase. After sequencing confirmation, the correct pPP2A-3 2Kb promoter 
was released from the pGem-T-easy vector with restriction enzymes EcoRI and BamHI, 
and then cloned into the pGII-n3xGFP vector.  After sequencing confirmation, the correct 
construct was designated as pPP2A-3::n3xGFP and used for floral dip transformation of 
A. thaliana Col-0 plants. 
Phage Display 
Phage panning experiments were performed as described earlier (19). Briefly, a 
random 21-amino acid phage-displayed library was panned against biotinylated synthetic 
15-mer peptides derived from the juxtamembrane domain containing the two 
phosphorylation sites Ser475 and Thr478. After four rounds of panning against both the 
phosphorylated and unphosphorylated peptides, consensus peptide motifs were queried 
against the Arabidopsis protein database using the Sequence Pattern search function 
Scansite 2.0 (http://scansite.mit.edu) (20) to identify proteins containing the identical 
motif. 
Yeast two-hybrid screen 
Yeast two-hybrid screening was performed by Hybrigenics Services, S.A.S., Paris, 
France (http://www.hybrigenics-services.com). The coding sequence for the Arabidopsis 
thaliana intracellular ACR4 domain (aa 456-895) (GenBank accession number 
gi:30694994) was PCR-amplified and cloned into pB27 as a C-terminal fusion to LexA 
(N-LexA-ACR4ICD-C). The construct was checked by sequencing the entire insert and used 
as a bait to screen a random-primed Arabidopsis thaliana seedlings cDNA library 
constructed into pP6. pB27 and pP6 derive from the original pBTM116 (21) and pGADGH 
(22) plasmids, respectively.  76 million clones (8-fold the complexity of the library) were 
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screened using a mating approach with YHGX13 (Y187 ade2-101:loxP-kanMX-loxP, 
matα) and L40ΔGal4 (mata) yeast strains as previously described (23). 50 His+ colonies 
were selected on a medium lacking tryptophan, leucine and histidine, and supplemented 
with 0.5 mM 3-aminotriazole to handle bait autoactivation. The prey fragments of the 
positive clones were amplified by PCR and sequenced at their 5’ and 3’ junctions. The 
resulting sequences were used to identify the corresponding interacting proteins in the 
GenBank database (NCBI) using a fully automated procedure. A confidence score (PBS, 
for Predicted Biological Score) was attributed to each interaction as previously described 
(24). The PBS relies on two different levels of analysis. Firstly, a local score takes into 
account the redundancy and independency of prey fragments, as well as the distribution of 
reading frames and stop codons in overlapping fragments. Secondly, a global score takes 
into account the interactions found in all the screens performed at Hybrigenics using the 
same library. This global score represents the probability of an interaction being 
nonspecific. For practical use, the scores were divided into four categories, from A (highest 
confidence) to D (lowest confidence). A fifth category (E) specifically flags interactions 
involving highly connected prey domains previously found several times in screens 
performed on libraries derived from the same organism. Finally, several of these highly-
connected domains have been confirmed as false-positives of the technique and are now 
tagged as F. The PBS scores have been shown to positively correlate with the biological 
significance of interactions (25, 26).  
Gene ontology analysis 
A Fisher exact test was used to test for enrichment of GO categories within the 657 
proteins when compared to the TAIR reference set (34274 proteins). P-values were 
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corrected for multiple testing using the false discovery rate (FDR) controlling procedure of 
Benjamini and Hochberg. A P-value < 0.05 and a cutoff of FDR < 0.02 was used to score 
significantly over- or under-represented GO terms. 
Protein expression and purification 
 Vectors encoding the 6X His fused to PP2A-3 were transformed into Rosetta2 
(DE3) pLysS (Novagen) cells and plated on Kanamycin containing plates. Luria Broth 
cultures supplemented with 50 µg/ml Kanamycin were initiated by standard procedures. 
Cultures were grown with shaking at 37 °C for ~3 h until an OD600 = 0.6-0.8 was reached. 
The temperature was reduced to 20°C and cultures were induced with 0.5 mM IPTG. The 
cultures were incubated overnight, harvested by centrifugation, and stored at -80°C until 
needed. The 6X His tagged PP2A3 was purified as follows. Frozen pellets from 250 ml 
cultures were thawed on ice and resuspended in 10 ml Lysis Buffer (50 mM Tris-HCl pH 
7.4, 150 mM NaCl, 10 mM imidazole, 0.1% Triton X-100, 8M urea, 1 mM DTT, and 1 
mM AEBSF). Cells were lysed by sonication on ice and the resulting lysate was centrifuged 
at 13,200 rpm for 15 min at 4 °C. Supernatants were then transferred to a 10-ml column 
containing 250 µl of Ni-NTA Superflow resin (Qiagen) equilibrated with Lysis Buffer. The 
resin/lysate mixture was incubated on a rocker at 4 °C for 1 h. After incubation, the 
unbound proteins were allowed to flow through the column. The resin was washed with 10 
ml of Wash Buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 20 mM imidazole, 6M urea, 
1 mM DTT). Bound proteins were eluted with three successive 250 µl aliquots of Elution 
Buffer (50 mM Bis-Tris pH 7.2, 50 mM NaCl, 250 mM imidazole, 6M urea, 1 mM DTT) 
on ice. Urea was removed by three rounds of dialysis against buffer and protein amount 
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was determined by the Bradford method. This showed that PP2A-3 could be expressed in 
E. coli with ~90% purity ~ and a yield of ~0.8 mg/ml (Figure S11).  
Circular Dichroism (CD) Measurements. 
 The conformation of PP2A-3 was examined by Circular Dichroism. The protein 
sample was dialyzed overnight against 10mM Tris HCl, pH 7.4 and 0.1mM TCEP and 
concentrated to an A280 value of approximately 1.0. Far-UV spectra of protein at varied 
concentrations, were obtained on a Jasco J-710 spectropolarimeter, in a 0.1cm path-length 
cuvette with excitation wavelengths ranging from 190 nm-260 nm. Scans were performed 
at an excitation wavelength of 280 nm, a bandwidth of 5 nm and a scan speed of 120 
nm/min. The CD profile indicated a highly α-helical conformation indicating that the 
protein was folded correctly, in keeping with the crystal structure of the holoenzyme, which 
shows the C subunit to be predominantly a-helical (Figure S12). 
Phosphopeptide analyses 
 The data-dependent tandem mass spectrometric analysis of the tryptic peptides 
revealed several phosphopeptides. Determination of the exact site of phosphorylation 
within the phosphopeptides was performed by inspection of their fragmentation pattern for 
specific diagnostic site-determining yn and bn ions (27). As an example, the collisional   
induced tandem mass spectrum for the phosphopeptide 299RGEPGVpTR305 is shown in 
Figure S13 A. The most prominent ion is the doubly charged [M+2H-H3PO4]2+ species at 
a m/z of 456.24. This is characteristic of a neutral loss of phosphoric acid by which 
phosphorylation sites are identified. An unambiguous confirmation of Thr304 as the 
phosphorylated residue was afforded by the presence of the site-determining non-
phosphorylated and phosphorylated ions b6, b7, y1 and y2 (SI Appendix).  Similarly, the 
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collision-induced high resolution mass spectrum of the peptide 260VVTIFSAPNYCYR272 
before and after phosphorylation (Figure S13 B-C) clearly identified the presence of 
phosphorylated y-series fragment ions y2-y5 with the expected mass shift of 80 m/z units, 
confirming a phosphorylated Tyr271 as the phosphorylated residue (Figure S13 C). 
Protein overlay assays 
To demonstrate interaction between PP2A-3 and naïve SUMO: ACR4ICD protein 
(naïve and auto phosphorylated), 1 µg of 6X-Histidine tagged PP2A-3, GST fused 
Polypyrimidine-Tract Binding protein (PTB) and BSA protein were separated by 12 % 
SDS-PAGE and blotted to PVDF membrane. Blots were then blocked with 5 % milk 
protein in PBS + 0.1 % Tween 20 overnight. They were then incubated with purified bait 
proteins, naïve and auto phosphorylated ACR4ICD in the protein-binding buffer to a final 
concentration of 10 nM. To demonstrate specific interaction between PP2A-3 and 
ACR4ICD, blotted proteins were also incubated with SUMO protein as a control on shaker 
platform for about 1.5 h at room temperature, followed by three washes with PBS + 0.1% 
Tween (PBST) at 10 min intervals. To detect protein binding, blots were first incubated 
with 1:1000 diluted anti-SUMO primary antibody (Rockland Immunochemical) for 1hr at 
RT in 3% milk in PBST followed by three washes with PBST, each for 10min, followed 
by incubation with polyclonal anti-rabbit secondary antibody conjugated to Alkaline 
Phosphatase (AP) (Sigma, 1: 3,000) for 1hr at room temperature. Specific protein binding 
was calorimetrically detected by using AP Substrate kit (Bio-Rad). 
Protein extraction and Phosphatase Assay 
Arabidopsis lines for acr4-2, rcn-1-6, pp2a-3, and Col-0 were gas-sterilized (3mL 
100% HCL + 97mL thin bleach solution) for 4 hours then stratified for 2 days at 4°C. Seeds 
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were sown on ½ Murashige-Skoog medium (including myoinositol and MES) and 1% 
bacteriological agar. Approximately 5g of seedlings, grown until 12 days post germination, 
were ground whole in liquid nitrogen. Fresh phosphatase storage buffer [50mM Tris-HCl 
pH 7.5, 0.05% (v/v) Triton X-100, 100uM EDTA, 500uM PMSF, 0.05% (v/v) β-
mercaptoethanol, 10% (v/v) glycerol, 0.5% (v/v) protease inhibitor cocktail (Sigma)] was 
added (½ volume/weight) directly to the frozen tissues and ground to a fine paste, then 
filtered through miracloth (in a cold room) to remove cell debris. The resultant cell lysate 
was centrifuged for 10 min at 4°C at 13,000 g. Endogenous phosphate was removed using 
the supplied Sephadex G-25 columns (Promega) according to the manufacturer’s 
instructions. Protein levels were quantified using the Bradford assay. PP2A phosphatase 
activity was measured using a molybdate dye-based phosphatase assay kit according to the 
manufacturer’s instructions. The reactions were incubated at 37°C for 30 mins before being 
stopped by the addition of the molybdate dye and additive mixture. The glass bottomed 96-
well plate was read on a Tecan Infinite M200 Pro spectrophotometer at 30°C, utilizing 25 
flashes at 600 nm, with 4 reads per well (within a well-border of 1,700µm). The phosphate 
released by samples was determined by comparing the protein samples to the standard 
curves using Magellan v7.0 software. The experiment was performed in three independent 
biological repeats.  
Tandem Affinity Purification 
 For the TAP approach, transformation of Arabidopsis cell suspension cultures was 
carried out as previously described (28, 29). Tandem affinity purification of protein 
complexes was done using the GStag (30) followed by protein precipitation and separation, 
according to a previously described protocol (29). The protocols of proteolysis and peptide 
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isolation, acquisition of mass spectra by a 4800 MALDI TOF/TOF Proteomics Analyzer 
(AB SCIEX), and MS-based protein homology identification based on the TAIR genomic 
database have also been described previously (31). Experimental background proteins were 
subtracted based on approximately 40 TAP experiments on wild type cultures and cultures 
expressing TAP-tagged mock proteins GUS, RFP and GFP (31). 
Kinase and Phosphatase Assay 
 To demonstrate phosphorylation of E.  col i -expressed PP2A-3 by the ACR4 
kinase and dephosphorylation of ACR4ICD by PP2A-3, we used the following approaches. 
The kinase assay was performed as described previously (32). B r i e f l y ,  SUMO 
fused ACR4ICD was first auto phosphorylated using 2µCi of [γP32] ATP as reported 
previously (32). 10 µg of PP2A-3 was subsequently added to 20 µl reaction volume, 
containing 1 µg of auto phosphorylated ACR4 ICD in kinase buffer.  The react ion was  
incubated  for  1  hour  a t  RT and subsequently terminated by the addition of 6 µL of 
4X Laemmli buffer and boiling for 5 min.  Proteins were resolved by 12% SDS-PAGE, 
stained with Coomassie Brilliant Blue R-250, and then analyzed by exposure to a 
phosphorimaging screen. To test the phosphatase activity of PP2A against phosphorylated 
ACR4ICD, two approaches were utilized: (1) Pro-Q Diamond phospho-protein staining 
technique and (2) Radioactive assay. In the Pro-Q Diamond staining protocol, ~125 µg of 
ACR4ICD was first auto phosphorylated with 100 µM cATP in a 200 µl reaction volume of 
kinase buffer for 1hr at RT. The free ATP was then removed by affinity purification of the 
phosphorylated protein using Ni-NTA resin and multiple washing steps with wash buffer 
(1X TBS, 30 mM Imidazole, 1 mM DTT). The protein was subsequently eluted from the 
resin and used in the phosphatase assay as follows. 1µg of phosphorylated ACR4ICD was 
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incubated with 10 µg of PP2A-3 in a 40 µl reaction volume in phosphatase buffer (50mM 
Tris, pH 7.4, 5 mM MnCl2 and 10 mM MgCl2) for 1hour at room temperature. The reaction 
was terminated by 4X SDS buffer/heating followed by SDS-PAGE. The control proteins 
for comparative phosphorylation state measurement were 1µg of mutant ACR4 
(mACR4ICD) and 10 µg of PP2A in phosphatase buffer. The gel was stained with Pro-Q-
diamond stain (as described in the next section) and analyzed by typhoon imaging. The 
destained gel was then stained with SyPro Ruby protein stain (Invitrogen) to determine the 
total protein. For the radioactive assay, γ32P labeled ACR4ICD was first prepared using a 
mix of 25 µM cold ATP and 2 µCi of [γ32P] ATP in a 200 µl reaction volume in kinase 
buffer. The removal of ATP and the phosphatase assay was performed as described above. 
The proteins were resolved on a 12% SDS PAGE and further analyzed by exposure to a 
phosphoimaging screen. Coomassie Blue staining determined the total protein. 
Dephosphorylation of auto phosphorylated ACR4ICD by human PP2A 
 Human PP2A, consisting of both the catalytic C chain and the scaffolding A chain 
was obtained from Millipore. Phosphorylation status of the proteins was determined using 
a phospho-protein stain, Pro-Q Diamond (Invitrogen). Naïve ACR4ICD was first auto-
phosphorylated with cold ATP as described elsewhere. Subsequently, 1 µg of auto-
phosphorylated ACR4ICD was incubated with 0.4 units of human PP2A in 20 µl reaction 
volume of 50 mM Tris HCl, pH 7.4, 5 mM MnCl2 and 10 mM MgCl2 (phosphatase buffer) 
for 1 hour. The reaction was then terminated by boiling in 4X SDS sample buffer. To 
compare the phosphorylation status, 1 µg of inactive mACR4ICD, naïve ACR4ICD and auto 
phosphorylated ACR4ICD were also separated on 12% SDS gel along with the phosphatase-
treated auto-phosphorylated ACR4ICD. The gel was then fixed for 2x30 min with solution 
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containing 50% methanol and 10% acetic acid followed by three washes with deionized 
water. Staining with Pro Q diamond stain was achieved for 90 min in the dark and then de-
stained with 50 mM sodium acetate buffer pH 4.0 containing 20% acetonitrile. Images of 
the stained gel were acquired on a Molecular Dynamics Typhoon scanner (GE healthcare) 
with an excitation source of 532 nm laser and a 580-nm bandpass emission filter.   
Gel Filtration.        
 Interaction between sACR4ICD and 6X His-PP2A-3 was also analyzed by gel-
filtration on an AKTA FPLC system. An equimolar mixture (5 µM) of purified naïve 
SUMO: ACR4ICD and PP2A-3 was incubated in 500 µl column buffer (50 mM Tris pH 7.2, 
100 mM NaCl, 1 mM DTT and 100 µM MnCl2) for 1 hour at room temperature and 
subsequently loaded onto a Global 10/300 Superdex G-200 Column (GE healthcare, bed 
volume 24 ml) equilibrated with column buffer. The column was developed at a flow rate 
of 0.3ml/min and 0.5ml fractions were collected. Fractions corresponding to the peak were 
analyzed by SDS-PAGE. Gel filtration was also performed on the individual proteins 
sACR4ICD and 6X His-PP2A-3. 
High-Resolution Mass Spectrometry 
 The endoprotease (trypsin) digests were analyzed by using nano-LC-MS with a 
linear ion trap orbitrap mass spectrometer (Orbitrap ELITE) (33) (Thermo Fisher 
Scientific). Chromatographic separations were performed by using a nano-LC 2D Plus 
(Eksigent, Dublin, CA) for gradient delivery and a cHiPLC-Nanoflex system (15-cm × 75-
µm C18 packing (ChromXP C18-CL, 3 µm, 120 Å; Eksigent). The liquid chromatograph 
was interfaced to the mass spectrometer with a nanospray source (PicoView PV550; New 
Objective, Woburn, MA). Mobile-phase components were 1% FA in water (solvent A) and 
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1% FA in 99% ACN (solvent B). After equilibration of the column in 98% solvent A/2% 
solvent B, the samples were injected (10 µl) by using an AS2 autosampler (Eksigent), at a 
flow rate of 800 nl/min. The peptides were separated by using an AcN gradient at 800 
nl/min, as follows: isocratic elution at 2% solvent B, 0 to 3 min; 2% solvent B to 40% 
solvent B, 3 to 240 min; 40% solvent B to 80% solvent B, 240 to 250 min; 80% solvent B 
to 2% solvent B, 250 to 255 min; isocratic elution at 2% solvent B, 255 to 275 min. The 
total cycle time, including column equilibration, sample loading, and gradient elution of 
peptides, was 305 min. The survey scans (m/z 350-2000) (MS1) were acquired at 120,000 
resolution at m/z 400) in the Orbitrap in profile mode, and the product-ion mass 
spectrometry spectra (MS2) were acquired at 15,000 resolution in profile mode, after high 
energy collision-induced dissociation. The maximal injection times for the LTQ and 
Orbitrap were 50 ms and 200 ms, respectively. The automatic gain-control targets for the 
LTQ and the Orbitrap were and 3 × 104 and 1 × 106 respectively. The MS1 scans were 
followed by 20 MS2 events in the linear ion trap with collision activation in the ion trap 
(parent threshold, 15,000; isolation width, 2.5 Th; normalized collision energy, 30%; 
activation Q, 0.250; activation time, 30 ms). Dynamic exclusion was activated for 60 s after 
MS2 acquisition. A repeat count of 3, a repeat duration of 15 s, and a maximal exclusion 
list size of 500 were used. The following ion source parameters were used: capillary 
temperature, 200°C; source voltage, 4.0 kV; source current, 100 µA; tube lens, 79 V. The 
data were acquired by using Xcalibur 2.2.48 (Thermo Fisher). 
In-vitro pull down assay 
15 µl packed volume GST-Sepharose 4B (GE Healthcare) was washed 3X with 1ml 
HEPES/NaCl (100mM HEPES, 25 mM NaCl, pH 8) buffer. Beads were pre-blocked with 
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1% BSA for 10min at 4°C with rotation. 1µg of each protein was added to binding buffer 
(100mM HEPES, 25 mM NaCl, pH8, 10 mM MgCl2, 0.2 mM CaCl2, 300 µM ATP, 5mM 
DTT, 1% BSA (v/v)) in a total volume of 400 µl. Pre-blocked beads were added to the pull 
down mix and incubated for 1h at 4°C with rotation. After incubation supernatant was 
removed and beads washed 3X with HEPES/NaCl buffer. Bound proteins were eluted 
using 50 µl sample loading buffer (100 mM Tris-HCl pH 6.8, 20% glycerol (v/v), 0.2% 
bromophenol blue (w/v), 4% SDS (w/v), 0.2M DTT), heated at 95°C for 5 min and 
centrifuged for 1 min at 14000 x g. Eluted proteins and their respective inputs were 
separated on a 10% SDS-PAGE gel and blotted onto PVDF membrane (GE Healthcare). 
Membranes were probed using using anti-MBP (Abcam) 1:12000 and anti-GST 1:10000 
(Abcam) and visualised using ECL prime chemiluminescence (GE Healthcare) prior to 
exposure on film (GE Healthcare). 
In planta co-immunoprecipitation 
 Nicotiana benthamiana transient transformation was performed as previously 
described. Protein extraction and co-immunoprecipitation were performed as previously 
described (34) with modifications (extraction buffer at pH 9.5). GFP Trap was used for the 
co-immunoprecipitation. Co-immunoprecipitated proteins were detected using mouse anti-
flag 1:2000 (Sigma) and rabbit anti-HA 1:5000 (Sigma), secondary antibodies used were 
HRP conjugated anti-mouse IgG 1:50000 (Sigma) and HRP conjugated anti-rabbit IgG 
1:20000 (Sigma). Western blot transfer was performed using pH 9.5 transfer buffer. 
In silico analyses 
 CORNET (COrelationNETworks) is online software that utilizes gene expression 
and protein-protein interaction databases to create potential functional associations for any 
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number of query genes and putative interacting partners (https://cornet.psb.ugent.be). Co-
expression between pairs of query genes, and between query genes with neighbours 
(directly interacting partners) was determined using the Pearson correlation coefficient 
(PCC) (35). The output of this analysis was then analyzed using Microsoft Excel database 
software. For the initial ACR4 PPIs, all databases and interactions were included for the 
CORNET analyses, and focusing ACR4 and interactions with/between neighbors. 
Cytoscape software (36) was used to visualize protein–protein interaction networks. To 
identify similarities in possible biological processes and molecular functions of the genes 
in our networks we used the Cytoscape add-on BiNGO. BiNGO analyses the Gene 
Ontology (GO) identifiers of specified genes and categorises them into a list of either 
biological processes or molecular functions (among others). Through this approach an 
entire network, or a subset, can be selected to observe the overall trend of gene function 
and process. Interactome databases were individually analyzed by BiNGO to observe if 
there were any similarities in gene function.  
Homology Modeling of PP2A-3 catalytic chain. 
The MODELER program (37) in Discovery Studio v4.0 (BIOVIA, formerly 
Accelrys) was used to build a model for the catalytic chain of the Arabidopsis protein based 
on the 74% amino acid sequence identity and 83% similarity with the C chain of the human 
phosphatase holoenzyme. The homology model was built using the C chain coordinates 
within the context of the crystal structure of the trimeric human enzyme (PDB 
identification 2IAE) (38). Ten energy minimized models were generated and one model 
with the lowest value of the objective function was selected for further refinement. The 
compatibility of the modeled structure with its amino acid sequence was validated using 
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the Verify Protein (Profiles 3D) program (39). Percent side-chain solvent accessibility of 
the phosphorylation sites was computed based on the solvent accessibility of the 
corresponding residues in the catalytic chain of the human holoenzyme trimeric structure. 
Phosphorylation sites at Ser 5 and Thr 305 are not seen as the first 5 residues at the N-
terminus and the last 15 residues at the C-terminus are not included in the homology model. 
(Phospho)proteomics          
  For (phospho)proteomics 50 mg of seeds of Arabidopsis thaliana (Columbia-0) 
and acr4-2 plants were surface sterilized and sown in 100 ml liquid half-strength Murashige 
and Skoog (MS) medium containing 1% (w/v) sucrose. Seeds were vernalized for 2 days 
at 4°C, after which they were grown for 5 days at 21°C in a day/night regime (16h light/8h 
dark) while mixing at 90 rpm. Three biological repeats were done. 
The phosphoproteome pipeline was based on a previously published protocol (40), 
except that we opted for label free quantitation instead of the proposed 15N metabolic 
labeling. Other than that, only minor adjustments were implemented. In brief, Arabidopsis 
five-day-old seedlings were ground in a mortar under liquid nitrogen. Proteins were 
extracted in a buffer consisting of 250 mM triethylammonium bicarbonate (TEAB) pH 8, 
290 mM sucrose, 25 mM EDTA, 1 mM DTT and the appropriate amount of the Complete 
protease inhibitor mixture and the PhosSTOP phosphatase inhibitor mixture (both from 
Roche, Basel, Switzerland). After centrifugation, the proteins in the supernatant were 
precipitated via chloroform/methanol precipitation. The protein pellets were washed with 
80% acetone and solubilized with 8 M urea. Before digestion, the samples were diluted to 
1 M urea with 50 mM TEAB buffer (pH 8). S-reduction and S-alkylation were performed 
with DTT and iodoacetamide, as described by Minkoff et al., 2013. 1 mg of the proteins 
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was digested with trypsin overnight at 37 °C (Promega Trypsin Gold, mass spectrometry 
grade) at an enzyme-to-substrate ratio of 1:100 (w:w). The digest was acidified to pH ≤ 3 
with trifluoroacetic acid (TFA) and desalted with SampliQ C18 SPE cartridges (Agilent, 
Waldbronn, Germany). The elutions were dried down in a vacuum centrifuge and re-
dissolved in 100 µl of 80% acetonitrile, 6% TFA. The peptides were loaded on house-made 
chromatographic columns packed with 500 µg Sachtopore-NP TiO2 beads (5 µm, 300 Å; 
ZirChrom, Minnesota, USA), washed twice with 50 µl of 80% acetonitrile, 0.1% TFA and 
eluted with 30 µl of 1% ammonium hydroxide solution. Before drying down, the eluate 
was acidified with formic acid to pH < 3. 
Each phosphopeptide sample was re-dissolved in 50 µl of 2% acetonitrile with 0.1% 
TFA. A 15 µL aliquot of each sample was subjected to LC-MS/MS analysis using an 
Ultimate 3000 RSLC nano LC (Thermo Fisher Scientific, Bremen, Germany) system 
coupled to an Q Exactive mass spectrometer (Thermo Fisher Scientific, Bremen, 
Germany). The sample mixture was first loaded on a trapping column (made in-house, 100 
µm internal diameter (I.D.) × 20 mm, 5 µm beads C18 Reprosil-HD, Dr. Maisch, 
Ammerbuch-Entringen, Germany). After flushing from the trapping column, the sample 
was loaded on an analytical column (made in-house, 75 µm I.D. × 150 mm, 3 µm beads 
C18 Reprosil-HD, Dr. Maisch). Peptides were loaded with loading solvent (0.1% TFA in 
water) and separated with a linear gradient from 98% solvent A’ (0.1% formic acid in 
water) to 55% solvent B′ (0.1% formic acid in water/acetonitrile, 20/80 (v/v)) in 170 min 
at a flow rate of 300 nL/min. This is followed by a 5 min wash reaching 99% solvent B’. 
The mass spectrometer was operated in data-dependent, positive ionization mode, 
automatically switching between MS and MS/MS acquisition for the 10 most abundant 
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peaks in a given MS spectrum. The source voltage was 3.4 kV, and the capillary 
temperature was 275°C. One MS1 scan (m/z 400−2000, AGC target 3 × 106  ions, 
maximum ion injection time 80 ms) acquired at a resolution of 70000 (at 200 m/z) was 
followed by up to 10 tandem MS scans (resolution 17500 at 200 m/z) of the most intense 
ions fulfilling predefined selection criteria (AGC target 5 × 104  ions , maximum ion 
injection time 60 ms, isolation window 2 Da, fixed first mass 140 m/z, spectrum data type: 
centroid, underfill ratio 2%, intensity threshold 1.7xE4,  exclusion of unassigned, 1, 5-8, 
>8  charged precursors,  peptide match preferred, exclude isotopes on, dynamic exclusion 
time 20 s). The HCD collision energy was set to 25% Normalized Collision Energy and 
the polydimethylcyclosiloxane background ion at 445.120025 Da was used for internal 
calibration (lock mass). 
MS/MS spectra were searched against the TAIR10 database (35,386 entries, 
version January 2012) with the MaxQuant software (version 1.5.0.30) with a precursor 
mass tolerance set to 20 ppm for the first search (used for nonlinear mass re-calibration) 
and set to 4.5 ppm for the main search. Trypsin was selected as enzyme setting. Cleavages 
between lysine/arginine-proline residues and up to two missed cleavages were allowed. 
Carbamidomethylation of cysteine residues was selected as a fixed modification, and 
phosphorylation of serine, threonine and tyrosine residues and oxidation of methionine 
residues were selected as variable modifications. The false discovery rate for peptide and 
protein was set to 1%, and the minimum peptide length was set to 7. The MaxLFQ 
algorithm allowing label free quantification (41) and the ‘Matching Between Runs’ feature 
were enabled. 
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Supplemental Figures
 
Figure S1. (A-B) Tracing of primary root tip (A) and lateral root initiation site (B). 
Yellow indicates region of interest, namely columella (A) and dividing pericycle (B). (C-
F) pACR4::ACR4:GFP in the primary root tip stem cell / columella region (C), during 
lateral root initiation (D-E) and in a lateral root primordium (F). Overlay with propidium 
iodide staining (C) and differential interference contrast image (F) to outline the primary 
root tip and lateral root, respectively. (G) Representative image of pPP2A-3::n3xGFP 
during lateral root initiation of 4 day old seedlings. *, columella stem cells; pink arrowhead, 
quiescent center; red arrowhead, boundary between position of two adjacent pericycle cells 
before asymmetric cell division; blue arrowhead, subsequent asymmetric cell divisions; 
white arrowhead, pericycle.
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Figure S2. (A) CORNET-based interactions. ACR4 (AT3G59420) highlighted in 
yellow. (B) Root tip expression based on Arabidopsis eFP Browser data (absolute values 
– orange to red indicates gradation of increased expression.
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Figure S3. (A) Detection by western blot of ACR4ICD fused to an N or C-terminal TAP 
tag produced in transgenic Arabidopsis cell suspension cultures. Detection was 
achieved with PAP antibody binding to the protein G domain in the GS-tag. (B-E) Protein 
overlay assay (see SI Supplemental Note below for further details.) showing that PP2A-3 
can interact with naïve and phosphorylated ACR4ICD. (B) Lane 1, ~1 µg of PP2A-3. Lanes 
2 and 3 GST-fused POLYPYRIMIDINE-TRACT-BINDING PROTEIN (PTB) and 
BOVINE SERUM ALBUMINE (BSA) as negative controls. (C) Blot probed with SUMO 
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protein shows no specificity towards PP2A-3. (D) Blot probed with SUMO- ACR4ICD 
shows specific binding to PP2A-3 (Lane 1, *). (E) Blot probed with phosphorylated 
SUMO- ACR4ICD also shows specific binding to PP2A-3 (Lane 1, *). The results shown 
here are representative of experiments performed at least 3 times. (F-K) Gel filtration 
analysis (see SI Supplemental Note below for additional details) of the interaction between 
PP2A-3 and ACR4ICD on a Superdex G-200 Column. (F-G) Elution profile of PP2A-3 (5 
µM) at a flow rate of 0.5 ml/min. 0.3 ml fractions were collected and the fractions indicated 
by double-headed arrows were analyzed by SDS-PAGE (F). SDS-PAGE of fractions 
indicated by double-headed arrows (G). Note that PP2A-3 with a MW of ~37 kDa elutes 
as an oligomer (full line double headed arrow) in gel filtration and that the lower band is a 
PP2A-3 degradation product.  (H-I) Elution profile of ACR4ICD (5 µM) under the same 
conditions as A (H). SDS-PAGE of fractions indicated by double-headed arrows (I). Note 
that ACR4ICD with a MW of ~62 kDa elutes closer towards the end of the bed volume 
(dashed line double headed arrow) and that there is no evidence of a higher order oligomer 
(full line double headed arrow). (J-K) Elution profile of a mixture of PP2A-3 and ACR4ICD 
(5 µM each) under the same conditions as A (J). SDS-PAGE of fractions indicated by 
double-headed arrows (K). Note that the band for ACR4ICD now appears along with PP2A-
3 in the peak fraction, indicative of the interaction between the two proteins. 
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Factors Degrees of freedom Sum Sq Mean Sq F value Pr(>F) 
















3 0.12 0.039 0.147 0.931 
Residuals 134 35.37 0.264   
 
Figure S4. (A) Impact of NPA on Col-0, acr4, pp2a-3 and acr4 pp2a-3 primary root length 
at 7 days after germination (seedlings continuously grown on 1 µM NPA). *, p-value < 
0.05 according to Student’s t-Test compared to mock. Boxplots with outliers are shown. 
Table indicates two-way ANOVA analysis for A (n ≥ 15). (B) Impact of NPA on Col-0, 
acr4, pp2a-3 and acr4 pp2a-3 columella stem cell differentiation at 4 days after 
germination (seedlings continuously grown on 1 µM NPA) (n ≥ 33). Statistical significance 
(Z Test Calculator for 2 Population Proportions) compared to Col-0 (*, p < 0.05) or through 
connected lines (n.s., not significant at p > 0.05) is indicated.
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Figure S5. (A) PP2A-3 and PP2A-4 expression in Col-0 and acr4 roots of 7-8 day old 
seedlings. (B) ACR4 expression in Col-0, pp2a-3 and pp2a-3 pp2a-4 root tips of 6 day old 
seedlings. (C) ACR4: GFP expression levels (monitored through GFP levels) in control 
and pp2a-3 pp2a-4 of root tips of 6 day old seedlings. Student’s t-test compared to control 
revealed no significant difference at p > 0.05. (D) ACR4 expression in 5 day old -0 seedling 
roots upon cantharidin treatment for indicated periods. (E) pACR4::ACR4:GFP in 5 day 
old root tips of a control line and in pp2a-3 pp2a-4. Although not as discrete as in the 
control, the pp2a-3 pp2a-4 double mutant still displays higher GFP (white box), and some 
membrane localization. Graphs show average ± standard error of 2 or 3 biological repeats. 
Statistical significance (Student’s t-test) compared to Col-0 is indicated: *, p-value < 0.05




Figure S6. Expression of QC184 and pWOX5::GUS in 5-day-old transferred to 10 µM 
cantharidin for indicated times (hrs). Representative pictures with number of seedlings with 
similar expression pattern indicated. The WOX5 expression domain appears to expand 
quickly, but more significantly at 48 hours after transfer.






Sum Sq Mean Sq F value Pr(>F) 
Line 5 233.71 46.74 123.87 < 2e-16 
Treatment 1 163.14 163.14 432.34 < 2e-16 
Line: Treatment 
(interaction) 
5 23.43 4.69 12.42 6.36e-11 
Residuals 288 108.67 0.38   
 
Figure S7. Impact of cantharidin on Col-0, acr4, pp2a-3, pp2a-4 and pp2a-3 pp2a-4 
primary root length at 7 days after germination (seedlings continuously grown on 
cantharidin 50 µM). * or #, p-value < 0.05 according to Student’s t-Test compared to mock 
or Col-0 (within mock or cantharidin treated), respectively. Boxplots with outliers are 
shown. Table indicates two-way ANOVA analysi
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Figure S8. (A-B) ACR4-mediated phosphosites on PP2A-3. (A) Summary of ACR4-
mediated phosphosites as determined by mass spectrometry of in vitro phosphorylated 
PP2A-3 and mapped on PP2A-3 protein sequence from TAIR. (B) Homology model of 
PP2A-3 showing 7 of the 9 phosphorylated residues (red ball and stick). (C-D) E. coli-
expressed PP2A-3 does not dephosphorylate ACR4ICD. (C) Phosphatase assay using [γ32P] 
labeled ACR4ICD and autoradiogram. Lower panel, Coomassie stained gel; upper panel, 
corresponding autoradiogram. From left to right, molecular weight standards; 1 µg of 
mutant inactive kinase mACR4ICD (lane 1); 1 µg of auto phosphorylated [γ32P] ACR4ICD 
(with free ATP removed) (lane 2); 1 µg of auto phosphorylated [γ32P] ACR4ICD (with free 
ATP removed) incubated with 10 µg PP2A-3 in phosphatase buffer (lane 3); 10 µg PP2A-
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3 in phosphatase buffer (lane 4). (D) Phosphatase assay using ACR4ICD phosphorylated 
with cold ATP and phosphoprotein Pro-Q Diamond staining. Lower panel, Sypro Ruby 
stained gel; upper panel, corresponding Pro-Q Diamond stained gel. From left to right, 1 
µg of mutant inactive kinase mACR4ICD (lane 1); 1 µg of auto phosphorylated ACR4ICD 
(with free ATP removed) (lane 2); 1 µg of auto phosphorylated ACR4ICD (with free ATP 
removed) incubated with 10 µg PP2A-3 in phosphatase buffer (lane 3); 10 µg PP2A-3 in 




Figure S9. Localization of membrane marker FH6: GFP following treatment with DMSO 
or 50 µM cantharidin for 24 hours. (A) Localization of FH6: GFP.  (B) Quantification of 
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Figure S11. Analysis of PP2A-3 protein purification by SDS-PAGE. Lane 1, total 
protein from E. coli lysate; Lane 2, flow-through after incubation of lysate with Ni-NTA 
resin; Lane 3, fraction collected after washing the resin with buffer containing 6M urea; 
Lanes 4-7, four fractions collected with elution buffer containing 250 mM imidazole and 
6 M urea.





Figure S12. Conformational analysis of PP2A-3. Far UV CD spectra in 10 mM Tris (pH 
7.4) and 0.1 mM TCEP at concentrations of 0.5 mg/ml, 0.25 mg/ml and 0.10 mg/ml. 
Minima are observed at ~208 and 222 nm, indicating a dominant α-helical structure. 
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Figure S13. Examples of phosphopeptide determination. (A) Collision-induced high 
resolution fragmentation spectrum of the phosphopeptide RGEPDVpTR encompassing 
residues 299-305 (underlined). The presence of phosphorylated y-series fragment ions y2-
y7 confirms T305 as the site of phosphorylation. (B-C) Collision-induced high resolution 
fragmentation spectrum of the peptide VVTIFSAPNYCYR (Mascot ion score 65) (B) and 
the phosphorylated VVTIFSAPNYCpYR (Mascot ion score 62) (C), encompassing 
residues 260-272 of the PP2A3c sequence (underlines). The MS1 panels show the MS 
spectrum of the doubly charged protonated molecular ion [M+2H]2+ for each peptide (B-
C). Isotope clusters are separated by 0.50 Da, confirming the charge state of each peptide. 
The MS/MS spectrum demonstrates the presence of the phosphorylated y-series fragment 
ions, y2-y8, confirms Y271as the site of phosphorylation (C). As an example, the nominal 
mass shift of a 80 m/z units is represented for the phosphorylated y2-y5 fragments ions is 
shown.
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Additional Experiments 
 
Pull down assay 
The MBP fused intracellular domain of ACR4 kinase (20 µg per reaction) was used 
as bait to pull out 6XHis-tagged PP2A3c (30 µg per reaction). Depending on the assay 
conditions, MBP-ACR4(ICD) was auto phosphorylated in 200 µl Kinase Buffer (20 mM 
Bis-Tris pH 7.2, 25 mM NaCl, 5mM MnCl2, 1 mM DTT) and 100 µM ATP, 1 h prior to 
pull-down experiments[1]. Separate reactions with phosphorylated and naïve ACR4-ICD 
were incubated with 25 µl bed volume of amylose resin. Binding buffer was added (50 mM 
Tris-HCl pH 7.4, 150 mM NaCl, 1 mM DTT, 0.02% NP-40) to a final reaction volume of 
500 µl and the proteins were allowed to bind to resin for 1h on a rotator at room 
temperature. Subsequently, 30 µg of PP2A3c was added and the reactions were further 
incubated for 1h at room temperature on rotator. Reactions were spun down at 1,000 rpm 
for 30 sec to pellet the resin. The resin was washed three times with binding buffer to 
remove unbound protein. After the third wash, the supernatant was removed and 100 µl of 
1X SDS buffer was added to the resin. The resin/protein mixture was boiled at 95ºC for 5 
min, and then centrifuged at max speed to pellet resin. 50 µl of supernatant from each 
reaction was separated by 12% SDS-PAGE and proteins were analyzed by Coomassie 
staining. 
Kinase Assay between PP2A3c and ACR4 kinase phospho mutants. 
1 µg SUMO fused ACR4 ICD (wild type, inactive SUMO-ACR4- 2m mutant, and 
alanine mutants of ACR4 phosphorylation sites) were first auto phosphorylated using 2 
µCi of [γ-32P] ATP in kinase buffer for 1 h at room temperature as reported previously. 
Sixteen sites of phosphorylation were determined and the non-phosphorylated alanine for 
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each phospho-site mutant were prepared as described in [2]. Subsequently, 10 µg of 
purified PP2A3c was added to 20 µl reaction volume containing 1 µg of the auto 
phosphorylated sACR4 protein(s) in kinase buffer for 1 h at RT. Reactions were terminated 
by the addition of 6µL of 4X Lammeli buffer and boiling for 5 min at 95°C. Proteins were 
resolved by 12% SDS-PAGE, stained with Coomassie Brilliant Blue R-250, and then 
analyzed by exposure to an autoradiograph film or a phosphor imaging screen.  
Analytical ultracentrifugation 
 Sedimentation velocity analysis of PP2A3-6H, was performed on an XL-A 
analytical ultracentrifuge (Beckman Coulter). The purified protein was dialyzed overnight 
at 4 °C in 10 mM Tris- HCl (pH 7.4), 50 mM NaCl, and 0.1 mM TCEP. The protein sample 
was concentrated to an A280 of 0.5; 300 µL of the sample was loaded into a preassembled 
flow-through assembly housing an Epon, two-channel centerpiece and quartz windows. 
The rotor and sample cell temperatures were allowed to equilibrate to 20°C for 2h. The 
sample was spun at 30000 rpm and 20°C for a total of 300 scans with a scan rate of one 
scan per minute. Boundaries were monitored by recording the absorbance at 280 nm. Scan 
analysis was performed using Van Holde-Weischet analysis [3] as implemented in 
Ultrascan II. Sedimentation coefficients (S20, w) were corrected for 20 °C and water. 
Results & Discussion 
ACR4 interacts with PP2A3c 
In addition to the pull-down assay performed by our collaborators (Figure 1 C), and 
previously described gel filtration and overlay assays which established the interaction 
between ACR4 and PP2A3c (Figure. S3 and SI Supplemental Notes), we provide evidence 
of interaction between PP2A3c and ICD of ACR4 independent of the phosphorylation state 
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of ACR4-ICD by means of a pull-down assay (Figure A1), where both naïve and auto 
phosphorylated MBP-fused ACR4 (ICD) interact with PP2A3c (Lane 3 and Lane 4) 
Oligomeric state of PP2A3c 
 The denatured and renatured PP2A3c purified through affinity chromatography and 
a secondary size exclusion chromatography was predominantly produced as an oligomer 
(FigureS3, F-G). To eliminate unordered aggregates caused due to possibility of any 
unaccounted disulfide bonds in the purified fractions, the affinity enriched PP2A3c-6H (in 
an elution buffer (described previously) containing 1mM DTT), was further dialyzed under 
high reducing conditions into a buffer with 10mM DTT and purified through a G200 size 
exclusion chromatography superdex column in a buffer containing 50 mM Tris pH 7.2, 
100 mM NaCl, 10 mM DTT and 100 µM MnCl2 (data not shown). We also attempted to 
break open the oligomer by running the affinity enriched sample under high salt conditions 
in a buffer containing 50 mM Tris pH 7.2, 1M NaCl, 10 mM DTT and 100 µM MnCl2. 
(data not shown). Under both these conditions, the protein solely eluted in the void volume 
fraction of G200 column, suggesting the oligomer is not a disordered aggregate but a high 
molecular weight ordered aggregate. We performed sedimentation velocity to determine 
the self-association property of PP2A3c-6H.  The homogenous non-interacting molecules 
sediment with discrete sedimentation coefficients (S) values, whereas the higher ordered 
oligomers formed by interacting molecules exhibit a broad range of sedimenting species.  
Figure A2(top) represents the sedimentation velocity analysis of PP2A3-6H where the 
percent distribution of species is plotted as diffusion –corrected sedimentation coefficients 
along the sedimentation boundary. Figure A2 (bottom) represents the Van Holde –
Weischet analysis of the same data, where the sedimenting boundary is divided into 
 97  
numerous segments and the data is fit by linear least-square analysis to the apparent 
sedimentation coefficient of each boundary segment. Figure A2 (top) shows about 25% of 
sedimenting species exists as homogenous non-interacting monomeric species with S20, w 
value of 4 and the rest 75% show a considerably wider range of much higher S values, 
representing heterogeneous mix of polymeric species. The sedimentation coefficient of 
non-interacting homogenous samples yield a same sedimentation coefficient as a function 
of time in all the parts of the sedimenting boundary and the extrapolated lines for the 
various segments converge to a single value at the y-axis [3,4] but PP2A3c-6H, 
(Figure A2, bottom) show different sedimentation coefficients when the different parts of 
the sedimenting boundary are extrapolated, indicating the heterogeneous nature of 
PP2A3c-6H.  Together these results suggest the high ordered oligomeric nature of PP2A3c-
6H. 
Phosphorylation of PP2A3c is independent of the phosphorylation state of ACR4. 
To further analyze the nature of substrate (PP2A3c) phosphorylation by 
intracellular domain of ACR4, we utilized non-phosphorylated alanine mutants of sixteen 
phosphorylated residues of ACR4 ICD and performed kinase assay against PP2A3c. 
Clearly, we did not observe any phospho- mutant to inhibit or enhance the phosphorylation 
state of PP2A3c qualitatively, suggesting the phosphorylation of PP2A3c is independent 
of the specified phosphorylated state of ACR4 or it is also reasonable to speculate these 
phosphorylated residues are not important for the interaction between ACR4 and PP2A3c. 
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Figure A1: Pull-down assays were performed to determine the interaction between MBP-
fused ACD4-ICD and PP2A3c as described in Materials & Methods. Supernatants from 
pull-down reactions were separated by 12% SDS-PAGE. Lane 1, MBP-ACR4; Lane 2, 
His-tagged PP2A3c; Lane 3, auto phosphorylated ICD of ACR4 (pACR4) and His-tagged 
PP2A3c; Lane 4, naïve ACR4 and His-tagged PP2A3c. Lanes 3 and 4 demonstrate that 
PP2A3c interacts with both naïve and auto phosphorylated ACR4.   
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Figure A2:  Top: Sedimentation velocity analysis of PP2A3-6H performed on an XL-A 
analytical ultracentrifuge using a protein sample with an A280 of 0.4. The sample was 
spun at 30000 rpm and 20 °C for a total of 300 scans with a scan rate of one scan per 
minute; (Bottom) Van Holde-Weischet analysis of PP2A3c. 




Figure A3: PP2A3c is phosphorylated by alanine mutants of ACR4 kinase phospho-
sites. The assay was performed as described in Materials & Methods. 1 µg ACR4 protein 
(wild type, inactive mutant and described alanine phospho-mutants) were incubated in the 
kinase reaction with 10 µg of PP2A3c-6H. Proteins were resolved on a 12% SDS-PAGE 
gel, coomassie stained (Bottom) and, analyzed by phosphor-imaging (Top). 
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CHAPTER 3: TOWARDS THE IN VITRO ACTIVATION OF ARABIDOPSIS 
PHOSPHATASE PP2A3 CATALYTIC SUBUNIT EXPRESSED IN 
ESCHERICHIA COLI 
A manuscript prepared for submission to PLOS one 




 Protein Phosphatase 2A (PP2A) is a serine/threonine phosphatase that exists as a 
hetero-trimeric complex composed of the Scaffold A subunit, the catalytic C subunit and 
the substrate specific variable B subunit. PP2A-3 and PP2A-4 are the two isoforms of the 
C subunit in Arabidopsis. We have previously demonstrated that one of the key steps in 
the regulation of formative cell division in the root is the interaction between the catalytic 
subunit of PP2A3 (PP2A3c) and the kinase domain of the receptor like kinase Arabidopsis 
CRINKLY4 (ACR4). Importantly, PP2A3c is phosphorylated by ACR4 and the 
phosphatase is the first described novel substrate for the receptor kinase. In vivo, the 
catalytic activity of PP2Ac and its interaction with other proteins is regulated by a variety 
of post-translational modifications and, owing to the intrinsic availability of all necessary 
regulatory proteins necessary for differential regulation and activation, expression in 
eukaryotic systems such as insect cell or mammalian cell cultures has been the preferred 
method for obtaining catalytically active human PP2Ac. Here, we describe an alternative 
expression system in Escherichia coli. Although the protein is initially expressed in an 
inactive form, distinct but measurable activity can be detected over time at room 
temperature suggesting a slow conformational change to an active state. Importantly, we 
demonstrate the ability to recover phosphatase activity in vitro in the presence of the 
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protein PP2A PHOSPHATASE ACTIVATOR also referred to as phosphotyrosyl 
phosphatase activator (PTPA). 
Abbreviations 
PP2A, protein phosphatase 2A; PP2A3c, catalytic subunit of PP2A3 isoform; ACR4, 
Arabidopsis CRINKLY 4; PTPA, phospho-tyrosyl phosphatase activator; LCMT-1, 
leucine carboxyl methyl transferase-1; PME-1, phospho methylesterase-1; MBP, maltose 
binding protein; MBP-PP2A3c, MBP-fused PP2A3c subunit;  PP2A3c-Tr, MBP fused 
PP2A3c missing the C terminal  residues RTPDYFL; LIC, ligation independent cloning; 
IPTG, isopropyl b-D-1-thiogalactopyranoside; DTT, dithiothreitol; AEBSF, 4-(2-
aminoethyl) benzene sulfonyl fluoride hydrochloride; IMAC, immobilized metal ion 
affinity chromatography; TBS, Tris buffered saline; FBS, fetal bovine serum; AP, alkaline 
phosphatase; SD, standard deviation; TCEP, [tris(2-carboxyethyl)phosphine]; F-PP2A3c, 
FLAG tagged PP2A3c; PP2A3c-6H, C-terminal 6xHistidine tagged PP2A3c.    
Introduction  
Protein phosphorylation is an important regulatory mechanism in eukaryotic cell 
signaling. Reversible phosphorylation is coordinated by kinases and phosphatases. PP2A 
is a major phosphatase that belongs to the Phosphoprotein Phosphatase (PPP) family of 
phosphatase enzymes and is highly conserved among eukaryotes. It regulates diverse 
physiological and cellular processes in humans [1] and is implicated in diseases such as 
cancer [2]  and Alzheimer’s [3]. In plants, PP2A is one of the major plant serine/threonine 
phosphatases with important roles in growth and development [4,5], cytoskeleton structure 
formation [6], auxin transport [7,8], biotic and abiotic stress signaling [9], abscisic acid and 
ethylene signaling [10,11,12]. In a previous study [13], we have demonstrated that PP2A3c 
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is a substrate for ACR4 and that a signaling pathway mediated by this interaction could be 
a key determinant in the regulation of formative cell division in the Arabidopsis root.he 
core PP2A enzyme exists as a heterodimer composed of the catalytic subunit (PP2A-C) 
and a scaffolding/regulatory subunit (PP2A-A). Specificity of phosphatase activity is 
provided via a combinatorial array of holoenzymes from an assembly of the core enzyme 
with different isoforms of the B subunit[14]. Arabidopsis has five genes encoding PP2A-
C (C1-5), three genes encoding ‘A’ subunit (A1-3) and seventeen genes encoding ‘B’ 
subunits[15]. In vivo, the biogenesis, assembly and activity of the enzymatic complex is 
regulated by a variety of post-translational modifications and protein-protein interactions. 
These include activation of inactive PP2A-C by PTPA through interaction with both active 
site residues and the conserved C-terminal tail of PP2A-C [16,17], the carboxy-methylation 
of the C-terminal leucine by Leucine Carboxy-Methyl Transferase LCMT-1 that is required 
for binding to ‘B’ subunit and holoenzyme assembly [14], the subtle interplay with the 
PP2A specific phospho-methylesterase PME-1 that modulates holoenzyme interactions by 
reversing the C-terminal methylation [18,19] and, phosphorylation of Thr 304 and Tyr 307 
in the catalytic subunit that inhibit catalytic activity [20]. Significant insights into PP2A 
function have been obtained from biochemical investigations of the protein in different 
organisms and structural investigations of the core and holoenzyme have advanced our 
mechanistic understanding of catalysis. Notwithstanding these studies, the molecular basis 
of what appears to be a tightly controlled linear process in vivo may be better understood 
through parallel structure-function studies in vitro with individual recombinantly produced 
proteins that can be used to query the biochemical context of specific interactions through 
biochemical, biophysical and mutagenesis experiments.   
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Owing to the intrinsic availability of all necessary regulatory proteins necessary for 
differential regulation and activation, hitherto, our understanding of the role of post-
translational modifications in the structure and function of PP2A-C has been developed 
predominantly through studies on protein expressed in mammalian cell cultures [21], insect 
cell cultures [22] and yeast cells [23] or direct extraction from animal (bovine) or plant cell 
extracts [24,25,26]. Given the expense and laboriousness of these systems, we now report 
on the expression of the catalytic chain of the isoform PP2A-3 from Arabidopsis (PP2A3c) 
in E. coli, to produce a platform for in vitro structural and functional investigations of PP2A 
assembly and regulation and, further delineate the important role of specific post-
translational modifications in a more facile manner. To this end, in this study we describe 
the properties of MBP tagged PP2A3c and its mutants and demonstrate the ability to 
generate phosphatase activity in vitro in the presence of PTPA, also expressed in E. coli.  
Material and methods 
Construction of expression plasmids 
 The catalytic subunit of PP2A3 (TAIR, The Arabidopsis Information Resource; 
AT2G42500). Full length catalytic subunit of PP2A3c (PP2A3c, residues 1-313) and the 
truncated form (missing the C terminal  residues RTPDYFL) PP2A3c-Tr [(residues 1-306) 
were cloned as C terminal fusions to Maltose binding protein (MBP) in pMAL-C2E vector 
(Addgene)  using the same forward primer 
5’GCGGGCGCGGCCTTAATGGGCGCGAATTCTATTCC 3’ for both clones with the 
reverse primer 5’CCAACCGCGGCCTCATCACAGGAAATAGTCTGGAGTCCT 3’ for 
the full length clone and 5’CCAACCGCGGCCTCATCGGGTGACGTCTGGTTCT 3’ for 
the truncated form producing MBP-PP2A3c and MBP-PP2A3c-Tr respectively. The PCR 
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amplified product was cloned by ligation independent cloning (LIC) [27] into an in-house 
modified pMAL–C2E vector containing the inserted LIC site ‘CGGCCTTA’ and, verified 
by DNA sequencing. Preparation of the mutant protein containing an Ala substitution at 
Tyr 311 (MBP-PP2A3c-Y311A) was completed using the Quick Change Multi Site-
Directed Mutagenesis Kit (Stratagene) with the primer 5’ 
CGAAGGACACCTGACGCTTTCCTTTGAGGC 3’ and mutation was verified by DNA 
sequencing. 
PP2A phosphatase activator (also referred to as phosphotyrosyl phosphatase 
activator, PTPA). (TAIR; AT4G08960) was cloned as a N-terminus fusion to 6x His tag 
(PTPA-6H) in a pET-28c vector (Novagen) using forward primer 5’ 
GCAGCGGCACCATGGAACCTCCAAAGGAACAACAAAAC 3’and reverse primer 5’ 
GCAGCGCTCGAGGCCCTGAAAATACAGGTTTTCCTCTTCCCATTTGATGAGCC
AG with NcoI and XhoI restriction sites respectively.   
Intracellular domain of ACR4. N-terminus SUMO fused ACR4 ICD was 
produced as described by Meyer et al. [28]  
Cloning of PP2A3c for Baculovirus Insect cell expression. PP2A3c was PCR 
amplified using forward primer 
5’CACCATGGACTACAAAGACGATGACGACAAGATGGGCGCGAATTCTATTCC
GACG 3’and reverse primer 5’TCACAGGAAATAGTCTGGAGTCC3’as a C-terminal 
fusion to FLAG epitope tag. The amplified gene (F-PP2A3c) was cloned into pENTR/D-
TOPO vector using pENTR directional TOPO cloning kit (Invitrogen). In-frame cloning 
was verified by DNA sequencing. LR clonase II enzyme (Invitrogen) was used to 
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recombine pENTR vector containing the PP2A3c subunit in vitro with BaculoDirect C-
Term Linear DNA (Invitrogen) according to the manufacturer's instructions (Invitrogen). 
Protein Expression and Purification 
MBP-PP2A3c, MBP-PP2A3c-Tr and MBP-PP2A3c-Y311A. Respective plasmids 
were transformed into chemically competent T7 express cells (NEB). A 500-ml culture 
supplemented with ampicillin (50 µg/ml) was grown at 37 °C until O. D600 of 0.6 before 
inducing for 5 h at 20 °C with 0.5 mM IPTG. Cell pellets were harvested by centrifugation, 
resuspended in 20 ml of lysis buffer (1x TBS pH 7.4, 0.5% Triton, 1mM DTT and 1 mM 
AEBSF). Cells were sonicated on ice and clarified lysate was prepared after centrifugation 
at 24470 x g for 20 min at 4 °C. Supernatant was incubated with 250 µl of amylose resin 
(NEB) equilibrated with lysis buffer for 1 h at 4 °C. Unbound protein was removed with 
1x TBS pH 7.4 and 1mM DTT. Bound protein was eluted from the amylose resin using 
freshly prepared elution buffer 1x TBS pH 7.4, 1 mM DTT and 10 mM Maltose. A 
secondary purification was performed on an ÄKTA FPLC system (Amersham) using 
Global 10/300 Superdex G200 column (GE Healthcare) equilibrated with column buffer 
(50 mM Tris-HCl pH 7.4, 100 mM NaCl, 1 mM DTT, 100 µM MnCl2 and 100 µM MgCl2). 
Protein was eluted at a rate of 0.4 ml/min and 300 µl fractions of appropriate peaks 
collected and pooled to be used for further study. Approximately 1 mg of purified protein 
is obtained from 2.5 L of culture as determined by Bradford assay [29].  
The C-terminal of MBP protein includes a ‘DDDK’ motif, a cleavage site for 
enterokinase protease which specifically cleaves after the lysine residue. Enterokinase 
protease (NEB) was used to cleave the tag from the fusion protein (MBP-free). Briefly, 25 
µg of Maltose free MBP-PP2A proteins were incubated in 20mM Tris pH 8, 50 mM NaCl 
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and 2 mM CaCl2, with 1unit of enterokinase protease in a 100 µl reaction volume overnight 
at 23 °C in a temperature controlled water bath. Cleaved MBP protein was removed by 
incubation with amylose resin (NEB) equilibrated with 1x TBS pH7.4, 1mM DTT and 
1mM AEBSF, and the MBP- free protein present in the supernatant was carefully pipetted 
out.  However, we were unsuccessful in obtaining enriched tag less PP2A3c after the 
enterokinase cleavage. 
PTPA-6H. Briefly, PTPA-6H was expressed in Rosetta (DE3) pLysS (Novagen) 
expression cells. A 500ml culture was grown to O.D600 of 0.6 at 37 °C and, expression was 
induced with 0.25 mM IPTG at 23 °C for 4 h. Protein was purified by resuspending 100 
ml culture pellet in lysis buffer 1x TBS pH 7.4, 30 mM Imidazole, 0.5% Triton, 1 mM 
DTT & 1 mM AEBSF. Clarified lysate obtained after sonication and centrifugation was 
incubated with 250 µl of Ni2+ IMAC Sepharose High Performance resin (GE Healthcare) 
equilibrated with lysis buffer. Unbound protein was removed using wash buffer 1x TBS 
pH 7.4, 40 mM Imidazole and 1 mM DTT. Protein was eluted with 50 mM Bis-Tris pH 
7.2, 50 mM NaCl, 200 mM Imidazole and 1 mM DTT (Figure. 9D). Concentration of 
eluted protein was determined by Bradford assay [29]. 
Expression of PP2A3c in Baculovirus. The recombined baculovirus DNA (N-
terminus FLAG tagged PP2A3c; F-PP2A3c) produced using the gateway technology was 
transfected into Sf9 cells using Cellfectin II according to the Invitrogen’s Manual. Sf9 cells 
(Invitrogen B825-01) were maintained as adherent culture at density of 4X105 cells/ml in 
10% FBS (Invitrogen) supplemented Sf900III SFM (1x) medium (Gibco). Four rounds of 
viral selection and amplifications were carried out as described by the manufacturer 
(Invitrogen). Cells were maintained at 27 °C and sub-cultured every 36 h. Recombinant 
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Baculovirus/viral stocks were produced and amplified in Sf9 cells and stored at 4 ºC/dark 
until further infection of Sf9/High-five cells. Small scale expression of F-PP2A3c was 
tested using viral stocks (50 µl to 1ml per 16 ml of adherent culture plate) and was 
compared with uninfected control adherent Sf9 cells. High five cells (Invitrogen) were 
grown in suspension culture in Express Five serum-free medium (Gibco Life) 
supplemented with 1x of Antibiotic Antimycotic Solution (Corning) and 10x of L-
Glutamine (Gibco). Appropriate amount of fourth round of amplified Baculovirus stock 
(F-PP2A3c) determined from small scale test expression was used to infect 1X106 cells/ml 
in suspension (20 ml of phage per 500 ml of High-five suspension cells). Cells were 
harvested after 36 h, resuspended in 1x TBS, pH 7.4, 1% Triton and 1 x of complete 
protease inhibitor cocktail tablet (Sigma). After sonication on ice, cells were centrifuged at 
13,000 rpm for 1h at 4 °C. The supernatant was filtered through a 0.45 µm (corning) filter 
and loaded onto 1x TBS pH7.4 equilibrated ANTI-FLAG-M2 affinity resin (Sigma) for 2 
h at 4 ºC. Unbound proteins were removed with 1x TBS pH7.4 and the bound protein was 
eluted under native conditions using a competitive 1x Flag-peptide (Sigma). Secondary 
purification was performed on an anion exchange Hi-trap Q (GE healthcare) column using 
Buffer A- 30 mM ethanolamine pH 9 & Buffer B -30 mM ethanolamine pH 9, 1 M NaCl. 
Approximately 80-100 µg of F-PP2A3c is recovered from 500 ml of suspension culture.  
Protein was detected by Western blot analysis using primary antibody: Anti-PP2A3c 
monoclonal antibody (Millipore); Anti-FLAG monoclonal antibody (Sigma) and Anti-
methyl-PP2A antibody (Millipore) and Alkaline phosphatase (AP) conjugated Anti-mouse 
IgG secondary antibody (Sigma). The detection was completed using AP Conjugate 
Substrate Kit (Bio-Rad). 
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Functional Analysis of PP2A3c proteins 
Phosphatase Activity assay. Protein samples (MBP-PP2A3c, MBP-PP2A3c-Tr & 
MBP-PP2A3c-Y311A) were prepared by incubation at 4 °C and 23 °C for 16 h in a 
temperature-controlled water bath and protein concentrations were determined by the 
Bradford assay [29]. A non-radioactive colorimetric phosphatase assay was performed in 
a 96 well (Costar Cat. # 3690) plate as follows. In each microtiter well, 100 µM (5 µl of 1 
mM stock) of the supplied synthetic phospho-threonine peptide (RRApTVA) was 
incubated with 1x phosphatase assay buffer (50 mM Tris pH 7.4, 5 mM MnCl2, 10 mM 
MgCl2 and 1 mM DTT) for 3-5 min at room temperature and shaken prior to addition of 
enzyme. Reactions were initiated by addition of varying concentrations (0.5 µM-5 µM) of 
proteins in a total reaction volume of 50 µl for 20 mins at 30 °C. Negative controls without 
enzyme and without substrate were also set up. Reactions were terminated by addition of 
50 µl of Molybdate dye/Additive mixture (as described in the manufacturer’s protocol 
manual). The release of free phosphate from the phosphopeptide was detected after 15 min 
of stable color development at 23 °C. The optical density of the samples was read on a 
Spectramax 190 spectrophotometer (Molecular devices) at 630 nm. Each reaction was 
performed in triplicate. Absorbance readings were corrected for blank and data fitted by 
linear regression.  
Phosphatase activity of the proteins was also performed using [γ32P] labeled ACR4-
ICD (pACR4) as a substrate. Briefly, auto phosphorylation of ACR4 (pACR4) was 
performed for 1 h as described by Meyer et al. [30] and the excess of unbound ATP was 
removed on a Ni-NTA column with multiple washes using 1x TBS/1 mM DTT followed 
by elution of bound pACR4 with elution buffer. 1 µg of the pACR4 was incubated for 1 h 
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at room temperature with 1 µg of PP2A3c protein in a 20 µl reaction volume containing 1x 
phosphatase buffer. Control reaction contained 1µg of pACR4 in phosphatase buffer with 
no PP2A3c protein. Reactions were stopped by addition of 4x SDS buffer and boiling for 
5 min at 95 °C. Proteins were resolved by 12 % SDS-PAGE, stained with Coomassie 
Brilliant Blue R-250, and the radioactive bands were analyzed by phosphor imaging. 
Potentiation of phosphatase activity by PTPA. Activation of the PP2A3c 
phosphatase activity was performed using PTPA-6H protein in vitro in the presence of ATP 
and MgCl2. In the first step, 0.8 µM of MBP-PP2A3c was incubated with 0.8 µM of PTPA 
in phosphatase buffer in 40 µl reaction volume with 0.2 µM or 1 mM ATP for 1 h at 30 °C. 
Subsequently, phosphatase activity assay was performed by addition of 0.8 µM of pACR4 
to the PTPA-PP2A3c samples and incubating for various time periods. Reactions were 
stopped by addition of 4x SDS buffer and boiling for 5 min at 95 °C. Control reactions 
were performed under similar condition but in absence of PTPA activator. Proteins were 
resolved by 12 % SDS-PAGE, stained with Coomassie Brilliant Blue R-250, and then 
analyzed by exposure to a phosphor imaging screen. The gel bands corresponding to 
radioactive pACR4 at varying time points were excised, incubated in 5 ml of scintillation 
cocktail and amount of radioactive [γ32P] incorporation was quantified by liquid 
scintillation counting. Each condition was tested at least three times and all results are 
presented as mean (SD).  Error bars were calculated for each data point using the standard 
deviation from the mean.  
Conformational studies  
The conformational difference between MBP-PP2A3c at 23 °C and 4 °C was 
probed by intrinsic fluorescence measurements and limited proteolysis by trypsin. 
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Intrinsic fluorescence: MBP-PP2A3c was first dialyzed against 10 mM Tris-HCl pH 7.4 
and 0.1 mM TCEP and incubated at 23 ºC and 4 ºC overnight. Fluorescence scans were 
then performed on protein samples adjusted to an A280 of 0.1. Measurements were made 
in a 1 cm cuvette at room temperature with a Cary Eclipse spectrofluorometer (Varian). 
Scans were executed at an excitation wavelength of 280 nm, a bandwidth of 5 nm, and a 
scan speed of 120 nm/min.  
Limited proteolysis: 125 µg of the overnight incubated MBP-PP2A3c at 23 °C and 4 °C 
was diluted into a 200 µl solution containing 50 mM Tris-HCl pH 8.0, 1 mM CaCl2, and 1 
mM DTT. Proteolysis by trypsin (Promega) at a 1:1000 (w/w) protease: substrate ratio was 
initiated at room temperature for defined time-points. Aliquots (25 µl) removed at 
predetermined time points, were stopped by the addition of 6 µl of 4xSDS sample buffer 
and boiling at 95 °C for 5 min. Samples were separated on a 10 % SDS-PAGE, and stained 
by Coomassie Blue staining. 
Mass Spectrometry 
Identification of phosphorylated residues in naïve PP2A3c by mass spectrometry 
was performed as described previously [13]. Briefly, peptides were generated from the 
reduced-alkylated protein by digestion with sequencing grade modified trypsin (Promega, 
Cat. # V511A) overnight at 37 °C, desalted on a reversed-phase column and 
phosphopeptides subsequently enriched using the PHOS-Select Ga3+ Silica Spin Column 
kit (Supelco) according to the kit instructions. The endoprotease (trypsin) digests were 
analyzed by using nano-LC-MS with a linear ion trap orbitrap mass spectrometer (Orbitrap 
ELITE) (Thermo Fisher Scientific) as described in [13]. The data-dependent tandem mass 
spectrometric analysis of the tryptic peptides revealed at least 3 phosphorylation sites. 
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Determination of the exact site of phosphorylation within the phosphopeptides was 
performed by inspection of their fragmentation pattern for specific diagnostic site-
determining yn and bn ions [31].  
Results 
Expression, Purification, and Phosphatase activity of PP2A3c   
In a recent paper [13] we described the expression of PP2A3c with a C-terminal 
Histidine tag in E. coli and subsequent purification and solubilization of the protein from 
inclusion bodies using urea. Here, we report expression of PP2A3c in E. coli as a C-
terminal fusion to Maltose binding protein (MBP-PP2A3c) in a soluble form. An affinity 
(amylose resin) enriched PP2A3c preparation was purified by secondary size exclusion 
chromatography on a G-200 column as described in Materials and Methods (Figure. 1A). 
MBP-PP2A3c elutes in the void volume fraction presumably as an oligomer (peak 1) along 
with a fraction that elutes later in the chromatogram (peak 2). Changes in buffer 
composition, ionic strength and reducing conditions did not affect the elution of peak 1 
(data not shown). Peak 1 and 2 protein fractions were resolved by SDS-PAGE (Figure. 1B) 
and the identity of the protein as PP2A3c was confirmed by western blot analysis using 
mouse monoclonal antibody against PP2A (Millipore) (Figure. 1C) and by MALDI-MS 
analysis of tryptic peptides of the excised protein band (data not shown). The far-UV CD 
spectrum of the MBP-PP2A3c indicated a predominantly α-helical structure with typical 
minima at 208 nm and 222 nm (Figure. 1D), in keeping with the crystal structure of PP2A 
[14,32,33]. Both peak 1 and peak 2 fractions were inactive as a phosphatase against a 
synthetic phospho-threonine peptide RRA(pT)VA (Promega) in a colorimetric assay 
measuring released phosphate and could not dephosphorylate [γ32P] labeled pACR4 
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(Figure. 2A, lane 3). However, MBP-PP2A3c was a substrate for pACR4 and could be 
phosphorylated by pACR4 in a kinase assay using [γ32P] ATP (Figure. 2B, lanes 2 and 3). 
In a parallel effort, we also expressed PP2A3c recombinantly as C-terminal fusion 
to FLAG epitope tag (F-PP2A3c) in a Baculovirus insect cell expression system using 
High-five cells (Invitrogen) as described in Materials and Methods. Figure. 3A (lane 1) 
represents heterogeneous mix of proteins, including F-PP2A3c, obtained after an affinity 
enrichment with Anti-Flag M2 resin (Sigma) and anion exchange chromatography. The 
identity of F-PP2A3c was confirmed by mass spectrometry (data not shown) and none of 
the other proteins were identified as phosphatases. Importantly, this fraction containing F-
PP2A3c, showed phosphatase activity using the synthetic phosphopeptide (data not shown) 
activity and was also able to dephosphorylate [γ32P] labeled pACR4 (Figure. 3B, lane 2, 
autoradiogram). This may be attributed to an active PP2A3c with the methylated C-
terminal Leucine, an important post-translational modification influencing both 
phosphatase activity and PP2A complex formation in vivo and, presence of endogenous 
activation chaperones such as PTPA. Indeed, western blot analysis using anti-methyl 
PP2Ac antibody (Millipore) confirmed the expression of methylated F-PP2A3c in the cell-
lysate (Figure. 3C, last panel, lane 1) and enriched F-PP2A3c (Figure. 3C, last panel, lane 
2). Western blots were also performed with anti-PP2A3c (Millipore) and anti-Flag (Sigma) 
antibodies (Figure. 3C). 
Phosphorylated state of PP2A3c 
In mammalian systems, the inactivity in PP2Ac has been attributed in part to 
phosphorylation of conserved residues Tyr 307 and Thr 304 in the C-terminal tail [34,35]. 
To determine the phosphorylation state of MBP-PP2A3c expressed in E. coli (naïve 
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protein), we performed tandem-mass spectrometric analysis of tryptic peptides from MBP-
PP2A3c as well as the previously expressed PP2A3c-6H [13]. The conserved C terminal 
peptide containing the regulatory phosphorylation Tyr and Thr residues was not enriched 
in MBP-PP2A3c but was enriched in the PP2A3c-6H protein probably due to the presence 
of a basic histidine residues at the C terminus. We identified Tyr 311 to be phosphorylated 
as well as three other phosphorylated residues, Tyr 222, Thr 223 and Ser 265 (Figure. 4A 
and 4B). Tyr 311 corresponds to the conserved Tyr 307 residue in mammalian PP2Ac that 
is implicated in the phosphorylation dependent inhibition of phosphatase activity in 
mammalian system. Therefore, to verify this possibility in MBP-PP2A3c, we mutated Tyr 
311 to Ala (PP2A3c-Y311A) and created a truncated version of MBP-PP2A3c missing the 
C-terminal residues TRRTPDYFL (PP2A3c-Tr). However, the mutant proteins did not 
show any phosphatase activity in the colorimetric phospho-peptide assay and nor were they 
able to dephosphorylate [γ32P] pACR4 (Figure. 5A and 5B). This suggests that the observed 
lack of phosphatase activity of MBP-PP2A3c is unlikely to be due to the phosphorylation 
of Tyr 311.  
MBP-PP2A3c shows measurable phosphatase activity after incubation at 23 °C for 
16 h 
 To determine if the MBP-tag was inhibiting phosphatase activity, MBP-PP2A3c 
was incubated with enterokinase (NEB) at 23 °C for 16 h as described in Materials & 
Methods, to remove the tag.  In parallel, a control reaction of MBP-PP2A3c without 
enterokinase was also prepared. Unfortunately, adequate amount of untagged PP2A3c 
could not be recovered to test for phosphatase activity after the cleavage reaction. 
Interestingly, however, the similarly incubated control displayed measurable phosphatase 
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activity against the synthetic phosphopeptide substrate in comparison with the protein 
incubated at 4 °C for 16 h which showed no discernible activity. This is shown in Figure. 
6A as a function of MBP-PP2A3c concentration. Figure. 6B demonstrates that the Y311A 
mutant behaves similarly to the wildtype protein.  
Activation of phosphatase activity is accompanied by a conformational change  
 To address whether the phosphatase activity was influenced by conformational 
changes, we used fluorescence spectroscopy and limited proteolysis, both versatile 
techniques that are sensitive to perturbations in conformation [36,37,38,39]. Fluorescence 
spectroscopy is a particularly sensitive probe of protein folding and is significantly 
influenced by the microenvironment of tyrosine and tryptophan residues.  At 280 nm both 
these aromatic residues absorb and contribute to the emission spectra.  When excited at 
280 nm, the intrinsic fluorescence spectra of MBP-PP2A3c incubated at 4 °C and 23 °C 
showed an emission λmax around 342 nm. However, the quantum yield of fluorescence was 
significantly higher for the protein kept at 23 °C for 16 h, suggesting a distinct 
conformational difference (Figure. 7).  
Limited proteolysis is also a widely used reporter of structural changes in proteins 
and a sensitive probe for detecting changes in protein flexibility as measured by the 
susceptibility of peptide bonds to proteolysis in the context of the local structure and 
interactions [37]. The digestive patterns of proteins at 4 °C (Figure. 8A) and 23 °C (Figure. 
8C) show a distinct difference in the proteolytic fragments generated on digestion with 
trypsin as a function of time. The fragment(s), indicated with an *, was identified as MBP 
by mass spectrometry and appears as two fragments in the 4 °C sample (Figure. 8A) but 
just one in the 23 °C protein (Figure. 8C). Fragments labeled a, b and c are derived from 
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PP2A3c as analyzed by mass spectrometry and western blot analysis using Anti-PP2Ac 
antibody (Figure. 8B and 8D). Whereas the appearance of fragment a is similar in both 
samples, it is worth noting that fragment b has a significantly stronger presence in the 4 °C 
sample (Figure. 8A and B) compared to the 23 °C sample (Figure. 8C and D). Fragment c 
appears in both the 4 °C and 23 °C protein samples (Figure. 8A and C) but is less detectable 
in the Western blot of the 23 °C sample (Figure. 8D).	  
MBP-PP2A3c can be activated by PTPA 
PTPA is an ATP-dependent activation chaperone, known to play a key role in the 
biogenesis of active PP2A in eukaryotes [16,40,41,42]. It is also reported to have 
isomerization activity on the conserved Pro 190 of PP2Ac [43]. We therefore examined the 
potential ability of recombinantly expressed PTPA (Figure. 9A) to activate PP2A3c in vitro 
in the presence of MgCl2 and ATP, as described in Materials & Methods. We tested the 
phosphatase activity on both Peak 1 and Peak 2 protein fractions from gel filtration.  When 
activated with equimolar amount of PTPA (0.8 µM) in the presence of 0.2 µM ATP as a 
function of time in hours (Figure. 9B, top), there was clear evidence of dephosphorylation 
of [γ32P] pACR4 in the autoradiogram (Figure. 9B, bottom). A quantitative assessment of 
the radioactivity in the band indicated ~35% decrease in [γ32P] pACR4 after 5 h (Figure. 
9C). Measurable PTPA activated phosphatase activity was observed in both peaks 1 and 2 
in replicate experiments. Interestingly, the rate of reaction increased five-fold when the 
same reaction was performed in presence of 1 mM ATP. The autoradiogram (Figure. 10A, 
bottom) shows the progressive decrease in intensity of the [γ32P] pACR4 band from 0 to 
60 mins in contrast to the control without the PTPA (Figure. 10B). A quantitative 
assessment of the radioactivity in the [γ32P] pACR4 band indicated ~35% decrease in 
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intensity after 60 mins (Figure. 10C).  These experiments suggest that PTPA is able to 
activate PP2A3c phosphatase activity in trans, albeit to a modest extent.   
Discussion 
In this study, we describe the properties of an N-terminally tagged catalytic subunit 
of Arabidopsis PP2A3 (MBP-PP2A3c) expressed in E. coli. Previous attempts to over-
express human PP2Ac in E.coli cells have met with limited success [44]. Typically, 
biochemical and structural investigations of biologically active PP2Ac have been 
performed either by direct extraction from host tissues [45] or by recombinant expression 
in yeast [23,46], mammalian cells [21] or insect cells [47,48,49] However, mammalian cell 
culturing is time consuming and expensive, and optimal expression and yields in insect 
cells until now were achieved only with active-site mutants with an attempt to overcome 
the auto-regulatory mechanism exerted by endogenous PP2Ac which depresses the 
expression of the transgenic protein but a recent study by Ikehara et al. [47,48,49] 	  reported 
increase in expression of one of the two human PP2A isoforms (PP2B and not PP2Cα) in 
insect cells cultured at low temperature of 19 °C instead of 23 °C.  
Herein, we report yields ~1 mg of purified protein from a 2.5 L of E. coli culture 
that can be substantially scaled up to rapidly obtain high milligram quantities of protein 
without undertaking the intensive and expensive insect cell or mammalian cell culturing. 
However, the protein lacks phosphatase activity. Although plausible, it is unlikely that the 
inactivity is due to the MBP tag at the N-terminus since the addition of the nine-amino acid 
hemagglutinin-peptide at the amino terminal end of PP2A does not inhibit the activity of 
the protein expressed in mammalian and insect cells [21]. Furthermore, the solubility of 
the protein and the predominantly α-helical conformation indicated by the CD analysis, are 
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indicative of a properly folded protein. The elution of the protein in gel filtration (Figure. 
1) suggests that it forms native-like aggregates (from a normally folded protein) that is 
unlikely to be mediated by the MBP tag which is known to not dimerize [50]. Importantly, 
neither changes in salt concentration, reducing agent or low concentrations of urea were 
effective in disrupting the oligomeric fraction and the precise nature of the oligomer needs 
to be further investigated by other biophysical methods. It is worth noting, however, that 
there was little or no difference in the PTPA-mediated activation of the two peaks (Figure. 
10C). We were also unsuccessful in cleaving the MBP-tag to obtain tag free protein but in 
ongoing and future experiments we will examine expression in E. coli using other fusion 
partners, varying various parameters that are known to affect expression as well as 
targeting the expression to the periplasm. 
Since it is known that phosphorylation of Tyr 311 and Thr 304 can inhibit and 
regulate PP2A activity in vivo and in vitro [20,35], and that E. coli possess Tyr/ Ser/ Thr 
kinase activity [51,52], we speculated that the inactivity may be due to phosphorylation of 
these sites. We therefore investigated potential phosphorylation sites in naïve PP2A3c and, 
although we did not find evidence of Thr 304 phosphorylation, we clearly identified a 
phosphopeptide containing Tyr 311 phosphorylation and, interestingly, three other 
phosphorylation sites at Tyr 222, Thr 223 and Ser 265. There has been no previous report 
of phosphorylation at these sites and there is also no evidence of any associated inhibitory 
activity. Our future studies will examine the role of these sites in the activity of PP2A3c.  
Importantly, mutation of Tyr 311 to alanine did not restore phosphatase activity, suggesting 
that at least in the Arabidopsis PP2A3c homolog, phosphorylation of Tyr 311 may not be 
a regulatory step, although it remains to be verified in planta.  
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A particularly crucial step in the regulation of PP2Ac and its activity is its non-
covalent interaction with the activator protein, PP2A phosphatase activator, PTPA. 
Structural studies [16] indicate that the PP2A-PTPA interaction stabilizes the active site of 
the catalytic subunit and forms a joint ATP-binding pocket that properly orients the γ-
phosphate to chelate catalytic metal ions (Mg++) and facilitates a conformational change in 
PP2A to acquire phosphatase activity. Subsequently, ATP hydrolysis is achieved by the 
activated PP2A phosphatase. Significantly, the molecular mechanism of activation, 
correlates with the peptidyl-prolyl isomerization activity of PTPA and the isomerization of 
the conserved Pro 190 in PP2Ac is believed to underpin the activation of the catalytic 
subunit [14]. Furthermore, the ATP-dependent activation of PP2Ac by PTPA also enhances 
phosphotyrosine phosphatase activity [53] and promotes the essential steps of association 
with the ‘A’ subunit, carboxymethylation of the C-terminal Leucine, and subsequent 
interaction with the ‘B’ subunit driving the formation of the whole heterotrimeric complex 
[2,16,17,32,54]. Interestingly, using chemically inactivated PP2Ac, Guo et al [16] also 
demonstrated that PTPA was crucial to restoring and stabilizing a proper protein fold of 
the catalytic chain required for activity and other studies [41,42,43] attest to the ability of 
PTPA to activate the inactive form of PP2Ac.  We therefore examined the ability of 
recombinantly expressed PTPA to activate PP2A3c in vitro in the presence of ATP and 
Mg++ and observed significant activation of phosphatase activity against [γ32P] labeled 
ACR4-ICD phosphorylated ACR4 (Figure.10A) Approximately 40% activation of 
PP2A3c phosphatase activity was observed at both low (0.2 µM) and high concentrations 
(1 mM -5 mM) of ATP, but the activation was more rapid at 1 mM ATP (minutes vs hours).  
Thus, in accordance with the structural studies of PTPA [16,53], we attribute the activation 
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of PP2A3c to the PTPA catalyzed prolyl isomerization along with composite ATPase 
activity of PTPA-PP2Ac complex. It is important to also contextualize the catalytic 
function of PP2Ac vis-à-vis other protein-protein interactions. Thus, using knockout strains 
of yeast, Hombauer et al [55] have shown that a functional interaction between the A 
subunit (TPD3) and PTPA (RRD2) can generate catalytically active C subunit. Therefore, 
in our future experiments we will examine the co-expression of PTPA A and C subunits in 
E. coli to obtain maximally active PP2A3c. 
The modest but measurable phosphatase activity of MBP-PPA3c after overnight 
incubation at 23 °C is intriguing. We hypothesize that the purified protein exists in a near-
native conformational state and undergoes a slow conformational change to a more 
“activated state”. Although the exact structural difference between the two states is not 
obvious and remains to be determined, the observed change in the fluorescence spectrum 
and the difference in lability to proteolysis are indicative of significant differences in 
conformation. However, we do not have a clear understanding of the molecular basis of 
this activation. Importantly, even though prolyl cis/trans isomerization can be an 
enzymatically catalyzed process, it can also be an intrinsic mechanism in protein folding 
in native structures and regulate subtle conformational changes [56]. Therefore, in the 
absence of an isomerase, it may not unreasonable to propose that cis-trans isomerization 
of the peptide bond at Pro 190 could be one of the rate-limiting steps in protein folding to 
an “activated state”.  One must also consider the possibility of isomerization of non-prolyl 
cis peptide bonds in the slow activation of MBP-PP2A3c. Indeed, non-prolyl cis peptide 
bonds are not uncommon in the native structures of proteins [57] and can potentially affect 
folding kinetics time scale [58]. Another consideration is the role of the proline residue in 
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the SAPNYC sequence of PP2A3c (residues 265-270, Figure. 4B). This motif is highly 
conserved in the Ser/Thr PPP phosphatase family [43,59] and, in the case of calcineurin, 
the peptidyl-Pro undergoes isomerization from the trans to cis conformation, catalyzed by 
FKBP12 and cyclophilin A [43,59]. Although, there does not appear to be any structural 
evidence of a similar conformational state for peptidyl-Pro in PP2A3c [14,32], its potential 
role in the slow activation of MBP-PP2A3c may need further investigation. Sufficient to 
say, we do not presently, have a clear understanding of the molecular basis of this 
activation. Protein folding is a complex multistate process and proline residues play a 
particularly critical role in transitions to functionally different states [60,61]. Interestingly, 
slow structural transitions of proteins towards the native state have been observed in other 
proteins and a particularly interesting example is provided by rat muscle phosphoglycerate 
kinase that in vivo “ages” slowly to a different conformational state over time.  
In summary, we offer the following perspectives. Within cells, protein-protein 
interactions are fundamental to assembly of protein complexes and are dictated by specific 
binding partners, binding sites and affinity of interaction (high and low). Clearly, important 
molecular understanding of the structure and function of PP2A has come from biochemical 
analysis in eukaryotic systems including mammalian, yeast and insect cells 
[21,23,45,46,47,48,49]. However, these systems are not ideal for producing adequate 
amounts of protein for more robust biochemical/biophysical investigations that can 
enhance our understanding of the PP2A complex and PP2A controlled signaling in vivo. 
To this end, to better understand the molecular interactions between the component chains 
and the molecular architecture of the PP2A complex, we have developed a facile system in 
E. coli to express and purify adequate quantities of the catalytic chain of PP2A as a fusion 
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protein with MBP. Although the initially expressed protein is inactive as a phosphatase, it 
displays the ability to be activated by PTPA, in trans.  The system provides an excellent 
platform for reconstituting the complex with component proteins and dissecting and 
delineating the individual roles of the different modulators, both quantitative and 
qualitative, using diverse biochemical and biophysical approaches.  Thus, in vitro studies 
using purified proteins can provide greater clarity on our molecular understanding of the 
important but conflicting role of methylation at the C-terminus in PP2Ac catalytic activity, 
its interaction with ‘B’ subunits in holoenzyme assembly in vivo versus in vitro [33,62], 
and subtle synergistic interactions between PTPA and reversible carboxy-methylation 
mediated by PME1[63,64].  While in vivo studies using the tools of genetics and cell 
biology are necessary to understand physiological function and evaluate phenotypic 
responses, a more holistic understanding of biological processes can be derived through a 
mechanistic understanding of the role of individual genes at the protein level. To this end, 
the E. coli system offers a low cost in vitro platform to interrogate the specific function of 
each of the players in the biogenesis of PP2A and conditionally examine the importance of 
posttranslational modifications on PP2A function. Our on-going studies are directed 
towards recapitulating a maximally active PP2A3c by co-expression of PP2A core enzyme 
along with PTPA in E. coli. Although our initial attempts to obtain a stoichiometric 
complex of the AC dimer in E. coli was not successful, the crude lysate containing the AC 
dimer showed significantly enhanced phosphatase activity upon activation by PTPA as 
measured by dephosphorylation of radio-labeled pACR4 (data not shown).   
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Figure 1: Purification of MBP-PP2A3c from E. coli. (A) Gel filtration profile of affinity-
enriched MBP-PP2A3c in 50 mM Tris, pH 7.4, 100 mM NaCl, 1 mM DTT, 100 µM MnCl2 
and 200 µM MgCl2. The protein elutes as an oligomeric fraction (Peak 1) and as a smaller 
fraction (Peak 2). Peak 3 contains cleaved MBP protein. (B) 1 µg of protein from Peaks 1-
3 separated on 12 % SDS-PAGE: Lane 1, Peak 1; Lane 2, Peak 2; Lane 3, MBP (C) 
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Western blot analysis using monoclonal antibody against PP2A (Millipore) (D) Far UV 
CD spectra in 10mM Tris pH 7.4 and 0.1mM TCEP at concentration of 0.25mg/ml. Minima 
are observed at ~208 and 222 nm, indicating a dominant α-helical structure.   
 
 
Figure 2: (A) Functional regulation between MBP-PP2A3c and phosphorylated 
ACR4 kinase (pACR4) labeled with [γ32P] ATP. (A) Activity of M-PP2A3c determined 
by phosphatase assay against pACR4; (Top) Coomassie Blue stained 12 % SDS-PAGE 
showing Lane 1, 5 µg of PP2A3c control; Lane 2, 1µg of pACR4 and Lane 3 represents 
the phosphatase reaction between 1µg of pACR4 with 5µg of PP2A3c as described in 
Materials and Methods. (Bottom) corresponding autoradiogram. (B) pACR4 can 
phosphorylate PP2A3c in a kinase assay. (Top) Coomassie Blue stained 12 % SDS-PAGE 
showing Lane 1, 1µg of control pACR4, lanes 2 and 3 represent kinase reactions using 1µg 
of pACR4 with 1µg and 2µg of PP2A3c respectively. (Bottom) corresponding 
autoradiogram. 
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Figure 3: Purification and functional analysis of FLAG tagged PP2A3c (F-PP2A3c) 
expressed in Baculovirus insect cells. (A) Two-step purified (Amylose enriched and anion 
exchange purified) F-PP2A3c, separated on a 12 % SDS-PAGE gel stained with Coomassie 
Blue stain. (B) Phosphatase activity of F-PP2A3c. Lane 1, 1µg of Control [γ32P] labeled 
ACR4 (pACR4); Lane 2, phosphatase reaction between 1µg of pACR4 and 1µg of F-
PP2A3c protein separated on 12% SDS PAGE gel (Left) and analyzed by phosphor-
imaging (Right). (C) Western blot analysis of F-PP2A3c confirms a carboxymethylated C-
terminal residue. (Left) Coomassie Blue Stained SDS-PAGE gel showing Lane 1, soluble 
lysate fraction of Baculovirus cells expressing F-PP2A3c and Lane 2, 1 µg of two step 
purified F-PP2A3c protein sample. (Right) Western blot of individual gels probed with 
Monoclonal Anti-Flag M2 Ab (Sigma), Monoclonal Anti-PP2A, C subunit Ab (Millipore) 
and Anti-Methyl –PP2A, C subunit (Millipore) respectively.  
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Figure 4: Identification of endogenous phosphorylation sites in E. coli expressed 
MBP-PP2A3c. (A) Site-determining ions in MBP-PP2A3c (the percentage of maximal 
intensity for each site-determining ion in the averaged spectrum is shown in parenthesis 
(B) The sequence of PP2A3c is shown. The phosphopeptide identified by mass 
spectrometry are underlined and phosphorylated residues are colored red. The doubly-
underlined RTPDYFL motif represents the conserved C–terminal tail of the PP2A3c family 
of proteins. In vivo, the activity of PP2Ac is regulated by methylation-demethylation of the 
conserved C-terminal Leucine (in green) and phosphorylation-dephosphorylation of Y311 
(corresponds to mammalian Y307).  
 
 131  
 
Figure 5: Phosphatase activity of PP2A3c mutants against [γ32P] labeled ACR4-ICD. 
(Top) Coomassie blue stained 12 % SDS –PAGE gel, (Bottom) corresponding 
autoradiogram. (A) Assay with truncated MBP-PP2A3c missing the conserved C-terminal 
tail (PP2A3c-Tr). M, mol. wt standards, Lane 1, 1µg of control pACR4, Lane 2, 1 µg of 
pACR4 with 2 µg of PP2A3c-Tr. (B) Assay with the mutant PP2A3c-Y311A. Lane 1, 1 
µg of control pACR4, Lane 2, 1 µg of pACR4 with 2 µg of PP2A3c –Y311A. 
 
Figure 6: Phosphatase activity of MBP-PP2A3c after overnight incubation.  MBP-
PP2A3c incubated overnight at 23 °C and 4 °C was tested for phosphatase activity against 
a synthetic phospho-peptide substrate (Promega) as described in Materials & Methods. (A) 
Multiple replicates of increasing concentrations (0.5 to 5 µM) of protein incubated at 23 
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°C (●) and 4 °C (○) were assayed for phosphatase activity against a synthetic phospho-
peptide in a phosphatase reaction buffer at room temperature. Molybdate/additive dye 
mixture was used to stop the reaction and the absorbance of released free phosphate was 
determined at 630 nm on a plate reader. (B) Bar diagram showing the activity of 5 µM 
amounts of MBP-PP2A3c and the PP2A3c-Y311A mutant after overnight incubation at 23 
°C using the synthetic phosphopeptide. Data sets are means ± Standard deviation. 
 
 
Figure 7: Intrinsic fluorescence of overnight incubated MBP-PP2A3c at 4 °C and 23 
°C Intrinsic fluorescence spectra in 10 mM Tris pH 7.4 and 0.1mM TCEP with an A280 of 
0.1. Measurements were taken in a 1 cm cuvette at room temperature with a Cary Eclipse 
spectrofluorimeter (Varian) at an excitation wavelength of 280 nm.
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Figure 8: Conformational analysis of MBP-PP2A3c by limited proteolysis. Time 
course of the tryptic digest of overnight incubated protein at 4 °C and at 23 °C. Proteins 
were incubated at room temperature for the indicated times with a 1:1000 (w/w) ratio of 
enzyme to substrate followed by SDS-PAGE analysis (A & C) and corresponding western 
blot using a monoclonal antibody against PP2A ‘C ‘subunit (B & D).  A-B depicts the 
digestion pattern of protein that was incubated overnight at 4 °C and C-D depicts the 
digestion pattern of protein that was incubated overnight at 23 °C. Bands from cleaved 
MBP are indicated by * (confirmed by mass spectrometry) in the SDS-PAGE. Differences 
in digestion pattern are indicated by bands a, b and c in the SDS-PAGE (top) and the 
western blot (bottom)




Figure 9: (A) 12% SDS-PAGE of purified PTPA-6H. (B) Activation of PP2A3c 
phosphatase activity by the activator protein PTPA at µM concentrations of ATP. In 
separate reactions, 0.8 µM MBP-PP2A3c (Peak 1 from gel filtration) was incubated for 1, 
3 and 5 hours with equimolar concentration of PTPA-6H protein in the presence of 0.2 µM 
ATP. Subsequently, all reactions were further incubated with [γ32P] labeled pACR4 for 1h 
in a phosphatase reaction buffer. Reaction were stopped and separated on a 12 % SDS-
PAGE gel. Top, Coomassie Blue stained gel; Bottom corresponding autoradiogram (C) Bar 
diagram showing dephosphorylation of pACR4-ICD by activated PP2A3c in presence of 
0.2 µM ATP as a function of time. Data sets are means ± Standard deviation.
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Figure 10: Activation of PP2A3c phosphatase activity by the activator protein PTPA 
at mM concentrations of ATP. In separate reactions, 0.8 µM MBP-PP2A3c (Peak 1 from 
gel filtration) was incubated from 0 to 60 minutes with equimolar concentration of PTPA-
6H protein in the presence of 1 mM ATP. Subsequently, all reactions were further 
incubated with [γ32P] labeled pACR4 for 1h in a phosphatase reaction buffer. Reaction 
were stopped and separated on a 12 % SDS-PAGE gel (A) Coomassie Blue stained gel 
(top) and corresponding autoradiogram (bottom) (B) Control phosphatase reaction with 0.8 
µM MBP-PP2A3c under similar conditions but in absence of PTPA and ATP. Coomassie 
Blue stained gel (top) and corresponding autoradiogram (bottom) (C) Bar diagram showing 
% phosphorylated pACR4 remaining after dephosphorylation by activated MBP-PP2A3c 
(Peak 1 from gel filtration, dark grey bars; Peak 2 from gel filtration, light grey bars) at 
various time points. Data sets are mean ± Standard Deviation. 
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CHAPTER 4: BIOCHEMICAL PROPERTIES OF THE RECEPTOR-LIKE 
KINASE ATCRK1, AND ITS INTERACTION WITH THE CATALYTIC 
SUBUNIT OF PP2A3 (PP2A3c) PHOSPHATASE. 
A manuscript to be submitted for publication in ACS Biochemistry. 




In addition to ACR4, the Arabidopsis genome encodes four other members of the 
ACR4 receptor-–like kinase family high sequence similarity and conserved structural 
features. Among these, AtCRK1 and At CRR3 are the two homologs of ACR4 with a 
functional kinase domain.  Genetic, cell biology and in vitro biochemical studies have 
provided a robust understanding of the biochemistry of ACR4, its regulation by PP2A 
phosphatase and   compelling evidence for in vitro heteromeric interaction within the 
ACR4 family. In this study, we build on this foundation of reported interactions of ACR4 
with CRK1 and ACR4 with PP2A3c and demonstrate that PP2A3c is also a substrate for 
CRK1. Furthermore, we characterize the basic kinetics of the kinase activity of the 
recombinantly expressed intracellular domain of CRK1 including its auto phosphorylation 
and mass spectrometric mapping of auto phosphorylation sites. Quantitative mass 
spectrometry analysis using isobaric TMT labeling indicates that the naïve CRK1 and the 
auto phosphorylated CRK1 are similarly phosphorylated but the extent of phosphorylation 
is greater in the auto phosphorylated CRK1.  We anticipate that this study will catalyze in 
planta studies to understand the relationship between PP2A and the family of ACR4 RLK.
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Abbreviations 
ACR4, Arabidopsis CRINKLY4; ALE2, ABNORMAL LEAF SHAPE 2; ACN, 
Acetonitrile; ATP, adenosine triphosphate; BAK1, BRASSINOSTEROID INSENSITIVE 
1-associated receptor kinase 1; BRI1, Brassinosteroid insensitive 1; CORNET 2.0, 
correlation network; CR4, maize CRINKLY4; CD, circular dichroism; AtCRR, 
Arabidopsis CRINKLY4 related; CRK1m, inactive mutant; DTT, dithiothreitol; EGFR, 
epidermal growth factor receptor; Eph, ephrin binding receptor; FA, formic acid; FLS2, 
flagellin-sensitive 2; FHA, Fork Head-Associated domains; ICD, intracellular domain; 
MBP, maltose binding protein, PDGF, platelet derived growth factor; POL; 
POLTERGEIST; PLL1, POLTERGEIST-LIKE1; PP2A3c, Protein phosphatase -3 
catalytic subunit; RLK, receptor-like kinase; RTK, receptor tyrosine kinase; SERK, 
somatic embryogenesis receptor-like kinase; SYMRK, symbiosis receptor kinase; TCEP, 
Tris (2-carboxyethyl) phosphine hydrochloride; TMT, tandem mass tag; UV, ultraviolet.  
Introduction 
Mammalian systems utilize receptor tyrosine kinases (RTK) to perceive and transmit 
the extracellular signals to mediate diverse downstream signaling cascades affecting  
proliferation, migration, differentiation and cell cycle control [1]. Similarly, plants utilize 
receptor-like kinases (RLK) to mediate various plant signaling processes responsive to a 
plethora of stimuli [2,3,4,5]. RTKs and RLKs have comparable architectural features which 
drive similar activation processes.  Ligand binding on the extracellular domain transmits 
the signal via a trans membrane domain and activates the intracellular kinase domain by 
means of reversible phosphorylation which elicits differential downstream signaling 
cascade mediated by diverse yet specific signaling molecules. Structural, biophysical, 
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biochemical and functional studies of several RTKs such as the Epidermal Growth Factor 
Receptor (EGFR) family [6,7,8,9], Insulin-like Growth Factor Receptor [10], Platelet-
derived Growth Factor (PDGF) [11] Somatostatin and Opioid receptors [12], and RLKs 
such as FLS2 and BAK1 [13], CLAVATA2 [14], and BRI1[15,16] have demonstrated their 
ability to assemble as homo- or hetero-dimeric complexes with distinct ligand 
specificity/affinities and downstream signaling activity.  
The Arabidopsis genome encodes a receptor kinase Arabidopsis CRINKLY4 
(AT3G59420), as well as four homologs, termed Arabidopsis CRINKLY 4 related proteins 
or AtCRRs which share sequence and architectural similarity [17]. These are CRINKLY 4 
RELATED 1 (CCR1 or CRR1, AT3G09780), CCR2 (or CRR2, AT2G39180), CCR3 (or 
CRR3, AT3G55950), and CCR4/CRINKLY 4-RELATED KINASE 1 (CRK1, 
AT5G47850). ACR4 is a plasma-membrane localized RLK, which is part of a mechanism 
that controls formative cell divisions in Arabidopsis root [18,19,20]. Genetic, cell biology 
and in-vitro studies suggest potential interactions within the members of ACR4 family with 
functional redundancy towards a specific genetic pathway [17,18,21,22]. RT-PCR studies 
of ACR4 and CRR transcript levels and in-silico gene expression analysis by CORNET 
2.0 [18,22], demonstrate overlapping yet comparable levels of expression in the quiescent 
center, lateral root cap, root tip, root cortex and columella root cap cell, for all members of 
ACR4 family. Furthermore, in vitro studies provide evidence of heteromeric interactions 
between the intracellular domains of ACR4 and the CRRs in a phosphorylation 
independent manner along with the ability of ACR4 to phosphorylate inactive CRRs [22], 
also advocating the co-functionality of these spatio-temporally co-expressed proteins 
within the ACR4 family members [17]. Besides ACR4, CRK1 and CRR3 are the other two 
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RLKs in the ACR4 family that possess kinase activity and the interaction between the 
kinase domain of ACR4 and CRK1/CRR3 is mediated through a conserved KDSAF motif 
in the helix C of CRK1/CRR3 as demonstrated by peptide binding assays and H-D 
exchange studies [22] (Fig.  2B). Precedence for such heteromeric interaction exists within 
the members of AtSERK family [23] and members of brassinosteroid receptor kinases 
(BRI-1), known to mediate multiple signaling pathways and modulate the kinase activity 
of their partner RLK through phosphorylation [15,16]. 
Regulation of kinase activity is mediated by specific phosphatases, such as 
POLTERGEIST (POL) and POLTERGEIST-LIKE1 (PLL1) and KINASE ASSOCIATED 
PROTEIN PHOSPHATASE (KAPP) interact with CLAVATA-1/ CLAVATA2 and 
regulate cell proliferation and differentiation in shoot and root meristems [24,25]. We 
previously reported the catalytic subunit of PP2A3 (PP2A3c) phosphatase, as the first 
known substrate for ACR4 kinase  [26].  With compelling evidence of co-expression and 
functional interaction of ACR4 with CRK1 in root meristem, and the established regulatory 
interaction of ACR4 with PP2A3c, we propose PP2A3c to be a common downstream 
interacting protein for ACR4 and CRK1. In this study, we provide evidence of an in-vitro 
interaction between intracellular domain of CRK1 and catalytic subunit of PP2A3c and 
further characterize the kinase properties of the recombinantly produced intracellular 
domain of CRK1 kinase, including mass spectrometric mapping of auto phosphorylation 
sites and the importance of phosphorylation sites within the activation loop. 
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Material and Methods 
Vector construction and mutagenesis 
Constructs of SUMO-fused CRK1 (sCRK1) and SUMO-fused CRK1m (inactive) 
mutant (sCRK1m) were prepared as described in [22]. MBP-fused catalytic subunit of 
PP2A3 (M-PP2A3c) was cloned as C terminal fusion to Maltose Binding Protein (MBP) 
in pMAL-C2E vector (Addgene) using the forward primer 
5’GCGGGCGCGGCCTTAATGGGCGCGAATTCTATTCC 3’ and the reverse primer 
5’CCAACCGCGGCCTCATCACAGGAAATAGTCTGGAGTCCT 3’.  The PCR 
amplified gene was cloned by standard ligation independent cloning (LIC) procedures into 
an in-house modified pMAL-C2E vector generated for LIC, containing a 6X His tag at N-
terminus of MBP. DNA sequencing confirmed correct insertion of the PP2A3c gene into 
the pMAL-C2E vector. Mutagenesis to create non-phospho and phospho-mimetic mutants 
of the phosphorylation sites in and around the activation loop was carried out using the 
QuickChange Lightning Multi Site-Directed Mutagenesis Kit (Stratagene) using 
mutagenic primers listed in Table 1.  
Protein Expression and Purification of SUMO-tagged and tag-less CRK1 Proteins  
Expression and purification of SUMO-tagged CRK1 protein was performed as 
described by Meyer et al [27]. The cleavage reaction to remove SUMO tag was performed 
by incubating SUMO protease (gift from Nelson Lab, Iowa State University) with the 
affinity-enriched SUMO-CRK1 at 1:100 concentration in 50 mM Tris, pH 8, 0.2% NP40, 
150 mM NaCl and 1 mM DTT overnight at 4°C while dialyzing the cleavage reaction 
against 50 mM Tris, pH 8, 150 mM NaCl and 1 mM DTT. The cleaved SUMO protein was 
removed by affinity enrichment of the dialyzed cleavage reaction to obtain tag-less CRK1  
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Circular Dichroism (CD) measurements  
CRK1 purified from E. coli (naïve CRK1) and auto phosphorylated CRK1 
(pCRK1) were dialyzed overnight at 4°C in 10 mM Tris-HCl, pH 7.4 and 0.1 mM TCEP 
and concentrated to an A280 value of approximately 0.4. Far-UV spectrum of each protein 
was obtained on a Jasco J-710 spectropolarimeter, in a 0.1cm path-length cuvette with 
excitation wavelengths ranging from 190 nm-260 nm.  
Fluorescence Measurements 
Naïve CRK1 and pCRK1 were dialyzed in 10 mM Tris-HCl, pH 7.4 and 0.1 mM 
TCEP and brought to a concentration of A280 = 0.1 prior to fluorescence scans. 
Measurements were made in a 1 cm cuvette at room temperature with a Cary Eclipse 
spectrofluorometric (Varian). Scans were executed at an excitation wavelength of 280 nm 
and a band width of 5 nm and a scan speed of 120 nm/min.  
Kinase Activity Assays.  
 Auto phosphorylated cold pCRK1 was produced by incubating 1 µg of sCRK1 in 
1ml reaction buffer containing 20 mM Bis-Tris pH 7.2, 25 mM NaCl, 5 mM MnCl2, 1 
mM DTT, 100 µM ATP at a temperature of 30 ̊C.  
Phosphorylation of MBP- fused PP2A3c was performed in two separate reactions 
with sCRK1 and sACR4.  1 µM of kinase protein was incubated with 1 µM PP2A3c protein 
in 20 µl of Kinase Buffer (20 mM Bis-Tris pH 7.2, 25 mM NaCl, 5 mM MnCl2,1 mM DTT, 
25 µM ATP) supplemented with 2 µCi of [γ-32P] ATP (Perkin Elmer, 6,000 Ci/mmol). 
Proteins were incubated at room temperature for 1 h. Reactions were terminated with the 
addition of 4X SDS sample buffer and boiled. Proteins were separated by 12% SDS-PAGE 
and radioactive bands were analyzed by phosphor imaging. 
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Assays to determine the auto phosphorylation mechanism were performed using 
the SUMO-CRK1 (sCRK1) and SUMO free CRK1 (CRK1) proteins. A series of reactions 
were carried out containing increasing concentrations of sCRK1 and CRK1 in the range 
0.1-15µM (17.5 µM in case of sCRK1).  The protein was incubated in 20 µl reactions of 
optimized kinase buffer containing 2.5 µCi of [γ-32P] ATP. Reactions were initiated with 
the addition of the enzyme and incubated for 15 min at room temperature. They were then 
terminated and separated by 12% SDS-PAGE and radioactive bands were analyzed by 
phosphorimaging.  Protein bands were excised from the gel and radioactivity was 
determined by scintillation counting. Phosphate incorporation for each sample was 
calculated based on the radioactive counts and the use of a [γ-32P] ATP standard curve. The 
data was then used to generate a Van’t Hoff plot (log of enzyme activity vs log of enzyme 
concentration) and the intramolecular nature of the mechanism inferred from the slope of 
this plot. 
Initial velocity for CRK1 auto phosphorylation was determined at varying ATP 
concentration (0.1µM -50 µM) in a 40 µl kinase reaction volume containing 4 µCi of g-32P 
labeled ATP.  Kinase reaction at each ATP concentration was carried out at increasing time 
points from 0-50 mins at room temperature. Amount of phosphate incorporation was 
determined as described above. The initial velocity at each substrate (ATP) concentration 
was calculated by plotting the pmole of phosphate incorporation v/s time. The rate of the 
reaction was then calculated by plotting the initial velocities v/s substrate concentration 
using the Sigma Plot 11.2 (Systat Software Inc., San Jose, CA) Enzyme Kinetics module 
(version 1.3) and Michaelis-Menten constants were determined by non- linear regression 
analysis.  
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Pull down Assay 
The MBP fused PP2A3c (20 µg per reaction) was used as bait to pull out naïve 
CRK1 kinase and auto phosphorylated CRK1 kinase (50 µg per reaction), devoid of SUMO 
tag. Bait proteins (MBP-PP2A3c and MBP protein) were incubated with 25 µl bed volume 
of amylose resin in 1X binding Buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM 
DTT, 0.02% NP-40) in a 500µl volume for 1 h at room temperature. To remove unbound 
MBP proteins, the resin was washed three times with binding buffer by spinning the protein 
bound resin at 1000 rpm for 30 secs and carefully discarding the supernatant containing 
unbound protein at each wash step. CRK1 proteins were added to the amylose bound MBP 
proteins in separate reaction, in 500 µl of binding buffer and incubation for 1 h at room 
temperature on a rotator.  Unbound proteins were washed off in a similar fashion as 
described. Bound complex protein was eluted from resin by addition of 100 µl of Laemmli 
buffer and boiling the protein complex/resin mixture at 95°C for 5 min followed by 
centrifuging at max speed to pellet resin. 40 µl of supernatant from each reaction was 
separated by 12% SDS-PAGE and proteins were analyzed by coomassie staining and by 
western blots with polyclonal anti-ACR4 (cross reactive within ACR4 family) at 1:3000 
dilution and anti-mouse alkaline phosphatase (AP) conjugated secondary antibody at 
1:20000 dilution. 
Gel – filtration studies  
 
Purified CRK1 protein was incubated with MBP-PP2A3c protein at equimolar 
concentrations to determine possible interaction. 5 µM CRK1 was incubated with 5 µM of 
MBP-PP2A3c in 500 µl of Column Buffer (50 mM Tris pH 7.4, 100 mM NaCl, 100 µM 
MnCl2, 100 µM MgCl2 and 1mM DTT) for 1 h at room temperature. Protein mixtures were 
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then loaded onto a Global 10/300 Superdex G- 200 Column (GE Healthcare) coupled to an 
AKTA FPLC system. Proteins were passed through the column at a flow rate of 0.4 ml/min 
and 0.3 ml fractions were collected. Fractions corresponding to protein peaks were 
analyzed by 12% SDS-PAGE and western blot analysis using polyclonal anti-ACR4 
primary antibody and AP conjugated Anti-mouse IgG secondary antibody.  
Sample Preparation for Liquid Chromatography-Tandem Mass Spectrometry (LC-
MS/MS) Analysis.  
 
 To prepare peptides, proteins were concentrated by lyophilization. The lyophilized 
protein was dissolved in SDT buffer (4% SDS, 100mM Tris-HCl pH 8) containing 50mM 
DTT. Protein samples were heat denatured at 95°C for 5min, alkylated in 50mM 
Iodoacetamide for 45mins in dark, followed by addition of 600 µl of urea to each sample. 
The sample were loaded onto a YM-30 filter unit and SDS buffer was exchanged by 
washing twice with 200µl of Urea and one time wash with 200µl of 100mM Tris, pH 8. 
The protein(s) were digested in two steps, with 1µg of trypsin digestion carried out for 
2hours, followed by a second dose of overnight trypsinization.  The digested peptide 
samples were cleaned using Sep-Pak (Waters, part# WAT054960). 120 µg of peptide 
sample were dissolved in 200µl of HEPES, pH 8.0 and TMT (Pierce, part # 90060) labelled 
by addition of 1.6 mg of TMT-126 and TMT-127 (dissolved in 41µl of 100% acetonitrile) 
to phosphorylated and naïve CRK1 proteins with 1h of incubation at Room temperature. 
The reaction was quenched using 16µl of 5% hydroxylamine for 15 mins. The labeled 
sample was dried down in vaccum centrifuge and excess of unbound TMT reagent was 
removed by Sep-Pak. Phosphopeptides were enriched using FeCl3 activated Ni-NTA 
beads. Briefly, FeCl3 activated Ni-NTA beads were prepared by using 100ul of 5% metal 
activated Ni-NTA bead suspension. The beads were washed with Nano-pure water and 
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treated with 100mM EDTA, pH 8 for 30 min with end-over-end rotation in Invitrogen Hula 
Mixer. Excess EDTA by washed off the beads three times with nano-pure water. Metal 
free washed beads were then activated with 10mM FeCl3 in aqueous metal ion solution for 
30 min with end-over-end rotation in Invitrogen Hula Mixer. Excess metal ions were 
washed with nano-pure water as described. Aliquoted beads were washed with of 80% 
acetonitrile with 0.1% TFA. Phospho-peptides were enriched by resuspending dried 
peptide samples(100ug) in 200ul of resuspension/wash buffer containing 80% acetonitrile 
and 0.1% TFA. Suspended samples were incubated with activated beads for 30 minutes 
with end-over-end rotation in Invitrogen hula mixer. Unbound sample was washed with 
80% acetonitrile, 0.1% TFA, three times with each wash performed for a min. Phospho-
peptides were eluted with 1:1 5% ammonia water (Sigma 35% NH4OH to make 5% 
Ammonia) in 5mM pH 8 phosphate buffer, pH ~10. The phospho-sample were 
immediately acidified to pH 3.4-4 with 1/10th volume of 50% TFA. SPE with 1 set of 
C4+PGC tips without further drying in speedvac. Wet SPE tips with 60% Acetonitrile 
containing 0.1%TFA 10 times by aspirating 25µL and dispensing to waste. Equilibrate tips 
to loading conditions 10 times with 0.1%TFA by aspirating 25 µL and dispensing to waste. 
Load samples by aspirating and dispensing 65 µL 50 times. Wash loaded tips by aspirating 
65 µL of 0.1% TFA and dispensing to waste 10 times. Elute peptides with 60% Acetonitrile 
containing 0.1%TFA with 35 µL, aspirating and dispensing into elution vial 25 times. 
Rinse tip with an additional 25 µL of 60% Acetonitrile containing 0.1%TFA. Combine C4 
and PGC tip eluate, dry in speed vac. Solubilize dried peptides in 1%TFA to approximate 
concentration of 0.6µg/µL and transfer to AS vial.  
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Nano-LC-MS/MS Analysis of TMT-labeled Phosphopeptides  
 The samples were loaded (2.5 µL) onto a 75 µm i.d. × 50 cm AcclaimÒ PepMap 
100 C18 RSLC column (Thermo-Fisher Scientific) on an EASY nanoLC (Thermo Fisher 
Scientific) at a constant pressure of 700 bar at 100% A (0.1%FA). Before sample loading 
the column was equilibrated to 100%A for a total of 20µL at 700 bar pressure. Peptide 
chromatography was initiated with mobile phase A (0.1% FA) containing 5%B (100% 
ACN, 0.1% FA) for 1 min, then increased to 15% B over 102 min, to 25% B over 87 min, 
to 35% B over 40min, to 70% B over 6 min, hold for 6 min, then increased to 95% B over 
2 min and held at 95% B for 18 min, with a flow rate of 300 nL/min. The data were acquired 
in data-dependent acquisition (DDA) mode. The full-scan mass spectra were acquired by 
the Orbitrap mass analyzer with a scan range of m/z = 375 to 1500 and a mass resolving 
power set to 70,000.  Twelve data-dependent high-energy collisional dissociations were 
performed with a mass resolving power set to 35000, a fixed lower value of m/z 100, an 
isolation width of1. 2 Da, and the normalized collision energy setting of 32.  The maximum 
injection time was 60 ms for parent-ion analysis and 120 ms for product-ion analysis. The 
target ions that were selected for MS/MS were dynamically excluded for 40 sec. The 
automatic gain control (AGC) was set at a target value of 3e6 ions for full MS scans and 
1e5 ions for MS2. Peptide ions with charge states of one or ≥ 7 were excluded for CID 
acquisition.  
Phosphopeptide site identification and quantification. 
The unprocessed instrument data were converted to peak lists using Proteome 
Discoverer (version 2.1.0.81, Thermo-Fisher Scientific) with integration of reporter ion 
intensities from the TMT two-plex (TMT-126 and 127N) using a mass tolerance of ± 3.15 
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mDa. The Mascot software (Matrix Science, London, UK; version 2.5.1) was used to 
search against a database of SwissProt (species: Arabidopsis thaliana; 13,315 entries; 
version 2017_07), containing common laboratory contaminant proteins (cRAP, version 
2012_01; 116 entries) using “trypsin allows P” enzyme specificity with up to 4 missed 
cleavages. Phosphorylation of serine, threonine and tyrosine, deamidation of asparagine, 
formation of pyro-glutamic acid from any N-terminal glutamine, acetylation of protein N-
terminus, oxidation of methionine, iodoacetamide derivatization of any cysteine and pyro-
carbamidomethylation at any N-terminal cysteine were specified in Mascot as variable 
modifications.  Isobaric labeling with TMT was required for Lys residues and the N-
terminal residue for these peptides and not specified for label-free experiments. The peptide 
spectral matches (PSM) were filtered at 1% false-discovery rate (FDR) by searching 
against a decoy database and the ascribed peptide identities were accepted. The FDR of 
peptides was estimated using the approximated formula 𝑁"#$%&	  (#(/𝑁*+*	  (#(	  where 
𝑁"#$%&	  (#( and 𝑁*+*	  (#( denotes the number of decoy and and forward-Arabidopsis 
peptides, respectively. Using the principal of parsimony, protein identities containing ³ 2 
unique or Occam’s razor peptides were accepted. The FDR of the proteins was estimated 
using the approximated formula 𝑁"#$%&	  (,-,-/0	  /𝑁*+*	  (,-,-/0 where 𝑁"#$%&	  (,-,-/0	  and 
𝑁*+*	  (,-,-/0 denotes the number of decoy proteins and Arabidopsis proteins, respectively, 
containing ³ 2 peptides (Table 3).  Intensities of the reporter ions from the two TMT 
channels were obtained from Mascot.   The mean intensity of PSMs that can be assigned 
to a same peptide was taken to represent the intensity of the incumbent peptide. Peptide 
ratios between TMT channels were obtained with intensity normalization at the basis of 
equal summed intensity under each TMT channel.   
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Results 
Characterization of CRK1 and its kinase activity.	 	 
The intra-cellular domain of CRK1 (residues 364-75) was expressed as a C-
terminal fusion to yeast SUMO protein and, the expression and purification of CRK1 was 
performed as described by [22]. SUMO-fused CRK1 and SUMO-free CRK1 protein both 
exist as monomeric proteins as described by size-exclusion chromatography (Figure 1A). 
Figure 2A shows the far-UV CD spectrum of naive CRK1 with minima at 208 nm and 222 
nm, similar to the CD spectrum of its homolog ACR4 [27] and consistent with an a helical 
conformation observed in the CD spectra  many receptor tyrosine kinases [28,29].  
 The optimal condition for maximal kinase activity of CRK1 was reported in [22]. 
The auto phosphorylation assay of CRK1 was performed in 20 mM Bis Tris, pH 7.2, 25 
mM NaCl, 5 mM MnCl2, 1 mM DTT in presence of 100 µM cold ATP at room temperature. 
The time course of auto phosphorylation indicate maximal phosphorylation is achieved in 
1 h (Figure 3A). The enzyme displays typical Michaelis- Menten kinetics with respect to 
ATP (Figure 3B). The Km and Vmax of ~3  µM and ~24.9 pmol min-1mg-1 was identified 
for ATP dependent auto phosphorylation of CRK1. The values were obtained by fitting the 
data to the Michaelis - Menten equation (using the Enzyme Kinetics Module on SigmaPlot 
11.2). The Km for ATP, in case of ACR4 was twofold higher than CRK1, suggesting CRK1 
to be better kinase enzymatically. 
Intra-molecular mechanism of auto phosphorylation. 
Kinases can undergo auto phosphorylation either through intra molecular (first-
order with respect to enzyme concentration) or inter molecular mechanism (second-order 
with respect to enzyme concentration). In separate reactions, increasing concentration of 
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SUMO fused CRK1 (0.1 µM -17.5 µM) and tag less CRK1 (0.1 µM -15 µM) were 
incubated in series of kinase reactions. Rate of auto phosphorylation was linear with respect 
to enzyme concentration (Figure 4A & 4D) and, the specific activity defined as the amount 
of phosphate incorporation per molecule remained constant over increasing enzyme 
concentration indicating a first order of reaction (Figure 4B & 4E). The Van’t hoff analysis 
is a plot of logarithm of the phosphorylation rate over the logarithm of the enzyme 
concentration, the slope of 1.09 and 0.98 and linear regression coefficient of 0.99 and 0.98 
for sCRK1 and CRK1 respectively was obtained, suggesting intra-molecular mechanism 
of auto phosphorylation in case of both proteins.  It is likely that the SUMO tag adds to the 
stability of the protein, as suggested by the reduced specific activity observed in tag-less 
CRK1 in comparison to sCRK1. 
Mapping of auto phosphorylation sites.  
Approximately forty phospho-sites (comprised of twenty serines, twelve threonines and 
eight tyrosines) were determined by performing tandem mass spectrometric analysis on 
tryptic digests of CRK1 kinase. The identified phospho-peptides span the intracellular 
domain (ICD) of CRK1 kinase (Figure 5A). The precise phosphorylated residue in the 
sequence was confirmed by inspection of the fragmentation pattern for specific site-
determining y and b ions. As an example, the collision induced tandem mass spectrum for 
579DIKpSSNILLDATWTAK594, is shown in Figure 5B. The difference in the theoretical 
m/z and the observed m/z of the precursor ion is 80 Da, which is indicative of the presence 
of one phosphorylated residue in the peptide. Further, the presence of doubly charged 
[M+2H-H3PO4]2+ species at m/z of 879.47, a characteristic peak for neutral loss of 
phosphoric acid, indicates the presence of one phosphorylation site within the peptide.  The 
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ambiguity of which Serine residue (Ser582 or Ser583) is phosphorylated was solved by the 
presence of site determining y and b ions in the CID spectrum. Phosphorylated b4 
(theoretical m/z 524.21, observed m/z 524.21) and y13 (theoretical m/z 1499.71, observed 
m/z 1499.72), along with non-phosphorylated b3 (theoretical m/z 351.21 and observed m/z 
351.21) and y12 (theoretical m/z 1332.71 and observed m/z 1332.72 confirm the identity 
of the phosphorylated Ser582. The tryptic peptide 
595VSDFGLSQMGPTEEDDVSHLSLHAAGTLGYIDPEYYK631 harbors the activation 
loop has with nine probable phosphorylation sites, including six serine/threonine –Ser596, 
Ser601, Thr606, Ser612, Ser615, Thr621; and three tyrosines- Try624, Try629 and Try630. We 
identified the presence of site-determining b and y ions for Ser601 and Thr621. Figure 5C 
represents MS2 spectrum reported for one of the enriched phosphopeptide spanning the 
activation loop. The theoretical m/z of non-phosphorylated peptide with +5 charge is 
811.17 and the observed m/z of [M+5H]5+ is 844.56. The difference of 32 Da mass supports 
the presence of two phosphorylated residues within this peptide. We looked for peaks 
representing phosphorylated and/or non-phosphorylated b and y ions scanning through the 
peptide from N & C terminal end. Represented MS2 spectrum shows the presence of non-
phosphorylated b3 (m/z 302.11), b6 (m/z 619.31) and b13 (m/z 1365.599) ions and y12 
(m/z 1418.68) and y13 (1489.72) ions, which eliminated phosphorylation at sites Ser596, 
Ser601 and Thr606at the N terminus end and Thr621, Try624, Try629 and Try630 at the C terminus 
end of the peptide. The expected set of diagnostic ions were not identified for Ser612 and 
Ser615 in this MS2 spectrum, but we were able to narrow down possible phosphorylation 
sites to Ser612 and/or Ser615. The tyrosines in the activation loop were also analyzed 
separately using another MS2 spectrum. We analyzed the difference in the theoretical m/z 
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of activation loop for of a non-phosphorylated [M+4H] 4+ (m/z 1015.22) and the observed 
m/z of 1095.20. This is indicative of four phosphorylation sites within this peptide. The 
presence of tyrosine phosphorylation was confirmed with the presence of a peak at m/z of 
216.04, which represents the peak for immonium ion, generated on internal fragmentation 
of peptide containing phosphorylated tyrosine. However, the exact phosphorylation site at 
Try630 was confirmed by the presence of site-determining y ions. Non-phosphorylated y1 
(observed m/z 147.11 and theoretical m/z 147.11) and, phosphorylated y2 (observed m/z 
390.15 and theoretical m/z 390.143) was identified in the MS2 spectrum under study. We 
narrowed down four potential phosphorylation sites in the activation loop with confirmed 
Ser601, Thr 621, Try630 and either Ser612 or Ser615   by manually analyzing the various MS 
spectrums of enriched tryptic peptide containing activation loop. Table 2 shows the 
complete list of identified phosphopeptides and their site-determining ions. 
We also performed quantitative mass spectrometry analysis to detect the difference 
in phosphorylation states between naïve (as isolated from E. coli) and auto phosphorylated 
CRK1 by utilizing isobaric Tandem Mass tag (TMT) labeling on the digested peptides (as 
described in Materials and Methods). Using a cut-off of >2-fold intensity change 
(normalized intensity) for phosphopeptides derived from the phosphorylated protein 
compared with the corresponding phosphopeptides from the control naïve protein, we 
identified 16 peptides (Table 3) that correlated with the phosphosites in Table 2.  This study 
indicates that the peptide LCTLASLGNPGQLMEFSIDELALATDGFSVR, for example, 
is phosphorylated in both the naïve and phosphorylated CRK1 but the extent of 
phosphorylation is much greater in the latter as evidenced by a 6.5-fold higher intensity in 
the phosphopeptide derived from the phosphorylated protein relative to non-
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phosphorylated CRK1.  This analysis parallels our observation of minimal change in 
phosphorylation state between naïve and auto phosphorylated CRK1 on a qualitative Pro-
Q-Diamond phospho-proteome analysis (data not shown).  
Auto phosphorylation induces a conformational change 
Phosphorylation and dephosphorylation induce conformational changes and 
structural modifications within proteins [30,31,32]. To address whether phosphorylation of 
CRK1 causes any structural perturbations, we used circular dichroism (CD) and fluorescent 
spectroscopy, both techniques that are sensitive to changes in secondary structure and t 
microenvironment of proteins respectively [33,34,35,36]. The CD spectrum (Figure 2A) of 
auto phosphorylated CRK1 is similar to that of the naïve CRK1 but is indicative of slight 
perturbation in the secondary structure on phosphorylation of CRK1. Figure 2B represents 
the emission spectra of naïve CRK1 and pCRK1. Fluorescence spectroscopy is a sensitive 
probe of protein folding and tertiary structure and reveals variations in the 
microenvironment of tyrosine and tryptophan residues. At 280 nm both these aromatic 
residues absorb and contribute to the emission spectra [33,37]. While the λmax of emission, 
334 nm, is the same for both proteins, there is a substantial decrease in the quantum yield 
of fluorescence of pCRK1, indicating a distinct conformational shift. 
Auto phosphorylation of activation loop important for CRK1 kinase activity    
The activation loop in kinases is a key regulatory element.  Phosphorylation of 
specific residues within the activation loop critically regulates the overall kinase activity 
amongst receptor like kinases. Conserved residues within the activation loop are often 
indicative of conserved function of these residues throughout the RLK family of receptors. 
The activation loop, comprising ~ 25-30 residues, spans from residues “DFG” in 
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subdomain VII to residues “XPE” in subdomain VIII, which serve as hinge points for 
activation loop movement. The aspartate in DFG motif functions towards chelation of a 
Mg2+ ion and stabilization of β and γ phosphates of incoming ATP molecule, where XPE 
motif stabilizes the C lobe of kinase structurally.  Figure 6 represents a sequence alignment 
of activation loop within the plant Ser/thr RLK and indicates evolutionary conservation of 
specific residues (black box). Note that some of these conserved sites are also conserved 
phosphorylation sites amongst plant RLKs (Red).  We report four confirmed 
phosphorylation sites (S601, S612/615, T621, Y624) within the activation loop (Figure 6). We 
also tested the role of phosphorylation at a conserved tyrosine (Try 566) upstream to 
catalytic loop in CRK1. The phosphorylation of this conserved tyrosine was identified in 
vitro in trans-membrane bound ICD of ACR4 (unpublished data).  Site-directed 
mutagenesis of these residues differentially altered kinase activity (Figure 7). We replaced 
each of these phosphorylation sites within CRK1 with either an alanine or phenylalanine 
(in case of tyrosine), or a glutamic acid which mimics phosphorylation.  Mutation of S601 
to S601A abolished the kinase activity completely which was regained to some extent in 
S601E mutation, suggesting the requirement of negative charge at this position 601 for 
kinase activity, which suggests that it is most likely candidate for phosphorylation. The 
kinase activity of S612A was knocked down in comparison to S612E, hinting towards the 
necessity of negative charge at this position for maximum activity, which is fulfilled by 
phosphorylation. It also suggests that phosphorylation at S601 and S612 positively 
regulates the kinase activity of CRK1 kinase. Kinase activity of S615E was minimally 
knocked down relative to S615A mutant suggesting potential negative regulation by 
phosphorylation at this site. The kinase activity of both Y566E and Y566F were 
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comparable, but substantially less than wild type CRK1. Interestingly, the mutants T621E 
and Y624E/F indicate loss of activity, suggesting that T621 and Y624 are essential residues 
for kinase activity and that the kinase activity is not linked with the property of the 
introduced amino acid. The conservation of T621 and Y624 residues across many RLKs, 
and the fact that we do not observe any restoration of kinase activity on mutation to a 
phospho-mimetic or a non-mimetic residue, strongly   supports a structurally important role 
for these residues. [38,39,40].  
CRK1 interacts with PP2A3c  
 In silico analysis of mRNA expression data provides strong evidence of co-
expression of ACR4, PP2A3c and CRK1 in the same cellular environment. Co-expression 
of proteins is a strong indicator of interaction between proteins. We have previously 
reported the interaction of ACR4 with PP2A3c [26] and Meyer et al have demonstrated the 
interaction between ACR4 and CRK1[22].On this basis, we have rationalized that PP2A3c 
may be a common substrate and interaction partner for RLKs within the ACR4 family. We 
therefore investigated the ability of PP2A3c and CRK1 to interact with each other by gel-
filtration analysis (Figure 1 C & D) and pull down assay (Figure 8). For gel-filtration 
studies, we incubated tag-less CRK1 in equimolar concentration with MBP-PP2A3c (5 µM 
each) prior to loading on a Superdex G-200 column. It is evident that CRK1 by itself elutes 
as a monomeric protein (Figure 1A, Peak 3) and M-PP2A3c elutes as an oligomer protein 
(Figure 1B, Peak 1). When the proteins are incubated together, the gel-filtration profile 
clearly indicates co-elution of MBP-PP2A3c with CRK1 in the void volume fraction 
(Figure 1C, Peak 1), suggesting that majority of the monomeric CRK1 protein formed a 
complex with MBP-PP2A3c, with very little of monomeric CRK1 eluting by itself as seen 
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in the SDS-PAGE analysis (Insets). The presence of CRK1 in the eluted fractions from was 
confirmed using polyclonal Anti-ACR4 (cross reactive with CRK1) (Figure 1D)  
The interaction between CRK1 and PP2A3c was further confirmed by pull down 
experiment. The MBP-fused PP2A3c was used as bait and tag-less CRK1 was used as a 
prey. Our results indicate that MBP-PP2A3c can interact with both naïve (Figure 9A, Lane 
1) and auto-phosphorylated (Figure 9A, Lane 2). Control reactions between MBP protein 
and CRK1 showed that the interaction specifically occurred between ICD of CRK1 and 
PP2A3 catalytic domain and discounted any nonspecific interaction of CRK1 with the 
fused MBP-tag protein. The presence of CRK1 in each reaction was confirmed using 
polyclonal Anti-ACR4 (cross reactive with CRK1) (Figure 9B).  
PP2A3c is a substrate for CRK1 
We have previously reported the catalytic subunit of PP2A3 as a substrate for 
ACR4 kinase activity [26]. Here we used both MBP-PP2A3c and PP2A3c-6H as a 
substrate and assessed the kinase activity of CRK1 and ACR4. Figure 10A and 10B shows 
the difference in phosphorylation of PP2A3c mediated by sCRK1 and sACR4. Clearly, the 
ability of ACR4 to phosphorylate PP2A3c (both MBP fused and 6XHis fused) is much 
higher than the ability of CRK1 to phosphorylate PP2A3c (Lane 1 & 2, 9A- 9B). This 
difference notwithstanding, that PP2A3c is a common substrate for both ACR4 and CRK1 
phosphorylation. Note that MBP-PP2A3c (Figure 9A & B, Lane 1) was phosphorylated to 
a lesser extent than PP2A3-6H (Figure 9A & B, Lane 2). This could be attributed to 
conformational differences between MBP-PP2A3c and PP2A3-6H. The presence of 42 
kDa MBP tag could also block the accessibility of residues for phosphorylation by kinase. 
 
 156  
Discussion 
The  model of single ligand–single receptor mediating downstream signaling is  
challenged by the  growing evidence of multiple receptor interactions and signal perception 
and transduction in both RTKs and RLKs such as EFGR [6,7,9], Insulin–like Growth 
Factor Receptor [10], CLAVATA2 [14], BRI1 [15,16], FLS2 and BAK1 [13]. Specifically, 
in roots, a heterodimer/homodimer assembly of CLAVATA1 and ACR4 is known to 
moderate root stemness in Arabidopsis [20]. In this study, we have characterized the kinase 
activity of CRK1 and further build on the potential of heteromeric interactions within the 
ACR4 family of receptors and regulation by PP2A3c.  
Phosphatases regulate plant RLK activity and examples include regulation of 
CLAVATA 1 by kinase-associated protein phosphatase (KAPP), together with its co-
receptors CLAVATA 2 (CLV2) and CORYNE, striking a balance between cell 
proliferation and differentiation in the shoot meristem [52]. POL and PLL1 phosphatases, 
also act as signaling intermediates of CLV1 signaling, positively regulating stem cell 
specification. In-silico assessment for co-expression of proteins in root apical meristem 
was analyzed using Arabidopsis “electronic fluorescent pictograph” (eFP) browser 
(http://bar.utoronto.ca) [41], which described over-lapping expression patterns for ACR4 
and CRK1 [22] and weak overlap between ACR4 and PP2A3c in columella cells and lateral 
roots [26]. However, strong experimental evidence of co-expression of ACR4 and PP2A3 
in columella cells in root meristem has been obtained using GFP-fused proteins [26]. 
Similarly, although in silico analysis with the eFP browser shows weak overlap between 
CRK1 and PP2A3c expression patterns (data not shown) in roots, it does not preclude the 
possibility of their interaction in vivo.   Certainly, a case may be made for more 
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confirmatory spatio-temporal genetic analysis of the co-expression patterns of CRK1 and 
PP2A3c.  However, sequence similarity, co-expression and interaction between ACR4 and 
CRK1 provided a compelling reason to examine the interaction of CRK1 and PP2A3c.  
Thus, we performed in vitro investigations and report interaction of PP2A3c with both 
naïve and auto phosphorylated intracellular domain of CRK1 kinase, via gel-filtration and 
pull down experiments. In vitro kinase assay further indicates phosphorylation of PP2A3c 
by CRK1 (similar to ACR4 mediated phosphorylation) and, in conjunction with the known 
interaction between ACR4 and CRK 1 [22] is strongly suggestive of PP2A3c acting as a 
common substrate for both homologs and together or separately mediating the signaling 
pathway(s). It is not unreasonable to speculate that multiple related kinases share a 
common phosphatase. For example, recent studies in BRI1 signaling have reported the role 
of PP2A phosphatase to both positively and negatively regulate BR signaling cascades. 
Auto regulated inactive BRI1-BAK inhibits plant growth by phosphorylation of 
downstream BZR1 transcription factor, which in presence of low BR is dephosphorylated 
by PP2A, in-turn activating BR signaling[42,43]. Additionally, methylation of PP2A drives 
its membrane localization and its association with BRI1, leading to degradation and signal 
attenuation following dephosphorylation of BRI-1 [44]. Clearly these studies emphasize 
the importance of phosphatase mediated regulation of RLKs. and emphasize the need for 
further in planta studies to understand the significance of ACR4- CRK1- PP2A3c 
interactions in root meristem and lateral roots.  
We further characterized the biochemical properties of CRK1 kinase and identified 
over forty sites of auto phosphorylation spanning the entire intracellular domain of CRK1 
by means LC-MS/MS analysis. To a large extent, phosphorylation of key residues creates 
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binding surfaces and drive intracellular signaling via diverse phospho-amino acid binding 
modules such as the 14-3-3, WW and Fork Head-Associated domains (FHA) [45,46]. An 
example of FHA-containing module in Arabidopsis is the kinase-associated protein 
phosphatase (KAPP). KAPP binds to phosphorylated Ser/Thr residues of several plant 
RLKs such as CLAVATA 1 (CLV1), SERK1, HAESA, and FLS2 and acts as a negative 
regulator of receptor signaling [shah47,48,49,50]. These interactions could either involve 
stable formation of multi-meric complexes via adaptor and scaffolding proteins, or 
reversible interaction with phosphatases or could facilitate transient dynamic interactions. 
Besides phosphorylation at serines and threonines, we identified phosphorylation of 8 
tyrosine residues Recent reports of tyrosine phosphorylation in multiple plant RLKs such 
as BRI1, HAESA, show evolution of kinases with dual specificity towards both 
serine/threonine and tyrosine residues [39,40,51,52]. In a separate study with 
transmembrane bound intracellular domain of ACR4 in nanodiscs, we identified 
phosphorylation at Try566 (unpublished) and, interestingly, is also conserved in CRK1. 
Both Y566E and Y566F mutation showed reduced kinase in comparison to wildtype CRK1 
suggesting the structural importance of this residue in both CRK1 and ACR4.  Mitra et al 
[53] recently reported a database of in vitro auto phosphorylation sites for 223 LRR-RLKs, 
representing ~30% of LRR-RLKs in Arabidopsis, with a highest of 24 sites of auto 
phosphorylation (At2g01820.1) and an average of 10 auto phosphorylation sites amongst 
the RLKs under study, with 16 and 18 in vitro sites of auto phosphorylation identified in 
ACR4 [27] and BRI1[40,43,54] respectively. The vast number of in-vitro auto 
phosphorylation sites identified in CRK1 could be attributed to a mixture of endogenous 
phosphorylation sites and auto-phosphorylation sites, with comparable level of 
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phosphorylation observed in naïve and auto phosphorylated CRK1 proteins on Pro-Q-
diamond phospho-proteome analysis (data not shown). It should also be noted that E. coli 
genome possess endogenous tyrosine kinases such as Wzc and Etk kinases and serine/ 
threonine kinases (eSTKs) such has YihE kinase [55,56,57], which may drive 
phosphorylation at some sites in recombinantly expressed CRK1. However, the biological 
significance of the in vitro phosphorylation sites remains to be validated by in planta 
studies.  
Auto phosphorylation induces conformational change within the intracellular 
domain of CRK1 as indicated by changes in CD spectrum and fluorescence measurements. 
Very little to no change in phosphorylation state was observed between CRK1 and pCRK1 
from Pro-Q-diamond analysis and further quantitative mass spectrometry analysis, as 
illustrated in table 3, reveals phospho-peptides enriched with twofold (or more) change in 
phosphorylation relative to peptides from naïve CRK1. For example, phosphorylated 
peptide ‘ADKDSAFVNELESMSR’ enriched from auto-phosphorylated protein has 2.3-
fold occurrence relative to the phosphorylated version of this peptide in non-
phosphorylated protein, clearly indicating the presence of phosphorylation on Ser/Thr 
residues in both the naïve and auto phosphorylated peptide although to much higher extent 
in auto phosphorylated state.  More than likely, auto phosphorylation mediates the close to 
open conformational change which is otherwise held together by the different regions of 
intra-cellular domain in accordance with the regulatory role  of JMD and CTD regions in 
RTKs such as ephrin binding receptor (EpH) family, platelet-derived growth factor 
(PDGF) receptor family, and epidermal growth factor receptor (EGFR) family 
[58,59,60,61,62], and negative regulatory role of CTD  in the function of BRI-1 RLK [63].  
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 The classical paradigm of ligand mediated dimerization of receptor inducing 
conformational change and activation of kinase domain by cis (intramolecular) or trans 
(intermolecular) auto phosphorylation [64,65]. We report an intramolecular mode of auto 
phosphorylation of CRK1, and we speculate that in vivo, on binding to its ligand 
CRK1/ACR4 could undergo a conformational change in its intracellular domain which 
drives its subsequent interaction with a second kinase within/outside of the ACR4 family 
of RLKs, that is capable of trans phosphorylating at a specific site on the ACR4 
intracellular domain and “activating” an intramolecular auto phosphorylation event. 
Intriguingly, we identified multiple auto phosphorylation sites within the activation 
loop of CRK1 as opposed to just one site (T681) of phosphorylation within the activation 
loop of ACR4 [27]. The activation segment is a conserved region in protein kinases that 
occurs between subdomains VII and VIII of the kinase domain [66], harbors essential 
phosphorylation sites regulating the kinase activity and possesses elements important for 
substrate binding  [32,63,67]. Phosphorylation of specific residues within the activation 
loop is required to attain maximal enzymatic activity. There is strict conservation of 
Threonine 621, Tyrosine 624 and Serine 615 (specific to CRK1) throughout RD –type 
RLKs. The alanine mutation of corresponding conserved threonine in BRI-1, abolishes 
auto phosphorylation and substrate phosphorylation in vitro, and does not rescue the weak 
bri1-5 brassinosteroid insensitive mutant in planta (37). Similarly, phosphorylation of the 
conserved Thr468 in AtSERK1 [50] and Thr769 in SYMRK activity [68] are important for 
both auto phosphorylation and phosphorylation of artificial substrates in vitro. In CRK1, 
non-phospho and phosphor-mimetic mutations of conserved T621 (T621A and T621E) and 
Y624 (Y624F and Y624E) completely abolished the kinase activity indicating the 
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structural importance of these residues but the S615A/E mutation did not affect the 
phosphorylation state of CRK1 to any extent. However, in case of the RLKs BAK1 and 
HAE, mutations at these congruent sites facilitate regain in phosphorylation activity, 
suggesting phosphorylation at these sites positively regulate the kinase activity. We also 
observed phosphorylation at S601 to positively regulate the kinase activity of CRK1, 
clearly suggesting the functional importance of additional phosphorylation sites within 
activation loop, that are not conserved across RD-type RLKs alignment. Recent studies on 
HAE RLK opened a new avenue to understand the dual specificity within RLK where the 
phosphor-mimetic mutation at S856 and S861 in activation loop of HAE displayed elevated 
auto-phosphorylation at Y724. It is possible that the tyrosine phosphorylation (Try 624) 
within CRK1 activation loop is a result of phosphorylation at other residues thereby 
imparting dual-specificity to CRK1 kinase much like HAE RLK [52].  
In conclusion, we propose ACR4-CRK1-PP2A3c interactions as being important 
in the regulation of a common signaling pathway coordinating formative cell division in 
root meristems. With physiological effects reported from our prior work on PP2A3c-ACR4 
interaction in roots, and the involvement of PP2A in the regulation of other RLKs  
[26,42,43,44], our future studies are directed towards delineating the role of CRK1 and 
PP2A3c interacting in planta.  Furthermore, the biochemical characterization of the intra-
cellular domain of CRK1 and the mapping of in vitro auto phosphorylation sites lays a 
strong foundation for more in-depth genetic and in planta analysis of heteromeric 
interactions in the ACR4 family and PP2A affecting the differentiation of root cells and 
root formation. 
 
 162  
Acknowledgements 
We would like to thank R. Reid Townsend, Petra Gilmore and the Proteomics Core 
Lab at Washington University in St. Louis, MO, for the mass spectrometry analysis of the 
auto phosphorylated CRK1 and the quantitative mass spectrometry analysis of naïve and 
auto phosphorylated CRK1. 
References 
1. Lemmon MA, Schlessinger J (2010) Cell Signaling by Receptor Tyrosine Kinases. Cell 
141: 1117-1134. 
2. Afzal AJ, Wood AJ, Lightfoot DA (2008) Plant receptor-like serine threonine kinases: 
roles in signaling and plant defense. Mol Plant Microbe Interact 21: 507-517. 
3. Haffani YZ, Silva NF, Goring DR (2004) Receptor kinase signalling in plants. Canadian 
Journal of Botany-Revue Canadienne De Botanique 82: 1-15. 
4. Kim TW, Guan S, Sun Y, Deng Z, Tang W, et al. (2009) Brassinosteroid signal 
transduction from cell-surface receptor kinases to nuclear transcription factors. Nature Cell 
Biology 11: 1254-1260. 
5. Shiu SH, Bleecker AB (2001) Receptor-like kinases from Arabidopsis form a 
monophyletic gene family related to animal receptor kinases. Proc Natl Acad Sci U S A 
98: 10763-10768. 
6. Olayioye MA, Neve RM, Lane HA, Hynes NE (2000) The ErbB signaling network: 
receptor heterodimerization in development and cancer. EMBO J 19: 3159-3167. 
7. Prenzel N, Fischer OM, Streit S, Hart S, Ullrich A (2001) The epidermal growth factor 
receptor family as a central element for cellular signal transduction and diversification. 
Endocr Relat Cancer 8: 11-31. 
8. Wieduwilt MJ, Moasser MM (2008) The epidermal growth factor receptor family: 
biology driving targeted therapeutics. Cell Mol Life Sci 65: 1566-1584. 
9. Schulze WX, Deng L, Mann M (2005) Phosphotyrosine interactome of the ErbB-
receptor kinase family. Mol Syst Biol 1: 2005 0008. 
10. Morgillo F, Woo JK, Kim ES, Hong WK, Lee HY (2006) Heterodimerization of 
insulin-like growth factor receptor/epidermal growth factor receptor and induction of 
survivin expression counteract the antitumor action of erlotinib. Cancer Res 66: 10100-
10111. 
11. Saito Y, Haendeler J, Hojo Y, Yamamoto K, Berk BC (2001) Receptor 
heterodimerization: essential mechanism for platelet-derived growth factor-induced 
epidermal growth factor receptor transactivation. Mol Cell Biol 21: 6387-6394. 
12. Pfeiffer M, Koch T, Schroder H, Laugsch M, Hollt V, et al. (2002) Heterodimerization 
of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and 
desensitization. J Biol Chem 277: 19762-19772. 
13. Chinchilla D, Zipfel C, Robatzek S, Kemmerling B, Nurnberger T, et al. (2007) A 
flagellin-induced complex of the receptor FLS2 and BAK1 initiates plant defence. Nature 
448: 497-500. 
 163  
14. Guo Y, Han L, Hymes M, Denver R, Clark SE (2010) CLAVATA2 forms a distinct 
CLE-binding receptor complex regulating Arabidopsis stem cell specification. Plant J 63: 
889-900. 
15. Clouse SD (2011) Brassinosteroid signal transduction: from receptor kinase activation 
to transcriptional networks regulating plant development. Plant Cell 23: 1219-1230. 
16. Ye H, Li L, Yin Y (2011) Recent advances in the regulation of brassinosteroid signaling 
and biosynthesis pathways. J Integr Plant Biol 53: 455-468. 
17. Cao X, Li K, Suh SG, Guo T, Becraft PW (2005) Molecular analysis of the CRINKLY4 
gene family in Arabidopsis thaliana. Planta 220: 645-657. 
18. De Smet I, Vassileva V, De Rybel B, Levesque MP, Grunewald W, et al. (2008) 
Receptor-like kinase ACR4 restricts formative cell divisions in the Arabidopsis root. 
Science 322: 594-597. 
19. Nikonorova N, Vu LD, Czyzewicz N, Gevaert K, De Smet I (2015) A phylogenetic 
approach to study the origin and evolution of the CRINKLY4 family. Front Plant Sci 6: 
880. 
20. Stahl Y, Grabowski S, Bleckmann A, Kuhnemuth R, Weidtkamp-Peters S, et al. (2013) 
Moderation of Arabidopsis root stemness by CLAVATA1 and ARABIDOPSIS 
CRINKLY4 receptor kinase complexes. Curr Biol 23: 362-371. 
21. Gifford ML, Robertson FC, Soares DC, Ingram GC (2005) ARABIDOPSIS 
CRINKLY4 function, internalization, and turnover are dependent on the extracellular 
crinkly repeat domain. Plant Cell 17: 1154-1166. 
22. Meyer MR, Shah S, Zhang J, Rohrs H, Rao AG (2015) Evidence for intermolecular 
interactions between the intracellular domains of the arabidopsis receptor-like kinase 
ACR4, its homologs and the Wox5 transcription factor. PLoS One 10: e0118861. 
23. Albrecht C, Russinova E, Kemmerling B, Kwaaitaal M, de Vries SC (2008) 
Arabidopsis SOMATIC EMBRYOGENESIS RECEPTOR KINASE proteins serve 
brassinosteroid-dependent and -independent signaling pathways. Plant Physiol 148: 611-
619. 
24. Boyer F, Simon R (2015) Asymmetric cell divisions constructing Arabidopsis stem cell 
niches: the emerging role of protein phosphatases. Plant Biol (Stuttg) 17: 935-945. 
25. Wang Y, Li Z, Liu D, Xu J, Wei X, et al. (2014) Assessment of BAK1 activity in 
different plant receptor-like kinase complexes by quantitative profiling of phosphorylation 
patterns. J Proteomics 108: 484-493. 
26. Yue K, Sandal P, Williams EL, Murphy E, Stes E, et al. (2016) PP2A-3 interacts with 
ACR4 and regulates formative cell division in the Arabidopsis root. Proc Natl Acad Sci U 
S A 113: 1447-1452. 
27. Meyer MR, Lichti CF, Townsend RR, Rao AG (2011) Identification of in vitro 
autophosphorylation sites and effects of phosphorylation on the Arabidopsis CRINKLY4 
(ACR4) receptor-like kinase intracellular domain: insights into conformation, 
oligomerization, and activity. Biochemistry 50: 2170-2186. 
28. Sierke SL, Cheng K, Kim HH, Koland JG (1997) Biochemical characterization of the 
protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein. Biochem 
J 322 ( Pt 3): 757-763. 
29. Wente SR, Villalba M, Schramm VL, Rosen OM (1990) Mn2(+)-binding properties of 
a recombinant protein-tyrosine kinase derived from the human insulin receptor. Proc Natl 
Acad Sci U S A 87: 2805-2809. 
 164  
30. Groban ES, Narayanan A, Jacobson MP (2006) Conformational changes in protein 
loops and helices induced by post-translational phosphorylation. Plos Computational 
Biology 2: 238-250. 
31. Huse M, Kuriyan J (2002) The conformational plasticity of protein kinases. Cell 109: 
275-282. 
32. Nolen B, Taylor S, Ghosh G (2004) Regulation of protein kinases: Controlling activity 
through activation segment conformation. Molecular Cell 15: 661-675. 
33. Laskowicz JR (1986) Principles of Fluorescence Spectroscopy. Plenum Press, New 
York. 
34. Fontana A, Fassina G, Vita C, Dalzoppo D, Zamai M, et al. (1986) Correlation between 
sites of limited proteolysis and segmental mobility in thermolysin. Biochemistry 25: 1847-
1851. 
35. Polverino de Laureto P, Frare E, Gottardo R, Van Dael H, Fontana A (2002) Partly 
folded states of members of the lysozyme/lactalbumin superfamily: a comparative study 
by circular dichroism spectroscopy and limited proteolysis. Protein Sci 11: 2932-2946. 
36. Kamath N, Karwowska-Desaulniers P, Pflum MK (2006) Limited proteolysis of human 
histone deacetylase 1. BMC Biochem 7: 22. 
37. Barry JK, Selinger DA, Wang C, Olsen OA, Rao AG (2006) Biochemical 
characterization of a truncated penta-EF-hand Ca2+ binding protein from maize. Biochim 
Biophys Acta 1764: 239-245. 
38. Jaillais Y, Hothorn M, Belkhadir Y, Dabi T, Nimchuk ZL, et al. (2011) Tyrosine 
phosphorylation controls brassinosteroid receptor activation by triggering membrane 
release of its kinase inhibitor. Genes & Development 25: 232-237. 
39. Lin W, Li B, Lu D, Chen S, Zhu N, et al. (2014) Tyrosine phosphorylation of protein 
kinase complex BAK1/BIK1 mediates Arabidopsis innate immunity. Proc Natl Acad Sci 
U S A 111: 3632-3637. 
40. Oh MH, Wang XF, Kota U, Goshe MB, Clouse SD, et al. (2009) Tyrosine 
phosphorylation of the BRI1 receptor kinase emerges as a component of brassinosteroid 
signaling in Arabidopsis. Proceedings of the National Academy of Sciences of the United 
States of America 106: 658-663. 
41. Winter D, Vinegar B, Nahal H, Ammar R, Wilson GV, et al. (2007) An "Electronic 
Fluorescent Pictograph" browser for exploring and analyzing large-scale biological data 
sets. PLoS One 2: e718. 
42. Tang W, Yuan M, Wang R, Yang Y, Wang C, et al. (2011) PP2A activates 
brassinosteroid-responsive gene expression and plant growth by dephosphorylating BZR1. 
Nature Cell Biology 13: 124-131. 
43. Wu G, Wang X, Li X, Kamiya Y, Otegui MS, et al. (2011) Methylation of a 
phosphatase specifies dephosphorylation and degradation of activated brassinosteroid 
receptors. Sci Signal 4: ra29. 
44. Di Rubbo S, Irani NG, Russinova E (2011) PP2A phosphatases: the "on-off" regulatory 
switches of brassinosteroid signaling. Sci Signal 4: pe25. 
45. Chevalier D, Morris ER, Walker JC (2009) 14-3-3 and FHA domains mediate 
phosphoprotein interactions. Annu Rev Plant Biol 60: 67-91. 
46. Yaffe MB, Elia AE (2001) Phosphoserine/threonine-binding domains. Curr Opin Cell 
Biol 13: 131-138. 
 165  
47. Gomez-Gomez L, Bauer Z, Boller T (2001) Both the extracellular leucine-rich repeat 
domain and the kinase activity of FLS2 are required for flagellin binding and signaling in 
arabidopsis. Plant Cell 13: 1155-1163. 
48. Stone JM, Collinge MA, Smith RD, Horn MA, Walker JC (1994) Interaction of a 
Protein Phosphatase with an Arabidopsis Serine-Threonine Receptor Kinase. Science 266: 
793-795. 
49. Williams RW, Wilson JM, Meyerowitz EM (1997) A possible role for kinase-
associated protein phosphatase in the Arabidopsis CLAVATA1 signaling pathway. Proc 
Natl Acad Sci U S A 94: 10467-10472. 
50. Shah K, Vervoort J, de Vries SC (2001) Role of threonines in the Arabidopsis thaliana 
somatic embryogenesis receptor kinase 1 activation loop in phosphorylation. J Biol Chem 
276: 41263-41269. 
51. Gish LA, Clark SE (2011) The RLK/Pelle family of kinases. Plant J 66: 117-127. 
52. Taylor I, Wang Y, Seitz K, Baer J, Bennewitz S, et al. (2016) Analysis of 
Phosphorylation of the Receptor-Like Protein Kinase HAESA during Arabidopsis Floral 
Abscission. PLoS One 11: e0147203. 
53. Mitra SK, Chen R, Dhandaydham M, Wang X, Blackburn RK, et al. (2015) An 
autophosphorylation site database for leucine-rich repeat receptor-like kinases in 
Arabidopsis thaliana. Plant J 82: 1042-1060. 
54. Wang XL, Chory J (2006) Brassinosteroids regulate dissociation of BKI1, a negative 
regulator of BRI1 signaling, from the plasma membrane. Science 313: 1118-1122. 
55. Lee DC, Zheng J, She YM, Jia Z (2008) Structure of Escherichia coli tyrosine kinase 
Etk reveals a novel activation mechanism. EMBO J 27: 1758-1766. 
56. Vincent C, Doublet P, Grangeasse C, Vaganay E, Cozzone AJ, et al. (1999) Cells of 
Escherichia coli contain a protein-tyrosine kinase, Wzc, and a phosphotyrosine-protein 
phosphatase, Wzb. J Bacteriol 181: 3472-3477. 
57. Zheng J, He C, Singh VK, Martin NL, Jia Z (2007) Crystal structure of a novel 
prokaryotic Ser/Thr kinase and its implication in the Cpx stress response pathway. Mol 
Microbiol 63: 1360-1371. 
58. Griffith J, Black J, Faerman C, Swenson L, Wynn M, et al. (2004) The structural basis 
for autoinhibition of FLT3 by the juxtamembrane domain. Molecular Cell 13: 169-178. 
59. Hubbard SR (2004) Juxtamembrane autoinhibition in receptor tyrosine kinases. Nature 
Reviews Molecular Cell Biology 5: 464-470. 
60. Lee NY, Koland JG (2005) Conformational changes accompany phosphorylation of 
the epidermal growth factor receptor C-terminal domain. Protein Science 14: 2793-2803. 
61. Niu XL, Peters KG, Kontos CD (2002) Deletion of the carboxyl terminus of Tie2 
enhances kinase activity, signaling, and function. Evidence for an autoinhibitory 
mechanism. J Biol Chem 277: 31768-31773. 
62. Thiel KW, Carpenter G (2007) Epidermal growth factor receptor juxtamembrane 
region regulates allosteric tyrosine kinase activation. Proceedings of the National Academy 
of Sciences of the United States of America 104: 19238-19243. 
63. Wang XL, Li XQ, Meisenhelder J, Hunter T, Yoshida S, et al. (2005) Autoregulation 
and homodimerization are involved in the activation of the plant steroid receptor BRI1. 
Developmental Cell 8: 855-865. 
64. Jiang.G (1995) Protein kinases and phosphatases: the yin and yang of protein 
phosphorylation and signaling. Cell 80: 225-236. 
 166  
65. Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103: 211-225. 
66. Hanks SK, Hunter T (1995) Protein kinases 6. The eukaryotic protein kinase 
superfamily: kinase (catalytic) domain structure and classification. FASEB J 9: 576-596. 
67. Taylor SS, Kornev AP (2011) Protein kinases: evolution of dynamic regulatory 
proteins. Trends in Biochemical Sciences 36: 65-77. 
68. Yoshida S, Parniske M (2005) Regulation of plant symbiosis receptor kinase through 





Figure 1: Gel filtration analysis of M-PP2A3c and CRK1 interaction on a Superdex 
G-200 column. A, B and C represents individual elution profiles of CRK1 (5µM), M-
PP2A3c (5uM) and, CRK1(5uM) with M-PP2A3c (5uM) respectively. Insets show the 
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corresponding SDS-PAGE of the proteins present in peak fractions 1, 2, 3 and 4. (A) CRK1 
(~47kDa) elutes as a monomer in peak 3 as indicated in SDS-PAGE (Inset). (B) M-PP2A3c 
(~80kDa) elutes as an oligomer in void volume of the column represented in peak 1 and as 
identified in SDS-PAGE gel (Inset). (C) CRK1 co-elutes with M-PP2A3c in peak 1, with 
now CRK1 predominantly appears with M-PP2A3c as seen in corresponding SDS-PAGE 
(inset), indicative of the interaction between the two proteins. (D) A western blot analysis 
with Anti-ACR4 antibody on the eluted fractions from C, confirms the presence of CRK1 
elution in complex with M-PP2A3c. 
 
Figure 2: Conformational analysis of CRK1 proteins. (A) Far-UV CD spectra of naïve 
CRK1, and auto phosphorylated pCRK1 in 10 mM Tris, pH 7.4 and 0.1 mM TCEP with 
an A280 value of ~0.4. (B) Intrinsic fluorescence spectra of CRK1, and pCRK1 in the same 
buffer with an A280 of 0.1. Measurements were made in a 1cm cuvette at room temperature 
with a Cary Eclipse spectrofluorometer (Varian) at an excitation wavelength of 280 nm. 
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Figure 3: Auto phosphorylation of CRK1. (A) Time course of auto phosphorylation for 
CRK1. (B) Plot of enzyme velocity vs ATP concentration. Data were fitted directly to the 
Michaelis-Menten equation using SigmaPlot 11.2 and the Enzyme Kinetics 1.3 module. 
The Km value for ATP was 3µM and the Vmax value was 24.9pmol/min/mg.
Time	  in	  mins	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  =	  3	  uM 
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Figure 4:  CRK1 auto phosphorylates via an intramolecular mechanism. SUMO: 
CRK1 (A-C) and CRK1 (D-F) were incubated at increasing enzyme concentrations in an 
auto phosphorylation assay. (A and D) Plot of velocity vs enzyme concentration. (B and 
E) Plot of specific activity vs enzyme concentration. (C and F) Van’t Hoff plot of the 
logarithm of the enzyme velocity vs the logarithm of the enzyme concentration. Linear 
regression of the data in panels C and F estimates a slope of 1.09 for SUMO: CRK1 and a 
slope of 0.98 for CRK1. All data are means ± standard deviation.
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Figure 5: (A) Diagram showing the identified phosphorylation sites in the intracellular 
domain of CRK1. Solid boxed region corresponds to juxta membrane (JMD) domain. 
Confirmed phosphorylated Serine and threonine residues (red) and tyrosine residues 
(Blue). Phosphorylation on S612 and S615 residues (oval circle) are potential 
phosphorylation sites with the absence of site determining ions. The central kinase domain 
(KD) with a 37 amino-acid long tryptic peptide (underlined), and the activation loop 
(double underline) spanning between DFG and DPE residues (yellow highlight), the “RD” 
motif characteristic of RD-type kinases (blue) (B) Collision-induced low resolution 
fragmentation spectrum of phosphopeptides (Ranging from amino acids 579 - 594) 
DIKpSSNILLDATWTAK (mascot score 112) The presence of phosphorylated b4 
(theoretical m/z 524.24 and observed m/z 524.24) and non-phosphorylated b3 (theoretical 
m/z 357.21 and observed m/z 357.21), along with site determining phosphorylated y12 
(theoretical m/z 1332.72 and observed m/z 1332.72) and nonphosphorylated y13 
(theoretical m/z  1529.83 and observed m/z 1529.83) confirmed the phosphorylation at  
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Ser582. (C) CID MS/MS spectrum for tryptic peptide 
595VSDFGLSQMGPTEEDDVSHLSHAAGTLGYIDPEYYK631 containing the 
activation loop. The presence of [M+5H]5+ (m/z 841.38) indicate the mass of doubly 
phosphorylated peptide with +5 charge.    
 
Figure 6: Alignment of the activation loop sequences of select plant RLKs belonging to 
the RD kinase family with the activation loop sequence between “DFG” in subdomain VII 
(green) and “XPE” in subdomain VIII (green). Conserved residues are highlighted in red. 
Conserved residues (Ser/ Thr /Try) throughout the activation loop of plant RLK (black 
box). 
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Figure 7: Effect of mutating activation loop phosphorylation sites on kinase activity. 
Non-phospho mutations to Y566 (conserved phosphorylated tyrosine between ACR4 and 
CRK1 beyond the activation loop), S601, S612, S515, T621 and Y624 to Ala. Try566 and 
624 were mutated to Phe and Glutamic acid representing non-phospho and phospho-
mimetic mutations respectively, along with phospho-mimetic mutations of S601, S612, 
S515, T621 to Glu.  In vitro kinase assay on each purified protein was performed as 
described in material and methods. Equal amounts of recombinant proteins were loaded 
and separated by SDS-PAGE followed by autoradiography. In panels A and B, the top 
panel shows the autoradiogram and the bottom panel is the corresponding Coomassie Blue-
stained gel. Wild-type CRK1 and mutant CRK1m (inactive) were used as controls
S601A	  S612A	  S615A	  T621A 	  	  CRK1	  	  	  Y566E	  	  	  Y566F	  	  	  S601E	  	  	  S612E	  	  	  S615E	  	  	  T621E	  	  	  Y624E	  	  	  Y624F 
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Figure 8: CRK1 ICD interaction with M-PP2A3c. M-PP2A3c was incubated with 
naïve and auto phosphorylated CRK1 in an in vitro pull-down assay. (A) Pull down 
reactions were separated on a 12% SDS-PAGE and Commassie blue stained reactions. M-
PP2A3 specifically bind and pull-down naïve CRK1 (Lane 1) and autophosphorylated 
CRK1 (Lane 2). Control pull down reaction between MBP protein and CRK1. (B) A 
corresponding western blot analysis confirms the identity of CRK1 in the pull-down 
reactions. An anti-ACR4 (cross reactive with CRK1) polyclonal antibody confirmed CRK1 
binding in Lane 1 & Lane 2 (lower panel, arrow) and, no binding to MBP tag alone in Lane 
3. 
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Figure 9:  PP2A3c is a substrate for both CRK1 and ACR4. (A) 1µM of sCRK1 
incubated with 1µM MBP-PP2A3c (Lane 1) and 1µM PP2A3c-6H (Lane 2) in an in vitro 
kinase assay respectively; control 1µM of M-PP2A3c protein (Lane 3). (B) In vitro kinase 
assay between 1µM sACR4 and 1µM MBP-PP2A3c (Lane 1) and 1µM of PP2A3c-6H 
(Lane 2) respectively; control 1µM of M-PP2A3c protein (Lane 3). Proteins were separated 
on an SDS-PAGE gel. Top panel presents commassie stained gel and bottom panel 
represents the corresponding autoradiogram. Both MBP fused and 6XHis fused PP2A3c 
are phosphorylated to a larger extend by ACR4 in comparison to CRK1, suggesting it to 
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 S601A GATTTCGGCCTAGCTCAAATGGGTCCAACG 
 S612A GAAGATGACGTCGCACATCTCTCTTTACACG 
 S615A GTCTCACATCTCGCTTTACACGCTGCC 
 
 T621A CACGCTGCCGGTGCATTGGGATATATC 
 Y624F CGTGGGATCCAAGCCCTTCATGAGTTTATCGTG 
Phospho-mimetic mutant Y566E CGTGGGATCCAAGAACTTCATGAGTTTATCGTGCC 
 S601E TCAGATTTCGGCCTAGAGCAAATGGGTCCAACGGAAG 
 S612E GAAGAAGATGACGTCGAACATCTCTCTTTACACGCTGCC 
 S615E GATGACGTCTCACATCTCGAATTACACGCTGCCGG 
 T621E TTACACGCTGCCGGTGAATTGGGATATATCGACCCG 
 Y624E GCCGGTACATTGGGAGAAATCGACCCGGAGTAC 
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Table 2. Site-discriminating ions for phosphorylated Serine, threonine and tyrosine 
residues (in red) identified in the enriched phosphopeptides. The percentage of maximum 
intensity for each site-discriminating ion in the averaged high resolution CID spectrum are 




















b3 (+1, 12.38) 
 





401LDDTRTIDIPKLEK414 b4 (-) b5 (+1, 2.91) y10 (-) y11 (-) 
401LDDTRTIDIPKLEK414 b5 (+1, 2.73) b6 (+1, 2.63) y8 (+1, 2.07) y9 (-) 
415RLCTLASLGNPGQLMEFSIDELALATDGFSVR446 b17 (-) b18 (-) y14 (+1, 3.88) y15 (+1, 2.84) 
416LCTLASLGNPGQLMEFSIDELALATDGFSVR446 b5 (+1, 0.17) b6 (+1, 0.24) y25 (-) y26 (-) 
416LCTLASLGNPGQLMEFSIDELALATDGFSVR446 b24 (-) b25 (-) y6 (+1, 32.86) y7 (+1, 13.44) 
416LCTLASLGNPGQLMEFSIDELALATDGFSVR 446 b28 (-) b29 (-) y2 (+1, 35.75) y3 (+1, 17.61) 
447FHLGIGSFGSVYQGVLSDGR466 b6 (+1, 6.92) b7 (-) y13 (+1, 5.48) y14 (+1, 1.06) 
447FHLGIGSFGSVYQGVLSDGR466 b16 (+2, 2.32) b17 (-) y3 (+1, 7.2) y4 (+1, 2.54) 
447FHLGIGSFGSVYQGVLSDGR466 b9 (+1, 4.61) b10 (+1, 0.39) y10 (+1, 0.87) y11 (-) 
472RAELTNPTLSGTTMR486 b11 (-) b12 (-) y3 (+2, 11.59) y4 (+1, 0.21) 
472RAELTNPTLSGTTMR486 b7 (-) b8 (-) y7 (+1, 2.71) y8 (+1, 0.31) 
472RAELTNPTLSGTTMR486  b19 (+1, 
0.24) 
b10 (-) y5 (+1, 20.54) y6 (+1, 13.18) 
473AELTNPTLSGTTMR486 b3 (+2, 0.95) b4 (-) y11 (-) y12 (-) 
490ADKDSAFVNELESMSR505 b4 (+1, 23.29) b5 (+1, 1.12) y11 (+1,18.51) y12 (+1, 6.71) 
493DSAFVNELESMSR505 b9 (-) b10 (-) y3 (+1, 8.01) y4 (+2, 10.7) 
490ADKDSAFVNELESMSR505 b14 (-) b15 (-) y1 (+1, 23.4) y2 (+1, 1.86) 
514LLGFYEDTEER524 b7 (-) b8 (-) y3 (+1, 19.57) y4 (-) 
533NGSLADHLHNPQFDPLSWQTR553 b2(+2, 6.21) b3 (+1, 9.72) y18 (-) y19 (-) 
533NGSLADHLHNPQFDPLSWQTR553  b19 (-) b20 (-) y1 (+1, 24.45) y2 (+1, 0.94) 
533NGSLADHLHNPQFDPLSWQTR553 b16 (-) b17(-) y4 (+1, 20.93) y5 (+1, 68.58) 
579DIKSSNILLDATWTAK594 b3(+1, 4.99) b4 (+1, 1.04) y12 (+1, 7.21) y13 (+1, 3.51) 
579DIKSSNILLDATWTAK594 b4 (+1, 0.32) b5 (+1, 3.28) y11 (-) y12 (-) 
582SSNILLDATWTAK594 b8 (-) b9 (-) y4 (+1, 38.22) y5 (+1, 3.76) 
595VSDFGLSQMGPTEEDDVSHLSHAAGTLGYIDPEYYK631 b6(+1, 10.95) b7 (-) y29 (-) y30 (-) 
595VSDFGLSQMGPTEEDDVSHLSHAAGTLGYIDPEYYK631 b25 (-) b26 (-) y10 (-) y11 (+1, 2.06) 
632FQQLTTKSDVYSFGVVLLELLSGHK656 b7 (+1, 0.31) b8 (+1, 1.01) y17 (-) y18 (-) 
632FQQLTTKSDVYSFGVVLLELLSGHK656 b21 (-) b22 (-) y3 (+1, 17.71) y4 (+1, 19.83) 
632FQQLTTKSDVYSFGVVLLELLSGHK656 b5 (+1, 8.79) b6 (-) y19 (-) y20 (-) 
 178  
Table 2 continued:  
 
639SDVYSFGVVLLELLSGHK656 b4(+1, 5.52) b5(-) y13 (+1, 4.49) y14 (-) 
690IPPTPYEIEAVAHVGYLAAECLMPCSR716 b24 (-) b25 (-) y1 (+2, 7.1) y2 (+1, 3.95) 
718KRPSMEVVSK728 b8 (-) b9 (-) y1 (+1, 2.92) y2 (+1, 7.24) 
718KRPSMVEVVSKLESALAACLTAPK741 b20(-) b21 (-) y3 (+1, 20.3) y4 (+1, 5.42) 








b11 (+1, 1.17) 
 
b12 (+1, 1.21) 
 
y8 (+1, 1.36) 
 
y9 (+1, 12.75) 
563GIQYLHEFIVPPVIHR578 b3 (+1, 3.07) b4 (+2, 3.23) y12 (-) y13 (-) 
595VSDFGLSQMGPTEEDDVSHLSHAAGTLGYIDPEYYK631 b28 (-) b29 (-) y7 (+1, 7.65) y8 (+1,2.52) 
595VSDFGLSQMGPTEEDDVSHLSHAAGTLGYIDPEYYK631 b33 (-) b34 (-) y2(+1, 28.88) y3 (+1, 15) 
595VSDFGLSQMGPTEEDDVSHLSHAAGTLGYIDPEYYK631 b34 (-) b35 (-) y1 (+1, 8.35) y2 (+1, 6.82) 
632FQQLTTKSDVYSFGVVLLELLSGHK656 b10 (+1, 0.04) b11 (+1, 0.41) y14 (+1, 0.44) y15 (-) 
668NLVEYVVPYILLDEAHR684 b4 (+1, 7.03) b5 (+2, 19.7) y12 (+1, 8.1) y13 (+1, 4.19) 
668NLVEYVVPYILLDEAHR684 b8(+1, 1.69) b9(-) y8(+1, 2.41) y9 (+1, 3.97) 
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Table 3:   A consolidated list of phosphorylated peptides (phosphorylated at Serine, 
threonine and tyrosine residues) enriched from pCRK1 protein with a fold change of ³2, 
with respect to same phosphorylated peptide enriched from naïve CRK1. 






(naive)	   FC	  
1	   RLCTLASLGNPGQLMEFSIDELALATDGFSVR	   Phospho	  (ST)	   6862912.505	   1205060	   5.7	  
2	   LDDTRTIDIPK	   Phospho	  (ST)	   4384665.44	   833350	   5.3	  
3	   NGSLADHLHNPQFDPLSWQTR	   Phospho	  (ST)	   7274906.615	   1555024.167	   4.7	  
4	   DSAFVNELESMSR	   Phospho	  (ST)	   28421954.07	   7076761.917	   4.0	  
5	   DIKSSNILLDATWTAK	   Phospho	  (ST)	   12390203.6	   3602000	   3.4	  
6	   AELTNPTLSGTTMRHR	   Phospho	  (ST)	   36250385.09	   10735528.33	   3.4	  
7	   RADKDSAFVNELESMSR	   Phospho	  (ST)	   7000322.18	   2101950	   3.3	  
8	   LLGFYEDTEER	  
Phospho	  (ST);	  
Phospho	  (Y)	   14905386.36	   4789000	   3.1	  
9	   FHLGIGSFGSVYQGVLSDGR	  
Phospho	  (ST);	  
Phospho	  (Y)	   4384284.496	   1439720	   3.0	  





Phospho	  (Y)	   8656023.849	   2962565.833	   2.9	  
12	   VHDSGRLDDTR	   Phospho	  (ST)	   2195856.452	   759633.3333	   2.9	  
13	   RAELTNPTLSGTTMRHR	   Phospho	  (ST)	   38210632.14	   13262927.15	   2.9	  
14	   LESALAACLTAPKTETVSRSNTY	  
Phospho	  (ST);	  
Phospho	  (Y)	   17484533.08	   6227538.312	   2.8	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CHAPTER 5: PRODUCTION OF MONOCLONAL ANTIBODY DISPLAYING 
SPECIFICITY TO THE INTRACELLULAR DOMAIN OF ACR4 
 
Abstract 
Overall plant growth and development is to a large extent mediated by a diverse set 
of receptor-like kinases (RLK). In this regard, an important long-term goal is to better 
understand the role of the RLK, Arabidopsis Crinkly 4 (ACR4) in, in root differentiation.  
Major advances in fundamental biology, medicine and miscellaneous science disciplines 
have been catalyzed through the hybridoma technology and the ease of production of 
monoclonal antibodies. Here, we describe the production of a highly specific monoclonal 
antibody(5A4) towards the intracellular domain (ICD) of ACR4, with no detectable cross-
reactivity with other homologs of ACR4 or the unrelated RLK CLAVATA1. The 
monoclonal antibody recognizes both auto-phosphorylated and naïve ACR4 and, in 
preliminary studies, we have identified a potential epitope within the ACR4 domain 
spanning amino acid residues 531-616. We anticipate that this antibody will be an 
invaluable reagent in furthering more comprehensive investigations on the biology 
biochemistry and genetics of ACR4. 
Abbreviations 
ACR4, Arabidopsis CRINKLY 4; BSA, bovine serum albumin; CRR, CRINKLY Related 
receptor; CLV1, CLAVATA; DTT, Dithiothreitol; DMEM, Dulbecco's Modified 
Eagle Medium; EGFR, epidermal growth factor receptor; ELISA, enzyme linked 
immunosorbent assay; GFP, green fluorescent protein; HAT, hypoxanthine-aminopterin-
thymidine; HER2, human epidermal growth factor receptor 2; ICD, intracellular domain; 
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mAb, monoclonal antibody; pAb, polyclonal antibody; PEG, polyethylene glycerol; PBS, 
phosphate buffered saline; PBST, phosphate buffered saline with 0.05% tween; PP2A3c, 
protein phosphatase 2A; pNPP, p-nitro phenyl phosphate; PVDF, polyvinylidene 
difluoride; RLK, receptor like kinase; YFP, yellow fluorescent protein. 
Introduction 
Antibodies are highly specific and selective immunological proteins used as a 
biochemical tool in a range of applications including selection, identification, 
purification/immuno-precipitation [1,2,3], protein function and structure determination [4] 
and therapeutic targets [5,6].   
Antibodies are produced by differentiated B lymphocytes, plasma cells, of higher animals 
in response to foreign substances (antigens). B lymphocytes differentiate into plasma cells 
and secrete a single specific antibody in response to one antigenic determinant.  
Antibodies are classified broadly into two groups: Polyclonal and Monoclonal 
antibodies based on their specificity, distinguishing characteristics and applications [7]. 
Polyclonal antibodies (pAb) are heterogeneous mixture of antibodies directed against 
multiple epitopes (determinants) on the same antigen. Different B-cell clones of the animal 
generate the antibodies and hence are immunochemically dissimilar with respect to 
specificities and affinities. On the other hand, monoclonal antibodies are generated from 
identical B cells that are clones of a unique parent cell with monovalent affinity and 
specifically bind to a single epitope on the antigen.  Monoclonal Antibodies (mAb) are 
produced from B-cell secreting cell clones, produced by fusion of myeloma cells with 
mouse spleen cells immunized with desired antigen [8]. The fusion generates a hybridoma 
cell line which has two important properties: an immortal nature coupled to expression of 
an antigen-specific antibody. 
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Production of mAbs is an expensive, elaborate and painstaking process with a much 
longer turn-around time in comparison to pAb Polyclonal. Nevertheless, due to their 
homogeneity, consistency and mono-specificity, mAbs have been a preferred tool used to 
evaluate molecular conformation, protein-protein interaction, post-translational 
modification and identification of single members with protein families. Co-immuno 
precipitation with specific antibodies is a routinely used method to isolate complexes of 
physically interacting proteins in vivo  [1,2,3 & 9]. Many monoclonal antibodies, targeted 
to receptor tyrosine kinases such as EGFR and HER2, have been developed as therapeutic 
agents to treat human diseases [10,11,12,13,14,15].  While this is less important in the plant 
sciences, antibodies have still served as essential reagents in a variety of studies.  
Arabidopsis genome encodes four homologs of ACR4 (AtCRRs) with high 
sequence similarity and conserved structural features. ACR4 is expressed throughout the 
plant development and is required for the overall development to plant encompassing 
proper cell formation and cell division in both root and shoot apical meristem [16,17]. 
Genetic, in-silico co-expression analysis and in vitro studies have identified many 
important interacting proteins including  the AtCRRs [17,18], PP2A3c [19], unrelated 
RLKs [20], and the transcription factor WOX5 [21], that are implicated in the regulation 
of formative cell differentiation of columella stem cells in root apical meristem and lateral 
root formation [22,23]. However there many unanswered questions remain with regard to 
ACR4 mediated signaling pathways affecting developmental aspects of both root apical 
meristem and shoot apical meristem.  
To further the mechanism of ACR4 signaling, and identify the important players in 
the network of interactions, we undertook the development of antibodies to the ICD of 
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ACR4. In this study, we report the development, purification and characterization of a 
monoclonal antibody highly specific to the intracellular domain of ACR4. No cross 
reactivity within the highly similar and related RLKs could be detected by ELISA and 
western blot analysis. We also narrowed down a region within ACR4 as a potential epitope 
for the mAb using phage-displayed domains of the RLK.  
Material and Methods 
Construct design, protein production and isolation of Antigen (Intracellular domain of 
ACR4) and other proteins. 
 The intracellular domain of the proteins was recombinantly cloned C-terminal to 
SUMO in pE-SUMO vector (life sensors). Cloning, expression and purification of SUMO-
fused ACR4 (sACR4) and SUMO-fused CRRs (sCRK1, sCRR1, sCRR2, sCRR3) were 
prepared as described in Meyer et al [24]. Control SUMO protein was obtained by 
expressing the endogenous SUMO protein in the pE-SUMO (Kan) vector (Life Sensors) 
in a similar manner. SUMO-CLV1 was cloned in similar fashion using forward primer 5’-
GCGGCAGGTCTCTAGGTATGCGTCAGATGAATAAGAAGAAGA-3’ and reverse 
primer 5’-GCAGCAGGTCTCTCTAGATCAACGCGATCAAGTTCGCCAC-3. pSUMO 
tag was cleaved incubating SUMO protease (gift from Nelson Lab, Iowa State University) 
with the affinity-enriched SUMO-tagged proteins at 1:100 concentration in 50 mM Tris, 
pH 8, 0.2% NP40, 150 mM NaCl and 1 mM DTT overnight at 4°C while dialyzing the 
cleavage reaction against 50 mM Tris, pH 8, 150 mM NaCl and 1 mM DTT. The cleaved 
SUMO protein was removed by affinity enrichment of the dialyzed cleavage reaction to 
obtain tag-less proteins.   
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Production and initial screening of hybridomas 
Monoclonal antibodies were produced at the Hybridoma Facility at Iowa State 
University as described in http://www.biotech.iastate.edu/Hybridoma/cell-fusion-and-cell-
passage/. Briefly, 25µg of SUMO-fused Intracellular domain of ACR4 (Antigen) was 
injected per mice (4 mice used -N, R, L & RR). Three injections at an interval of 2 weeks 
were performed per mice. Each injection was a 1:1 volume of adjuvant Freund’s Complete 
Adjuvant to antigen.  Two weeks after the last boost, mice are bled and the sera is tested 
for titer by dot-blot analysis against antigen as described below. The mouse with the highest 
titer is sacrificed and the spleen cells used for fusion. All materials, media, solutions, 
equipment and apparatus used were autoclave sterilized. Four days prior to the fusion, three 
T-75 flasks of SP2/0's were split at 1:30 in Dulbecco's Modified Eagle Medium 
(DMEM) supplemented with 10%Horse Serum (D-10) to a final volume of 60 ml per flask. 
60 ml of Dulbecco's Modified Eagle Medium DMEM 50/10 HAT was 
supplemented with 0.15 ml Gentamycin, 1.5 ml Glutamine, 1.5 ml Penn/Strep, 3 ml 
HAT (50X), 75 ml conditioned media, 15 ml Horse Serum in the order listed making sure 
the minor components are evenly dispersed. The three T-75 flasks of SP2/0’s cells were 
pooled into one flask. 4 x 107 SP2/0 cells were aliquoted into three 50ml tubes. Meanwhile, 
2.7ml sterile PBS was added to dissolve to 2.25 g of Polyethylene glycol (PEG) in 60°C 
water bath. 20ml aliquot of DMEM in 50 ml centrifuge tube and dissolved PEG, both 
solutions were incubated at 37°C. The mouse was carbon dioxide asphyxiated and the 
spleen was harvested in a sterile petri dish. The spleen cells were counted and 4 x 107 
spleen cells were added to the SP2/0 cells, gently mixed and centrifuged at 200 x g for 8 
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mins. The supernatant was discarded and the pellet was gently loosened by flicking. Filter 
sterilized 1 ml of PBS solution was added dropwise to the pellet and swirled for 15 secs to 
30 secs and left undisturbed for an additional 90 secs. 1 ml of DMEM was added very 
gently dropwise for 30 secs with gentle mixing for 30 secs followed by similar dropwise 
addition and gentle mixing of 9 ml of DMEM for 46 seconds. The mixture was set aside 
for 5 mins before centrifuging at 200 x g for 8 min. The supernatant was discarded and 10 
ml of HAT media was added to cell pellet and resuspended by gently pipetting up and 
down. The entire mixture was slowly transferred to 100 ml of HAT media and incubated 
for 1 h at 37 °C. The contents of the bottle were gently mixed and a 25 ml aliquot of the 
mixture was transferred to sterile media boat. 200 µl of the mixture was aliquoted to each 
well of a 96 well plate using multichannel pipette with sterile filter tip.  These results in 
12-16, 96-well plates per mouse.   
Following a color change to yellow, which signified growth, supernatant fluids 
from 300-800 wells were sampled and an initial pre-screening was performed by ELISA 
or dot-blot against the ACR4 antigen. The cells in the wells containing the positive 
supernatant fluid were moved up to 48-well plates and allowed to expand. At each stage, 
the supernatant fluids were re-screened to confirm the positive hybridomas.  Positives 
were then expanded to 24-well plates, T25 flasks, T75 flasks and then finally frozen at -
140 °C.  
Pre- Screening by Dot-blot analysis. 
 Pre-screening of the sera from mouse bleed was performed by dot blot assay. 1 µg 
of sACR4 was carefully blotted to 1 cm x 1 cm cut nitrocellulose paper and allowed to 
adsorb. Five 1cm x 1cm blots were per prepared for each mouse serum. The blots were 
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blocked with 5% nonfat dry milk in PBST for 1 h at room temperature followed by three 
washes with PBST (0.5% tween). Serially diluted (1:300 to 1:4800) mouse sera in PBS 
from four mice were incubated with the blots for 1 h at room temperature followed by three 
washes with PBST and further incubated with 1:10000 dilution of alkaline phosphatase 
conjugated anti-mouse secondary Ab. The sera with highest titer were detected 
calorimetrically by AP Conjugate Substrate kit (Bio-Rad).  
ELISA Screening assay 
  The screening at each step was carried out by performing ELISA against sACR4 
antigen coated well. 10 µg/ml of sACR4 was immobilized per well in 100 µl of NaHCO3, 
pH 9.6 and incubated room temperature for 2 h on a shaker. Plate was washed two times 
with PBST (0.05% Tween) followed by blocking with PBST containing 0.1 % BSA for 1 
h at room temperature on a shaker. It was then washed three times with PBST followed by 
incubation with the appropriate solution of monoclonal Ab (monoclonal 
supernatant/purified monoclonal) for 1-2 h. Subsequently, the plate was washed three times 
with PBST followed by incubation with 50 µl anti-mouse alkaline phosphatase conjugated 
secondary antibody (Sigma) in PBST for 1 h. The plate was the again washed four times 
with PBST. The positives supernatants or specificity of purified mAbs was detected 
colorimetrically by incubating with 100 µl of a p-nitro phenyl phosphate (pNPP) solution 
(Sigma) to each well. The reactions were allowed to incubate for 5 mins with occasional 
manual shaking. Reactions were terminated with the addition of 50 µl of 2N NaOH to each 
well and absorbance was measured at 405 nm on a plate reader (Spectra Max 180).
 187  
Purification of monoclonal antibodies by Ammonium sulphate precipitation 
Monoclonal antibodies were purified from 50 ml of selected frozen supernatants by 
ammonium sulphate precipitation. 100% saturated ammonium sulphate (AmSO4), pH 7 
was prepared. At room temperature, 50 ml of prepared 100% saturated AmSO4 solution 
was added progressively with continuous gentle stirring with a magnetic stirrer. Stirring 
was continued for 20 mins after the last addition of AmSO4. The mixture was centrifuged 
at 12000 g for 30 mins at 4°C. The supernatant was discarded and the precipitated pellet 
was resuspended in 15 ml of PBS solution. Any remaining AmSO4 was eliminated by 
dialysis against PBS overnight at 4°C with three buffer changes. The dialyzed sample by 
further centrifuged at maximum speed for 15 mins to remove any aggregates. 15 ml of 
supernatant was concentrated down to 5 ml through vivaspin 20 MWCO 10000 (GE 
healthcare) by centrifuging at 4000 x g for 30 mins. Multiple 500 µl aliquots were prepared 
for long term storage at -20 °C.  
Characterization of mAbs 
The monoclonals (generally IgG) were isotype following manufacturer’s protocol 
for isotype testing (Pierce Kit: Fisher # PI-26178) (Table 2). An absorbance spectrum scan 
was collected for each purified mAb (with appropriate dilution in PBS) in the 210-310 nm 
ultraviolet range and concentration was determined by using O.D at 280 nm and molar 
extinction coefficient of 1.36 
The saturating concentration of mAbs was determined by an indirect ELISA assay. 
0.1 µg of sACR4 antigen coated wells were blocked and incubated with serially diluted 
(1:2 to 1:64) mAbs, diluted in PBS buffer for 1 h at room temperature followed by 1 h of 
incubation with 1:20000 alkaline phosphatase conjugated anti- mouse secondary antibody. 
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Colorimetric detection was performed by using pNPP substrate kit (Sigma) as described 
before. Saturation curves were plotted by subtracting the background control reading from 
each test reading. The concentration of each antibody required to saturate the antigen is 
determined from the saturation curves by extrapolating the reading from constant plateau 
region in the plot.  
Western blot Analysis and ELISA 
1 µg of purified proteins (sACR4, sCRK1, sCRR1, sCRR2, sCRR3, sCLV1 and 
SUMO) were separated on a 12% SDS-PAGE gel and blotted onto a PVDF membrane. 
The membrane was blocked and probed with saturating concentration of purified 
monoclonal antibody, washed, and then probed with a secondary anti-mouse IgG antibody 
(1: 10,000) conjugated to alkaline phosphatase (Sigma). Protein detection was completed 
using an AP Conjugate Substrate kit (Bio-Rad).  
Similarly, to test the specificity towards ACR4, and to eliminate any cross 
reactivity, microtiter plates were also coated with equal amount (10 µg/ml) of sCRK1, 
sCRR1, sCRR2, sCRR4, sCLV1 and control SUMO and ELISA was performed as 
described above. 
Construction of Phage-displayed Overlapping Domains of ACR4 ICD. 
 
Five overlapping domains of intracellular domain (ICD) of ACR4 (J1-J5) with five 
amino acid overlap were prepared as described by Shah et al [25]. The domains span amino 
acid residues 456- 895 within the intracellular domain. Individual domains J1, J2, J3, J4 
and J5 domains consists of 80, 85, 85, 85,85, 125 amino acids respectively. PCR of the 
cDNA of ACR4 fused in pE-SUMO vector was used as template and amplified using the 
forward and reverse primers listed in table 3.  The PCR fragments were then digested with 
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SfiI and NotI, ligated into a similarly digested pCANTAB 5E phagemid vector and 
subsequently transformed into E. coli XL1-Blue cells (Stratagene). Single colonies from 
each plate were inoculated into 5 ml 2YT/ carb/Amp media, grown to O.D at 600 l ~0.2–
0.3 at 37 °C and then infected with helper phage-VCSM13 (Stratagene). After 1 h the cell 
culture was transferred to 25 ml 2YT/Kan media and further incubated overnight at 37°C. 
After removing cell debris by centrifugation, phage particles were precipitated from the 
supernatant using 7.5 ml of 20% PEG solution containing NaCl. The precipitate was re-
suspended in 1 ml of PBS and phage concentration determined by measuring absorbance 
at 268 nm (O.D 268 nm = 1.0 for a solution containing 5 x 1012 phages per ml).  
Phage ELISA  
1 µg of purified monoclonal Antibody (5A4) was coated in triplicates (or a total of 
3 x 7 = 21 wells) on a microtiter Nunc plate (Thermo scientific) in 100 µl of 50 mM 
NaHCO3, pH 9.6 on gentle rotation for 2 h at room temperature. Plate was then washed 
two times with PBST (0.05%) followed by blocking with PBST containing 0.2% BSA for 
1 h. Subsequently, after three washings with PBST, wells were incubated with the 100 µl 
of appropriate concentration of phage domain (1 x 1012 phage particles) in PBST, 0.02% 
BSA, for 2 h at room temperature with gentle shaking followed by three time washes with 
PBST. Control reaction of 5A4 was against equivalent amount of the PP2A3c phage 
domain (prepared similarly to ACR4 domain) and helper phage. Each well was then 
incubated with anti-M13 HRP conjugated antibody for 1 h followed by four time washes 
with PBST. The bound phage in each well was detected by incubating with 50 µl of 
SureBlue Reserve TMB Microwell peroxidase substrate (KPL) till the blue color develops 
(usually 5-10mins). Thereafter, reactions were terminated by the addition of 50 µl of 1N 
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HCl, 0.6N Sulfuric acid and the absorbance of the developed yellow color was measured 
at 450 nm. Data were generated by subtracting the absorbance of the control (helper phage 
control) wells from the experimental wells. 
Results 
Screening and purification of Ten Monoclonal Antibodies (mAbs) 
 
  Pre-bleeds were obtained from four mice, injected with 25 µg of SUMO-
ACR4(ICD) after 2 weeks and tested via dot-blot assay (Figure 1). One mouse was selected 
to isolate spleen cells for fusion with SP20 cells. Two rounds of screening against the 
antigen was performed by ELISA and wells with readings with an absorbance of 0.05 
above background (about 30 lines) was advanced for further screening. After two further 
rounds of selection by the same process, 10 lines were finally selected to produce 50 ml 
supernatants. The selected 10 hybridoma supernatants were purified at 50% ammonium 
sulphate saturation, as suggested for IgG precipitation [26]. According to their general 
structure, antibodies are classified as IgG, IgM, IgE, IgA or IgD, with hybridomas 
primarily expressing the IgG type [27].  
Characterization of Monoclonal Antibodies  
 
The general structure of IgG consists of two long heavy chains (H) and two short 
chains light chains (L) linked by disulfide bonds. Each purified antibody was separated on 
an 12% SDS PAGE gel (Figure 2). The two bands corresponding to 50 kDa and 25 kDa 
(Figure 2) represents heavy and light chain of the IgG mAb. The other contaminating bands 
may correspond to lipids, albumin, transferrin, lipoproteins, endogenous IgG, other host 
proteins and depending on future applications, may require a secondary step of purification 
such as ion-exchange chromatography or size exclusion chromatography. Table 1 
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summarizes the concentration of diluted monoclonal antibodies calculated from A280 
values from absorbance curves for obtained for each antibody and specifies the saturating 
concentration of each diluted mAb to be used for ELISA and western blot analysis as 
determined from saturation curves. 
Table 2 classifies the mAbs according to their isotypes. The IgG immunoglobulins 
are subdivided into isotypes: IgG1, IgG2, IgG3, and IgG4 due the difference in the number 
of disulfide bonds linking the two heavy chains [28,29,30]. The ability to fix complement 
and specific response towards protein, polysaccharides and allergens vary within the 
members of IgG subclass [29,30]. The ten monoclonals represent different isomers of IgG 
immunoglobulins sub classified based on variability in the disulfide bonds within the hinge 
region. The kappa isomers are structural hinge isomers to IgG2 subclass. Hence, each 
isotype of the purified monoclonal could serve to recognize a different biomolecule within 
an epitope.  
5A4:  Specificity of mAb toACR4 
 The specificity of each purified mAb against the intracellular domain of ACR4 was 
analyzed by ELISA (Figure 5A). Preliminary ELISA indicated cross reactivity of 9 out of 
10 mAb against all the SUMO fused test proteins. Test proteins comprised members of 
ACR4 RLK family with high sequence similarity. The antigen injected was SUMO-fused 
ACR4 (ICD); hence SUMO protein was included as a control. SUMO-fused CLAVATA-
1 (sCLV1), an unrelated RLK, with little or no similarity to the ACR4 or its homologs, was 
an additional control. All Abs, except 5A4, showed cross-reactivity with SUMO. The O.D 
readings were obtained in triplicates and average mean values at 405 nm were plotted for 
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each mAb (Figure 5B), clearly indicating specificity of only one mAb (5A4) for ACR4 
antigen (red arrow and red boxed O.D reading) 
Further western blot analysis confirmed the specificity of 5A4 against sACR4, 
SUMO-free ACR4 with no indication of cross-reactivity against ACR4 homologs, sCLV1 
or SUMO (Figure 6). 
5A4 cross-reacts with naïve and auto phosphorylated ACR4. 
Injection of naïve sACR4 generated one highly specific mAb, 5A4, against the 
intra-cellular domain. We analyzed the cross reactivity 5A4 against naïve and auto 
phosphorylated (pACR4) by Western Blot analysis (Figure 7A) and ELISA (Figure 7B). 
Both the assays indicate that 5A4 recognizes both ACR4 and pACR4. 
Epitope mapping  
 
To further characterize 5A4, we attempted epitope mapping of by testing binding 
of the antibody to specific regions of ACR4 displayed on phage particles, as described in 
Materials and Methods. Overlapping domains (J1-J5) spanning the entire intracellular 
domain ACR4 were expressed as individual antigenic regions ligated to the pIII coat gene 
and displayed as a part of the outer coat protein of an M13 phage particle (Figure 8A). 
Phage-ELISA performed with homogeneous phage particles of the individual domains 
showed that the J2 domain has the strongest binding affinity towards 5A4 proteins followed 
by J4 domain. The relative binding affinities of other domains were significantly reduced 
compared to J2 domain (Figure 8B). To further delineate the epitope, sub-domains within 
J2 domain could be used for phage ELISA and mutagenesis of residues within the sub-
domains could pinpoint the important residues within the epitope. 
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Discussion 
Arabidopsis CRINKLY4 (ACR4) is a plant receptor like kinase with critical role in 
the overall development of the entire plant [16,17,21,31,32]. ACR4 regulates the columella 
stem cell differentiation in the root apical meristem and lateral root formation in the 
developing root, affects the epidermal cell morphology and formation in leaves, ovules, 
sepal margins, seed coat development. Arabidopsis genome encodes more than 600 RLKs 
[33], with four architecturally similar homologs of ACR4 RLK with high sequence 
similarity [17]. Recent advances in understanding the ACR4 signaling and the interactome 
have come from genetic, in-silico and in vitro studies  [19]. In an earlier report, we 
described its regulatory interaction with a downstream phosphatase PP2A3c [19]. It is 
apparent that the RLK is important in cell fate specification; however, an overall 
understanding at a biological level is quite limited. In vitro studies complemented with in 
planta and structure-function findings can provide valuable information about ACR4 
signaling. 
In this study, we report development of a highly specific monoclonal antibody 
(5A4) against the intracellular domain of ACR4 and identified its potential epitope on 
ACR4. Monoclonal antibodies are extremely important tool and have been widely used 
both in planta and in vitro studies. In-planta, 5A4 mAb can be utilized to dissect novel and 
existing protein-protein interactions by immunoprecipitation.   
  The cellular localization of endogenous ACR4 protein and recombinantly 
expressed ACR4 in transgenic lines can be visualized by fluorescently labeling the 
monoclonal antibody with organic dyes, fusion with fluorescent proteins such as GFP or 
phycobiliproteins or by quantum dots. In an earlier report, we established interaction 
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between ACR4 and PP2A3c in planta, by using fluorescently labeled epitope tagged 
ACR4 (ACR4: YFP: HA) to co-immuno precipitate PP2A3c (FLAG-PP2A3c) in 
transient expression lines in Nicotiana benthamiana [19]. However, the ACR4 is an over 
expressed version of a fluorescently tagged protein and does not represent the 
endogenous, native protein. With the generation of a monoclonal Ab against ACR4, with 
no cross-reactivity against the homologs with any other protein related (homologs) or an 
unrelated RLK, it is feasible to perform endogenous protein localization and immune-
precipitation to identify interacting partners.  
Monoclonal antibodies have been routinely used as probes to determine structure 
and function. Structure analysis of Na+/H+ anti-porter NhaA from E.coli [34] and crystal 
structure of cyclic AMP –dependent protein[4,35] have been reported in past which utilized 
monoclonal antibodies. The kinase structure of ACR4 is modeled against Interleukin-1 
receptor associated kinase used as template [36]. With the availability of ACR4 specific 
mAb, crystallization of ACR4 kinase domain can now be attempted. Structure-function 
studies will provide more in-depth understanding of the mode of ACR4 activation, auto-
phosphorylation mechanism and interaction with other proteins. 
 We mapped the potential epitope of 5A4 by means of phage ELISA assay and 
epitope was further narrowed down to the 531-616 amino acid sequence within the 
intracellular domain. However, this is 85 amino acid long region and our future studies are 
directed towards sub-cloning smaller sections within this region and narrowing down the 
epitope. A more comprehensive understanding of the binding motif will be analyzed by 
phage panning of the sub-domain library against a randomized peptide library. 
Mutagenesis of individual amino acid within the identified consensus motif (potential 
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epitope) will provide a better understanding of interaction between epitope and mAb at a 
single residue level. 
In conclusion, the developed highly specific monoclonal antibody will serve as an 
important reagent for both in planta and in vitro studies for researchers around the globe 
working towards a better understanding of ACR4 mediated signaling. 
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Figure 1: Schematic describing the screening and selection of the hybridoma 
supernatants. 
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Figure 2: Purification of Monoclonal Antibodies from supernatant by Ammonium 
sulfate precipitation. 5 µg of purified antibodies separated on a 12 % SDS PAGE gel 
and Coomassie stained. The two prominent bands at 50 kDa and 25 kDa represent the 




Figure 3: Absorbance spectra scan for purified 5A4 monoclonal antibody. A UV scan 
(210 nm- 310nm) was performed. The concentration of monoclonal was calculated from 
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divided by % extinction coefficient of 1.36. The concentration (mg/ml) and the A280 




Figure 4: Saturation curve for purified 5A4 monoclonal antibody 1:5 dilution of 5A4 
was further serially diluted (1:2 -1:64) in PBS buffer. The absorbance of the end-product 
(pNPP) obtained after ELISA was read at 405nm. O.D reading at each concentration was 
used to generate the scatter plot to obtain saturating dilution. Saturating concentration was 
obtained by extrapolating the absorbance value and the corresponding dilution from the 
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Figure 5: Cross-reactivity of monoclonal Antibodies. Binding specificity of each 
monoclonal towards ICDs of SUMO fused ACR4 (sACR4), ACR4 homologs (sCRK1, 
sCRR1, sCRR2, sCRR3, sCLV1) and sCLV1 along with control SUMO protein was 
determined by ELISA. (A) All antibodies cross- react with SUMO protein and hence 
cross react with SUMO-tagged RLK, except 5A4 which binds specifically to ACR4 (red 
circle) and does not cross reacts with SUMO protein or any other protein. (B) Absorbance 
measurements at 405 nm plotted as bar graph. Red arrow indicates specificity of 5A4 
against ACR4 Red box has its corresponding absorbance.   
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Figure 6: Specificity of 5A4 towards intracellular domain of ACR4. Ni-NTA purified 
SUMO fused proteins, along with SUMO-free ACR4 and control SUMO protein separated 
on a 12% SDS-PAGE gel (left) and the specificity of 5A4 towards ACR4 was analyzed by 
western blot analysis (right) using 1:400 dilution of 5A4 as primary antibody and 1: 10000 
dilution of alkaline phosphatase conjugated anti-mouse IgG secondary antibody (sigma) 
followed by detection by AP substrate kit. 
    A      B 
      
Figure 7: Cross reactivity of 5A4 against naïve ACR4 and auto phosphorylated 
ACR4(pACR4) demonstrated by (A) western blot analysis; (B) ELISA with control 
SUMO protein. Auto phosphorylated ACR4 was produced as described in Meyer et al [24]. 
The absorbance values at 405nm are plotted as a bar graph ± standard deviation.  
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Figure 8: Epitope mapping by Phage ELISA. (A) Overlapping domains (J1-J5) of 
intracellular domain used to generate phage particles displaying each domain 
homogenously. (B) 1 µg of 5A4 was coated on microtiter plate and incubated individually 
with 1 X 1012 phage particles expressing each domain. Maximal binding of 5A4 was with 
J2 domain.  PP2A3c (domain) phage and helper phage used as negative controls, showed 
no binding towards 5A4 Reactions were performed in triplicates (top); Bar diagram 
showing quantification of phage binding, absorbance reading corrected for negative control 
(helper phage) ± standard deviation. 
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Table 1:   The concentration (mg/ml), absorbance A280, & saturation dilution of purified 








10E12 1:10 0.5 3 1:200 
4E6 1:30 1.5 28.5 1:600 
4F7 1:15 0.57 4.75 1:200 
2B7 1:10 0.69 3.45 1:200 
6F9 1:5 1.45 4.5 1:50 
2A3 1:10 0.85 4.7 1:200 
2B6 1:5 1.65 5.45 1:200 
7A4 1:15 0.82 7.6 1:100 
5A4 1:5 1.92 6.65 1:200 
7B2 1:10 0.78 5.14 1:10 
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10E12 G1, Kappa 
4E6 G1, weak G2b, Kappa 
4F7 G2a, weak G2b, Kappa 
2B7 G2b, M Kappa 
6F9 G1, weak G3, M Kappa 
2A3 G2b, M Kappa 
2B6 G2b, Kappa 
7A4 G1, G2b, Kappa 
5A4 G1, Kappa 
7B2 G1, G2b, Kappa 
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Table 3: The sequence of overlapping domains of ICD of ACR4, with the respective 
sequence of forward and reverse primers used for PCR amplification. 
 




Forward Primer GCAGCGGCAGGCCCAGCCGGCCAGGTACAGATTGAGGAATTGTA 
Reverse Primer GCGGCAGCGGCCGCGGTTCCATCTCTCAGTACTC 
 





Forward Primer GCAGCGGCAGGCCCAGCCGGCCCTGAGAGATGGAACCACTGT 
Reverse Primer GCGGCAGCGGCCGCTCTTTTGACCCAATCTAGTTG 
 





Forward Primer GCAGCGGCAGGCCCAGCCGGCCGATTGGGTCAAAAGAGTAACG 
Reverse Primer GCGGCAGCGGCCGCGAGATAGTGAAGTCGATAGTACTC 
 





Forward Primer GCAGCGGCAGGCCCAGCCGGCCCGACTTCACTATCTCACAAC 
Reverse Primer GCGGCAGCGGCCGCTCTATCTTTCCCTCTCATTCT 
 




Forward Primer GCAGCGGCAGGCCCAGCCGGCCAGAGGGAAAGATAGACCATCA 
Reverse Primer GCGGCAGCGGCCGCGAAATTATGATGCAAGAACAAG 
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CHAPTER 6: CONCLUSIONS AND FUTURE WORK 
General Conclusion 
 
 In the past decade, studies have been increasingly directed towards mechanistic 
understanding of Arabidopsis CRINKLY 4 (ACR4) complemented by in planta studies. 
Collective in-silico, genetic and cell biology experiments have provided key in-sights 
towards the biological function of ACR4 in cell division and differentiation of root apical 
meristem [1,2,3,4].  Recent studies have described in vitro heteromeric interaction between 
the intracellular domains [3] (Figure 1) and potential homo dimerization interaction at the 
transmembrane level, within the ACR4 family members [5]. Additionally, transgenic lines 
with double and triple mutants within ACR4 family have displayed increased lateral root 
meristems suggesting functional redundancy within ACR4 family of RLKs [2,6]. Together, 
in vitro and genetic studies provide evidence of a concerted function within the ACR4 
family members at the membrane level.  Importantly, hetero-dimerization of ACR4 and 
CLAVATA1 (CLV1) has been shown to be a key interaction in the regulation of root 
meristem and restricting root stemness  [7]. However, not much is known about the 
downstream signaling partners of the ACR4 family, other than interaction of ACR4 with 
WOX5, [3,6]. The regulation of activated auto phosphorylated ACR4 and activated ACR4 
complexes is completely unknown.  
In this dissertation, I have built on this foundation in collaboration with plant 
biologists at University of Ghent, Belgium, to further understand the biological implication 
of our findings. The significant findings from each study is described chapter wise as 
follows:  
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CHAPTER 2: ACR4 interacts with PP2A3c. 
•   Identifies the catalytic subunit of Protein Phosphatase 2A-3 (PP2A3c) as the first 
reported substrate of ACR4 phosphorylation regulating formative cell division in root-tip 
and lateral roots.  
•   In vitro studies provide strong indication of a tight reciprocal regulation between 
PP2A3c and ACR4, wherein active PP2A3c has the ability to dephosphorylate ACR4 in 
vitro and ACR4 in-turn mediates phosphorylation of PP2A3c. 
•    In planta studies provide evidence of co-expression of PP2A3c and ACR4 in the 
columella root apical meristem and propose a mechanism of membrane localization of 
ACR4 coupled to dephosphorylation by PP2A3c, indicating the positive regulatory role of 
PP2A3c in ACR4 signaling. 
CHAPTER 3: Recombinant expression of PP2A3c in E. coli and its in-trans 
activation. 
•   The catalytic subunit of PP2A3c was expressed in prokaryotic (bacterial) 
expression system, with no known prior reports of successful expression of PP2A3c in E. 
coli. Milligram amounts of PP2A3c was obtained by expressing MBP-fused PP2A3c in E. 
coli. 
•   The E. coli produced MBP fused PP2A3c was inactive but a slow conformational 
change of MBP=PP2A3c is observed over a long period (16 h) of incubation at room 
temperature, and this is accompanied by regain in modest phosphatase activity against a 
synthetic phospho- peptide.  
•   Importantly, I provide evidence of significant in-trans activation of the inactive 
PP2A3c   by the chaperone Phosphatase 2A Protein Activator (PTPA) as demonstrated by 
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the dephosphorylation of radiolabeled ACR4.  
CHAPTER 4: Biochemical characterization of AtCRK1 and its interaction with 
PP2A3c 
•   I have characterized the biochemical properties of the intracellular domain of CRK 
and demonstrated the phosphorylation of Ser, Thr and even Tyr residues by mass 
spectrometry. 
•   I also demonstrate the interaction between PP2A3c and CRK1 by gel-filtration analysis 
and pull-down assays and suggest that there may be an analogous mechanism to that 
attributed to ACR4 
CHAPTER 4:  Monoclonal Antibody specific to ACR4 intracellular domain. 
•     I describe the development and characterization of a monoclonal antibody that will 
likely be an invaluable in the identification of novel and existing interactions of ACR4 both 
via in-planta and in-vitro studies.  
Future Work 
Role of post-translational modifications  
  The catalytic activity of PP2A3c and the assembly of the phosphatase holoenzyme 
is regulated through an array of post-translational modifications.  In my studies, I have 
described a method to produce adequate quantities of PP2A3c that could provide a template 
for understanding the molecular basis of catalytic activity and a stepwise examination of 
the PTMs in vitro. In vitro, ACR4 phosphorylates PP2A3c at nine residues (Chapter 2). 
Currently, we do not know the relevance of these phosphorylation sites with respect to 
interaction and role of these phosphorylation sites towards phenotype of the plant. I also 
identified phosphorylation at Y311 in the conserved C-terminal tail of C subunit (Chapter 
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3), which is reported to be inhibitory in mammalian systems [8,9]. However, my 
mutagenesis studies were not corroborative this and thus needs to be studied in future. 
    The recombinant expression of PP2A3c in baculovirus insect cell expression system 
generated active C subunit, with methylation at the conserved C-terminal Leucine residue, 
although not to a large extent (Figure 3C, Chapter 3). At this point, we do not have a good 
understanding of whether the methylation at C-terminal leucine is driving the production 
of active PP2A3c in insect cells or endogenous activation chaperones or other unknown 
factors guide the active conformation of C subunit and needs to be further investigated. 
Alternatively, I propose that the role of leucine methylation can be investigated by in-trans 
methylation of inactive or partially active C subunit in vitro, by means of Leucine Carboxyl 
Methyl Transferase (LCMT-1) in presence of S-Adenosyl methionine (SAM).  
Atomic level understanding of PP2A3c activation. 
My studies have shown a slow conformational change accompanied by mild yet 
measurable phosphatase activity, in absence of PTPA (Chapter 3). It will be interesting to 
investigate the difference in conformation by biophysical techniques, including NMR. My 
studies also indicate 35-40% regain in phosphatase activity of PP2A3c by PTPA activation 
chaperone (Figure 10, Chapter 3). PTPA is reported to be ATP dependent  [10] in addition 
to prolyl cis-trans isomerization activity [11], together coordinating the activation of 
inactive C subunit. I have proposed a similar mode of activation of PP2A3c by PTPA. 
However, at this point it is not clear if PTPA isomerizes the conserved Proline 190, as 
reported for mammalian PP2A or isomerization occurs at a different proline residue. 
Mutagenesis studies in the future can provide more in-sights towards this activation. 
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Role of other subunits of PP2A phosphatase 
The catalytic subunit is a part of the heterotrimeric PP2A holoenzyme that includes, 
a conserved ~65 kDa structural scaffold ‘A’ subunit that forms a PP2A core enzyme, and 
a variable B subunit that determines substrate specificity and cellular localization of PP2A  
[12,13,14].  With contradictory reports explaining inactivity of C subunit and the sequential 
order of active holoenzyme assembly, it will be interesting to understand the biogenesis of 
recombinant active holoenzyme assembly in E. coli. Our initial attempts to co-express A 
and C subunit in E. coli, strongly imply the additive role of A subunit in stabilizing the 
dynamic nature of C subunit. Future studies directed towards co-expression of A, B and C 
subunit in presence of PTPA chaperone could invoke a better understanding of active PP2A 
holoenzyme assembly.  
 Various in-planta studies have pinpointed the role of different isoforms of A, B and 
C subunits individually [15, 16,17,18, 19, 20, 21]. With such  mounting evidence of each 
subunit driving distinct biological function, it will be worth investigating the interaction of 
ACR4 kinase with other subunits of PP2A phosphatase and determine the physiological 
effects of these interactions. It may be possible to tailor specific combinations of 
heteromers influencing new signaling pathways and phenotypes. 
Role of phosphorylation sites on kinase activity of CRK1. 
In this dissertation, I provide evidence of intra-molecular auto phosphorylation 
mechanism of recombinantly produced intracellular domain (ICD) of CRK1, a homolog of 
ACR4, and identified several (~40) phosphorylation sites (Chapter 4). It is challenging to 
delineate the role of each phosphorylation site influencing ACR signaling, but it will be 
particularly interesting to examine the biochemical and physiological role of the four sites 
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of phosphorylation within the juxta membrane domain (JMD) of CRK1 vis-à-vis the 
reported importance of the phosphorylation sites in the JMD of ACR4 and other RLKs 
[22,23,24]. Intriguingly, I also identified eight phosphorylated tyrosine residues in CRK1 
and the mutagenesis of these residues could be revealing of CRK1 kinase activity, its 
interaction with ACR4 and downstream PP2A phosphatase.  
Interactions of CRK1 with ACR4 and PP2A3c. 
Earlier reports have reported a potential mechanism of inter-molecular interaction 
of ‘KDSAF’ motif in CRK1/CRR3 and ‘LLSLL’ region of ACR4 [3]. Interestingly, PP2A3 
catalytic subunit has a LLXXL motif, that is known to be a protein-protein interaction 
motif, and it will be interesting to investigate if ACR4 and CRK1 interact with LLXXL 
motif of PP2A3c. The precise role of individual residues within the interacting motifs needs 
to be studied in vitro in parallel with phenotypic consequence of these mutations in planta.  
 In chapter 4, I provide evidence of an interaction of CRK1 with PP2A3c (Figure 1 
& 8) and radioactive kinase assay indicated PP2A3c as downstream substrate for CRK1 
much like ACR4. However, the in vivo regulation of CRK1 kinase activity by PP2A3c is 
yet to be determined. More detailed mechanistic understanding of the interactions between 
PP2A3c, CRK1 and ACR4 can be provided by various biochemical and biophysical 
techniques such as alanine scanning, H-D exchange and NMR studies. Ultimate 
understanding of CRK1 activation and interaction with ACR4 and PP2A3c can be 
established by developing a three-dimensional structure. Additionally, much like ACR4 
interactome study described in Chapter 2, a CRK1 centered interactome study using 
complementary proteomic approaches may identify novel interacting partners common to 
ACR4 and CRK1 or unique to CRK1.  
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Outstanding questions of ACR4 family of RLKs. 
 In-planta knock out studies complemented with various proteomic approaches have 
provided a substantial information of the biological role of ACR4 driving stem cell 
differentiation in root tip [6] and proper differentiation of epidermis in vegetative and 
reproductive tissues, but other than functional redundancy within in ACR4 family 
members, no biological role of CRK1 kinase has been reported yet and hence it will be 
interesting to explore the role(s) of CR4 family members and assess the extent of their 
evolutionary conservation relative to their function. 
While ACR4, CRK1 and other members of the ACR4 family possess an 
extracellular ligand binding domain, other than a postulation by Stahl et al [6] that CLE40, 
a member of a class of hormone peptide, up regulates the expression of ACR4, and  
downstream activation of the transcription factor WOX5, there is no conclusive 
biochemical data supporting this hypothesis. Interestingly, expression of CRK1 is reported 
to be negatively regulated by the plant hormones auxin, ABA, and cytokinin [25]. 
Contradictory to negative regulation of CRK1 by cytokinin, cytokinin deficient plants 
display reduced ACR4 expression [26], with ACR4 not being a primary cytokinin response 
gene. It is possible that the members of ACR4 family are activated by different ligands and 
hence it will be interesting to determine not only the potential individual ligand(s) but also 
if ligand binding is mediated by singular RLK or homo/heteromeric interaction of RLKs.   
The interaction of ACR4 outside of the ACR4 family members has been recently 
reported, with evidence of dimerization of ACR4 with CLAVATA1 (atypical RLK) [7] 
and a phosphorylation driven dimerization with ABNORMAL LEAF SHAPE 2 (ALE2) 
[27]. Such studies provide a strong basis to further investigate the potential network of 
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interactions of ACR4 and homologs in plant growth and development and advance 
knowledge-based manipulation of signaling pathways for improved crops. 
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Figures 
 
Figure 1: Heteromeric interaction within the intracellular domain of ACR4 and its 
homolog proteins (CRRs). 
